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ABSTRACT 
Autophagy is a catabolic process that is important for degradation of cellular components, and for 
cell survival, and has also been associated with pathological disorders and tumour growth. 
Autophagy is a complex process; many factors and messengers converge to control steps along the 
autophagic pathway. Ca2+ has been proposed to regulate autophagy. However, Ca2+ has been 
proposed to be both pro- and anti-autophagic. To better understand how Ca2+ has these opposing 
effects, this study investigated in what ways particular sources of Ca2+, and the characteristics of 
Ca2+ signals impacted on autophagy. The fundamental need for Ca2+ in the activation of autophagy 
was demonstrated by loading cells with an exogenous Ca2+ buffer, which prevented various stimuli 
from triggering autophagy.  
Autophagy could be activated by inhibiting the transfer of Ca2+ from the endoplasmic reticulum to 
the mitochondrial matrix. This was achieved by expressing an enzyme that prevented Ca2+ release 
from inositol 1,4,5-trisphosphate receptors, inhibition of mitochondrial respiration, and knockdown 
of the mitochondrial Ca2+ uniporter. The triggering of autophagy under these conditions was due to 
reduced cellular ATP levels. These data suggest that Ca2+ signals arising from InsP3Rs suppress 
autophagy.  
Additional studies used a well-characterised Ca2+ transport pathway to generate cellular Ca2+ 
signals, and examined their ability to trigger autophagy. This pathway, known as ‘store-operated 
Ca2+ entry’ (SOCE), was activated by depleting endoplasmic reticulum Ca2+ stores using inhibitors of 
sarco/endoplasmic reticulum ATPases (SERCA). It was found that sustained cellular Ca2+ signals 
arising via chronic inhibition of SERCA were pro-autophagic. The activation of autophagy absolutely 
required the presence of extracellular Ca2+, and was not due to cellular stress. Using 
pharmacological inhibition of various Ca2+-sensitive kinases, it was found that at least part of the 
autophagy that occurred during SOCE was due to activation of Ca2+/calmodulin-dependent kinase 
kinase-β (CaMKK-β, also known as CaMKK-2). 
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ABBREVIATIONS 
 
AA: Arachidonic acid 
AMPK: AMP-activated protein kinases 
2-DG: 2-Deoxy-D-glucose 
2-APB: 2-Aminoethyl diphenylborinate 
Atg: Autophagy related gene 
ATP: Adenosine triphosphate 
BAPTA-AM: 1,2-bis-(o-aminophenoxy)-ethane-N,N,N′,N′- tetraacetoxymethyl ester  
Bax: Bcl-2-associated death promoter 
Bcl-2: B-cell lymphoma 2 
Bcl-xL: B-cell lymphoma-extra large 
Bid: BH3 interacting domain death agonist 
Ca2+: Calcium 
cADPR: cyclic ADP ribose 
CaM: Calmodulin 
CaMKK-β:  Ca2+/calmodulin-dependent kinase kinase-β 
CICR: Ca2+-induced Ca2+ release 
CPA: Cyclopiazonic acid 
CQ: Chloroquine 
CRAC: Ca2+ release-activated Ca2+ 
CytC: Cytochrome C 
DAG: Diacylglycerol 
DAPK: Death associated protein kinases 
DMSO: Dimethyl sulphoxide 
DNA: Deoxyribonucleic acid 
EGTA: Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid 
ER: Endoplasmic reticulum 
ERAD: Endoplasmic reticulum associated degradation 
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ETC: Electron transport chain 
Fura-2: Fura-2-acetoxymethyl ester 
GFP: Green fluorescence protein 
GPCR: G protein-coupled receptors  
HCQ: Hydroxychloroquine 
HEK: Human Embryonic Kidney 
HeLa: Henrietta Lacks 
IMM: Inner mitochondrial membrane 
InsP3: Inositol 1,4,5-trisphosphate 
InsP3R: Inositol 1,4,5-trisphosphate receptors 
LC3: Microtubule-associated protein1 light chain 3 
 
MAM: Mitochondria-associated (ER) membranes 
 
MCU: Mitochondrial Ca2+ uniporter 
MEF: Mouse embryonic fibroblast 
 
MP: Methyl pyruvate 
MPT: Mitochondrial permeability transition 
MPTP: Mitochondrial permeability transition pore 
mTOR: Mechanistic target of rapamycin 
mTORC1: Mechanistic target of rapamycin complex I 
NAADP: Nicotinic acid adenine dinucleotide phosphate 
NCX: Na+/ Ca2+exchanger 
NEAA: Non-essential amino acids 
NMDAR: N-methyl-D-aspartate receptor  
OMM: Outer mitochondrial membrane 
PCD: Programmed cell death 
PE: Phosphatidylethanolamine  
PERK: (PKR)-like ER kinase 
PI3K: Phosphoinositide3-kinase 
PKC: Protein kinase C 
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PLC: Phospholipase C 
PMCA: Plasma membrane Ca2+-ATPase 
PTP: Permeability transition pore 
Rhod-2: Rhodamine based Ca2+ indicator 
ROS: Reactive oxygen species 
RyR: Ryanodine receptor 
SERCA: Sarcoplasmic reticulum/ER Ca2+ ATPase 
SMOC: Second messenger-operated Ca2+ 
SOC: Store operated channels 
SOCE: Store operated Ca2+ entry 
STIM1: Stromal interaction protein 1 
STIM2: Stromal interaction protein 2 
Tg: Thapsigargin 
TPC: Two-pore channel 
TRPC: Transient receptor potential cation channels 
ULK1: Unc-51-like Kinase 1 
UPR: Unfolded protein response 
UPS: Ubiquitin-proteasome system 
VDAC: Voltage-dependent anion channel 
VOC: Voltage-gated operated channels 
 
 
 
 
 
 
 
 
18 
 
Chapter 1. Introduction 
Intracellular ionised calcium (Ca2+) is critical throughout the life and death of a cell [1, 2]. 
Whether in plants or animals, Ca2+ has an important role for growth, development and 
survival. In plants, Ca2+ has a structural role in the cell wall and membranes [3]. In animals, 
Ca2+ has a range of roles as an intracellular messenger controlling diverse processes such 
as fertilisation, muscle contraction, and cell fate [1, 4]. Additionally to its role as an 
intracellular messenger, Ca2+ can also act as an extracellular ‘first messenger’ through the 
Ca2+-sensing receptor (CaSR), a family of G-protein-coupled receptors [5]. 
This project, entitled ‘The Role of Ca2+ Signalling in Autophagy’, aims to understand the 
regulation of autophagy (a cell survival process) by cytosolic and mitochondrial Ca2+ signals. 
Specifically, the project sought to develop an understanding of the spatial and temporal 
characteristics of Ca2+ signals that affect autophagy in mammalian cells, and to characterise 
the relevant sources of Ca2+ that lead to the generation of these Ca2+ signals.  
In 1993, Gordon et al. were the first to show a link between autophagy and intracellular 
Ca2+ [6]. Their study demonstrated that both a decrease as well as an increase in cytosolic 
Ca2+ levels was effective in inhibiting autophagy in rat hepatocytes. The study by Gordon et 
al., was the first to hint at a complex role for Ca2+ in autophagy regulation. Subsequently,  
many studies have reported Ca2+ to have an inhibitory role in autophagy, while many others 
have suggested that Ca2+ activates autophagy [7]. Despite these contrasting views, there is 
clear evidence that Ca2+ plays a role in the regulation of autophagy. It is possible that 
autophagy regulation occurs by a variety of mechanisms [8].  Understanding the spatial and 
temporal characteristics of Ca2+ signals involved in the induction and inhibition of 
autophagy is key to resolving some of the apparently contradictory conclusions presented 
in the published literature. Studying the role of Ca2+ channels and sources involved in 
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autophagy further will hopefully contribute to the understanding of autophagy regulation 
during disease.  
Defects in autophagy are linked to a variety of pathological conditions such as cancer and 
Alzheimer’s disease (AD) [9, 10]. The role of Ca2+, and Ca2+-permeable channels, is quite 
well understood in cancer, however the regulation of autophagy in this context is a subject 
of intense current research [8]. Many clinical trials (over twenty) have assessed the efficacy 
of the autophagy inhibitors chloroquine and hydroxychloroquine (HCQ) in treating 
different cancers; either as a monotherapy, or in combination with other anticancer agents 
[11] [12]. The preliminary results of many of these trials show apparent antitumor activity. 
For example, HCQ (either alone or in combination therapy with tamoxifen), enhances 
tumour shrinkage  [13]. However, these autophagy inhibitors are not specific and can give 
rise to unexpected side effects in patients. Therefore, more specific and potent autophagy 
inhibitors are could prove useful in a therapeutic context. Understanding whether, and in 
which situations, Ca2+ signalling stimulates or inhibits autophagy may provide a novel 
approach to treat cancer, and other diseases [8]. Ultimately, it may be plausible that 
particular Ca2+ channels or Ca2+ stores can be new targets for autophagy regulation in 
disease. 
1.1 Ca2+ is a universal and versatile messenger within cells 
The ability of Ca2+ to regulate a diverse range of cellular functions is partially due to the fact 
that cells can modulate Ca2+ changes in the context of space, time and amplitude. This is 
known as spatio-temporal patterning [14]. Fluxes of Ca2+ perpetually occur between the 
cytoplasm and intracellular Ca2+ stores such as the endoplasmic reticulum (ER), 
mitochondria, the nucleus, the Golgi and endosomal organelles such as lysosomes [15]. 
Communication between organelles can be bidirectional, for example Ca2+ can be 
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transferred from the ER to lysosomes and vice versa, or between the ER and mitochondria 
and vice versa [16-18]. This coordinated signalling allows the cell to respond to both 
internal stimuli (e.g., messengers such as InsP3 and cADPR) and external stimuli (e.g., 
membrane depolarisation and extracellular agonists) [19].  
At rest, cells have an average cytosolic Ca2+ concentration of around 100 nM [20]. Following 
exposure to various physiological stimuli, the cytosolic Ca2+ concentration can rise to as 
high as 1 µM. In the immediate vicinity of open Ca2+ channels, the local Ca2+ concentration 
may reach tens or hundreds of micromolar. The process of triggering a cytosolic Ca2+ signal, 
effecting a change in cell behaviour and subsequent recovery to the basal state, can be 
divided into four stages: 1) exposure to trigger stimuli and signal generation 2) activation 
of ON mechanisms 3) activation of Ca2+-sensitive processes, and 4) action of OFF 
mechanisms that remove Ca2+ from the cytosol [14]. 
Trigger stimuli take many forms, including hormonal agonists, neurotransmitters and, 
growth factors as well as physical stimuli such as mechanical deformation of cell 
membranes, heat, osmotic changes and variations in pH [1, 21] . Induction of cytosolic Ca2+ 
signals can occur through a variety of mechanisms. Such mechanisms include the 
production of intracellular messengers and the direct activation of cation channels [14]. 
The release of Ca2+ from intracellular stores and Ca2+ entry from the extracellular space are 
common ways in which cells generate Ca2+ signals. The main Ca2+ store in non-excitable cells 
is the ER, and when depleted the ER is replenished by Ca2+ entry [22]. The release of Ca2+ 
from intracellular stores occurs as a result of the generation of Ca2+ ‐mobilizing messengers. 
Although a number of such messengers have been proposed, the four most prominent and 
clearly established are: inositol 1,4,5‐trisphosphate (InsP3), cyclic ADP ribose (cADPR), 
nicotinic acid adenine dinucleotide phosphate (NAADP), and Ca2+ itself [19]. InsP3 can be 
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hydrolysed to inositol 1,4-bisphosphate (InsP2) by a 5’-phosphatase enzyme, thereby 
preventing further Ca2+ release. Alternatively, InsP3 can be phosphorylated by a 3-kinase 
enzyme producing inositol 1,3,4,5-tetrakisphosphate (InsP4), which has been suggested to 
modulate ion channel activity [23] [24]. cADPR releases Ca2+ via the activation of ryanodine 
receptors (RyRs), although some alternative effects of cADPR on Ca2+ ATPases have been 
proposed [25]. Moreover, detectable levels of cADPR seem to exist in cells that do not 
express RyRs. These data may indicate that cADPR is a relatively constant endogenous 
regulator of Ca2+ ‐signalling or that it has cellular functions other than Ca2+ release [26]. The 
breakdown product of cADPR is ADP ribose (ADPR), which does not appear to mobilize Ca2+ 
however has been suggested to modulate events that occur during fertilisation [27] [28]. 
ON mechanisms are those vital for generating Ca2+ signals and depend on channels located 
in the membrane of the internal stores or in the plasma membrane. ON mechanisms result 
in Ca2+ flow into the cytoplasm, increasing its concentration and establishing a Ca2+ signal. 
Although Ca2+ signals are derived from messengers mentioned above, a major route of Ca2+ 
entry acting as an ON mechanism is via store-operated calcium entry (SOCE) (discussed in 
more detail in Chapter 5. Ca2 itself regulates InsP3 receptor (InsP3R) activity in a biphasic 
manner; low concentrations of Ca2+ (100–300 nM) are stimulatory but higher 
concentrations (> 300 nM) are inhibitory and switch the channel to an off-state [29]. 
Additionally, voltage-operated channels (VOCs) and receptor-operated channels (ROCs) are 
channels that open upon exposure to external stimuli and are discussed in detail in section 
1.2.3 and 1.2.4. Most of the Ca2+ that enters the cytoplasm binds quickly to many cytosolic 
buffers such as parvalbumin, calbindin-D28K and calretinin, as well as proteins such as 
calmodulin that are involved in transducing the effects of Ca2+ [14].  
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Following the generation of a Ca2+ signal, a range of processes take place to translate this 
Ca2+ signal into a cellular response. Ca2+-binding proteins respond to an increase in Ca2+ by 
undergoing conformational changes which further enable them to activate downstream 
effectors [30]. Classical sensors include calmodulin (CaM) and troponin C (TnC), which bind 
Ca2+ through EF hands. CaM is involved in the regulation of various processes including 
smooth muscle contraction, metabolism and gene transcription [31] whereas TnC is 
responsible for muscle contraction [20]. 
OFF mechanisms are mechanisms that remove Ca2+ from the cytosol to restore the resting 
state. Once Ca2+ has carried out its signalling functions, it is removed from the cytosol by 
pumps and exchangers. The plasma membrane Ca2+ ATPases (PMCA) [32] and Na+/Ca2+  
exchangers (NCX) [33] remove Ca2+ to the extracellular space, whereas sarcoendoplasmic 
reticulum ATPases (SERCA) transports Ca2+ into the ER [34]. The NCX and PMCA have 
different kinetics; the NCX has a high transport rate but low Ca2+ affinity however the PMCA 
has opposite characteristics. The NCX also functions in a reverse manner, allowing Ca2+ 
entry from the extracellular space. The NCX only functions when there is an electrochemical 
Na+ gradient, and exchanges one for Ca2+ every three Na+. Both Ca2+ entry and exit is 
accelerated by phosphorylation of the enzyme [33]. Four PMCA isoforms have been 
identified. PMCA1 and PMCA4 are expressed in most tissues, whereas PMCA2 and 3 are 
found in a smaller number of tissues, such as the brain and striated muscle [35]. The 
distribution of different PMCA isoforms is thought to be inherently linked to the rate of 
Ca2+ clearance, for example fast pumps can be found in cells that generate fast Ca2+ 
transients [36].  
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Figure 1.1 Reproduced with permission from Nature Publishing Group: Berridge, 
MJ,Bootman, MD, Roderick, L. (2003) Calcium signalling: dynamics, homeostasis and 
remodelling. Ca2+ -signalling within the cell. In the ‘ON’ reactions, stimuli induce the entry 
of external Ca2+ as well as the formation of second messengers. Second messengers release 
internal Ca2+ stored in the ER/SR. Most of this Ca2+ (shown as red circles) is bound to buffers 
and only a small proportion binds to the effectors that trigger a variety of cellular processes. 
In the ‘OFF’ reactions, Ca2+ leaves the effectors and buffers and is removed from the cell to 
the outside by various pumps such as the Na+/ Ca2+ exchanger (NCX) and the plasma-
membrane Ca2+-ATPase (PMCA). The sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), 
however, pumps Ca2+ back into the ER. From: (Berridge et al., 2003). 
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1.2 Mechanisms and channels of Ca2+ entry and exit 
Ca2+ influx into the cell and its exit occur via channels located on the plasma membrane and 
organelles such as the ER, mitochondria, lysosomes and the Golgi. The major channels 
involved in Ca2+ signalling are described in this section. 
1.2.1 Store-operated Ca2+ entry (SOCE) 
SOCE is a major Ca2+ entry pathway, which is activated in response to depletion of the ER 
[37]. This mechanism of Ca2+ entry, through which intracellular Ca2+ stores are replenished, 
occurs in almost all cell types (with the possible exception of some electrically-excitable 
cells) [38]. SOCE is vital for short and long term physiological processes such as muscle 
contraction and cell cycle control [39] and the maintenance of Ca2+  signals such as the 
hormone-induced repetitive Ca2+  oscillations detected in non-excitable cells [40, 41].  
Following depletion of ER Ca2+ stores, stromal interaction protein 1 (STIM1), (a Ca2+ sensor 
on the ER membrane) accumulates at the ER-plasma membrane junctions.  STIM1 forms 
oligomers with, and activates, Orai Ca2+ channels on the plasma membrane [42] resulting 
in influx of Ca2+. Orai channels are well characterised Ca2+ release-activated Ca2+ (CRAC) 
channels in non-excitable cells [43-47]. STIM2 is another activator of Orai channels. It is a 
weaker and slower activator than STIM1, but has been suggested to be mainly responsible 
for maintaining intracellular Ca2+ store levels rather than SOCE activation, given that its EF-
hand has a lower affinity for Ca2+ [48]. Store-operated currents, Icrac, involve the STIM1 
activation of Orai channels. Mitochondria also have a vital role in the regulation of ICRAC and 
control a range of CRAC channel-driven responses including enzyme activation, 
intercellular communication through paracrine signals and gene expression [49]. Therefore 
a dynamic interplay exists between the ER, mitochondria and the plasma membrane.  
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Many studies on SOCE have used Ca2+ influx inhibitors such as 2-APB, SKF96365, or 
gadolinium [50]. Often these inhibitors lack specificity and exert effects on other cellular 
targets [51] [52]. The canonical transient receptor potential cation channels (TRPC) also 
have a role in SOCE in many cell types. TRPCs have been shown to cooperate in the 
development of beating in developing hearts [53]. Upregulation of TRPC expression 
correlates with increased SOCE and pro-arrythmic spontaneous Ca2+ waves [54]. 
Experiments have shown that cation influx via TRPCs takes place independently of Ca2+ 
store depletion and STIM1 expression [55]. Studies have also shown that TRPCs may be 
activated by STIM, and that STIM1, Orai and TRPCs act together to promote Ca2+ influx [56]. 
The action of this triad may result from Ca2+ entry through a STIM1-Orai interaction 
subsequently leading to the insertion of TRPC channels into the plasma membrane 
prolonging SOCE [57]. The interaction of STIM1, Orai and TRPCs results in a current termed 
ISOC. Both ISOC and ICRAC currents involve STIM1 and Orai isoforms [58]. 
1.2.2 Messenger-operated Ca2+ entry  
Messenger-operated Ca2+ entry is sometimes referred to as ‘second messenger-operated 
Ca2+ entry or SMOC. SMOC can be activated by cellular molecules such as arachidonic acid 
(AA). Studies by Shuttleworth and colleagues have demonstrated that AA activates a Ca2+ 
entry pathway that involves STIM1 and Orai channels in a different configuration to that 
required for SOCE. The current derived from AA-dependent activation of Orai channels is 
denoted IARC, and has been shown to be necessary for repetitive Ca2+ oscillations [59]. 
InsP3Rs, which are the central route of Ca2+ release from intracellular stores, are 
transmembrane proteins mostly located on the ER membrane [60] and are also found on 
the plasma membrane [61]. The receptors exhibit greater conductance than CRAC 
channels, which have a distinctive feature of a small unitary conductance [62].  
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1.2.3 Receptor-operated Ca2+ entry 
Receptor operated Ca2+ (ROC) entry involves channels which are non-voltage gated [63]. 
ROC is activated upon binding of an agonist to the extracellular domain of a Ca2+ channel, 
such as the N-methyl-D-aspartate receptor (NMDAR) [64]. Receptor activation can lead to 
Ca2+ entry into smooth muscle cells by mechanisms independent of membrane 
depolarization. ROC channels show varying degrees of Ca2+ selectivity [63]. 
1.2.4 Voltage-Operated Ca2+ channels 
Electrophysiological studies have indicated the existence of three types of Voltage-
Operated Ca2+ channels (VOC) - K+, Na+ and Ca2+ channels [65]. The function of VOC channels 
is closely connected with the activity of enzymes and phosphorylation of membrane 
proteins. Many types of VOC have been described in both the nervous system and 
peripheral tissues. Based on their pharmacological and biophysical properties, VOC have 
been classified into high voltage activated (HVA) and low voltage activated (LVA) channels. 
HVA channels require a relatively large depolarization to induce channel opening and 
typically open at voltages > –30 mV. LVA channels inactivate within ~100 ms in response to 
a step voltage change. LVA are fast-inactivating, slow deactivating channels that are initially 
activated at low holding potentials [66]. 
1.2.5 Plasma membrane Ca2+ ATPase 
Located on the plasma membrane, plasma membrane Ca2+ ATPase (PMCA) pumps extrude 
Ca2+ into the extracellular space against the electrochemical gradient. The PMCA is an 
important regulator of the Ca2+ concentration in the extracellular space [67]. Four genes 
encode the PMCA, PMCA 1-4 of which exist more than twenty splice variants [68]. PMCA 
constitute a minor component of the total protein of the plasma membrane (less than 
0.1%) [69].  
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1.2.6 Sarco/endoplasmic reticulum Ca2+ ATPase 
SERCA, a P-type ATPase, is responsible for re-establishing the low cytosolic Ca2+ 
concentrations, which are required for normal cell function [70]. There are three different 
SERCA isoforms, all of which located on the endoplasmic/sarcoplasmic membrane. Three 
genes encode SERCA; SERCA 1-3 all of which have splice variants [71]. SERCA pumps are 
responsible for removing Ca2+ from the cytosol and consequently replenishing Ca2+ levels 
in the ER [34, 72]. The function of the SERCA pump is modulated by endogenous 
phospholamban (PLB) and sarcolipin (SLN), which are expressed in cardiac and skeletal 
muscles [73]. Sequestration of Ca2+ occurs coupled with adenosine triphosphate (ATP) 
hydrolysis [74] and similar to PMCA, SERCA pumps have a low transport rate but high Ca2+ 
affinity [75], which enables them to respond to modest Ca2+ elevations.  SERCA pumps 
translocate two Ca2+ ions and hydrolyse one ATP for each catalytic turnover [75]. [76]. 
 
1.2.7 Na+/Ca2+ exchanger 
The Na+/Ca2+ exchanger (NCX) is found predominantly on the plasma membrane and 
mitochondria. It can also be found on the inner membrane of the nuclear envelope. The 
NCX extrudes Ca2+ to the extracellular space using the electrochemical gradient of Na+. 
During each cycle, three Na+ ions enter the cell and one Ca2+ ion is extruded against its 
concentration gradient [77, 78]. In mitochondria, the NCX pumps Ca2+ from the 
mitochondrial matrix into the cytosol. The NCX has a low affinity for Ca2+, but a high capacity 
for Ca2+  transport [79]. It is particularly abundant in excitable tissues such as the brain and 
the heart. The NCX is can also be regulated by pH, ATP, protein kinases such as PKA and 
Protein Kinase C (PKC) [32]. When mitochondria are in close proximity to the ER, Ca2+ 
release from NCX takes place quickly, otherwise the release takes place in a slower fashion 
[60]. A fast interchange of Ca2+ can also take place during apoptosis, when Ca2+ release from 
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the mitochondria is taken up by the ER quickly in order to potentiate apoptotic signals in a 
positive feedback manner. 
1.2.8 Secretory Pathway Ca2+-ATPases 
Secretory Pathway Ca2+-ATPases (SPCA) are localised to the Golgi body and transport Ca2+ 
ions from the cytosol to the lumen of the Golgi following a Ca2+ signal. This serves to reduce 
the cytoplasmic Ca2+ concentration to resting levels [80] [81]. Additionally, SPCAs also 
transport Mn2+ ions into the Golgi from the cytosol with high affinity, and thus have a role 
in the prevention of manganese toxicity [80]. Two isoforms exist, SPCA 1 and 2, of which 
SPCA1 has splice variants. Similar to SERCA and PMCA, SPCAs are members of the P-type 
family of ion pumps that require ATP for their function [75]. 
 
1.3 ER-Mitochondrial and lysosomal Ca2+ signalling  
The ER, mitochondria and lysosomes are major organelles involved in shaping Ca2+ signals 
that can trigger a range of cellular responses. Each organelle possesses Ca2+ channels 
responsible for uptake and/or release of Ca2+ and is recognised as a Ca2+ store. 
1.3.1 ER-Mitochondrial Ca2+ regulation 
The key determinants in mitochondrial Ca2+ uptake are the distance between the ER and 
mitochondria, the cytosolic Ca2+ concentration and the spatial and temporal properties of 
cytosolic Ca2+ signals [60]. As well as Ca2+ uptake from the ER, mitochondria can also take 
up Ca2+ from the extracellular space through the plasma membrane [82, 83].In the context 
of cell fate, one particularly important aspect of Ca2+ signalling is the flux of Ca2+ between 
the ER and mitochondria [60]. Within the cell, mitochondria are found in close proximity to 
the ER and there are contact sites between the two types of organelles [84, 85], termed 
mitochondria-associated (ER) membranes (MAMs) [86] [87]. The typical distances between 
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mitochondria and the smooth ER in a MAM is ~10-15 nm. Up to 20% of mitochondrial 
surfaces are in close contact with the ER [88]. ER stress causes an increase of the number 
of contact sites and the total length of MAMs [89, 90]. MAMs are important for a number 
of physiological processes; e.g. lipid synthesis, Ca2+ uptake into mitochondria, 
mitochondrial movement and fission, apoptosis, and autophagy [91-93]. Alteration of 
MAMs have been linked with a number of disease conditions, including cancer [94, 95] and 
neurodegenerative diseases such as Parkinson’s and amyotrophic lateral sclerosis [91, 92, 
96-99]. These points of contact means that Ca2+ signals arising from InsP3Rs and RyRs on 
the surface of the ER originate close to the sites of Ca2+ uptake into the mitochondria. They 
involve the 35kDa channel protein voltage-dependent anion channel (VDAC) in the OMM 
and the mitochondrial uniporter complex (MCU) in the IMM [89, 100].  
Mitochondria consist of two membranes, the outer mitochondrial membrane (OMM) and, 
the inner mitochondrial membrane (IMM) separated by an intermembrane space [89, 101]. 
The IMM has many folds in the matrix (cristae) which are the sites of ATP production [102].  
Mitochondria are capable of translating many extracellular stimuli into different 
intracellular actions, such as cell death and ATP production. They sequester Ca2+ rapidly 
during development of a Ca2+ signal and release it back slowly during the recovery phase 
[14]. These abilities mean that mitochondria are crucial to Ca2+ signalling within the cell; 
they have high Ca2+ buffering and storage capabilities and the ability to both remove and 
replenish cytosolic Ca2+ [103]. Although this function is highly important to Ca2+ signalling, 
the prime role of mitochondria is ATP production, which takes place through the 
tricarboxylic acid (TCA) cycle. The uptake of Ca2+ to the mitochondrial matrix is important 
for the activation of three dehydrogenases involved in the TCA cycle; pyruvate 
dehydrogenase, isocitrate dehydrogenase and 2-oxoglutarate dehydrogenase [104]. The 
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disturbance of mitochondrial Ca2+ homeostasis can contribute to a variety of pathological 
conditions. 
Factors such as Bcl-2 and NADH regulate VDAC [105]. The precise mechanisms of VDAC 
conductance are still under debate but studies have shown that VDAC are fully opened with 
high-conductance and weak anion-selectivity at low transmembrane potentials (< 20–
30 mV). However this switches to cation selectivity and lower conductance at higher 
potentials [106]. Once across the OMM, Ca2+ traffic across the inner mitochondrial 
membrane (IMM) takes place through an electrogenic transporter, termed the 
mitochondrial Ca2+ uniporter (MCU) that transports Ca2+   down the electrical gradient 
established by the respiratory chain. 
Ca2+ release from the ER generates global cytosolic Ca2+ signals that peak around 0.5 - 1 µM 
[18], but within the small volume of the MAMs, the local Ca2+ signal reaches around 5 – 10 
µM [107]. This Ca2+ concentration is sufficient to activate the MCU despite its relatively low 
affinity for Ca2+ (Kd 20 - 50 µM) [93]. Ca2+ that accumulates within the mitochondrial matrix 
is consequently released via the mitochondrial NCX and can be taken back up into the ER 
via SERCA pumps, in order to restore the ER Ca2+ levels [108]. Ca2+ cycling between the ER 
and mitochondria may be enhanced by mitochondrial production of reactive oxygen 
species ROS, which in turn sensitises the ER Ca2+ release channels [109].  
Mitochondria regulate the generation and characteristics of cytosolic Ca2+ signals [110-
113]. Chronic cytosolic Ca2+ signals (for example those arising as a result of cell stress or 
damage) can lead to prolonged mitochondrial Ca2+ uptake, and consequent activation of 
the mitochondrial permeability transition pore, swelling and rupture. Consequently, 
cytochrome C and other pro-apoptotic factors are released [93]. Dysfunctional or 
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depolarised mitochondria are removed by mitophagy (a selective type of autophagy) to 
prevent cellular damage [114, 115]. 
 
Figure 1.2 reproduced with permission from Elsevier: Raffaello, A, Mammucari, C, 
Gherardi, G, Rizzuto, R. (2016) Calcium at the Center of Cell Signaling: Interplay between 
Endoplasmic Reticulum, Mitochondria, and Lysosome. The ER Ca2+ Store and 
mitochondria signalling. Following ligand binding to a G protein-coupled receptor (GPCR), 
phospholipase C (PLC) is activated and triggers the production of inositol 1,4,5-
trisphosphate (InsP3) and diacylglycerol (DAG) from phosphatidylinositol 4,5-bisphosphate 
(PIP2). InsP3 binds to InsP3 receptors (InsP3Rs) at the ER surface releasing Ca2+ into the 
cytosol. Since the ER and the mitochondria are close to each other, high [Ca2+] 
microdomains, allow mitochondria to quickly take up Ca2+. Voltage-dependent anion 
channels (VDACs) are responsible for the rapid transfer of Ca2+ through the outer 
mitochondrial membrane (OMM) and then accumulation of Ca2+ in the mitochondrial 
matrix occurs via the mitochondrial calcium uniporter (MCU). Many proteins regulate ER–
mitochondria contact sites. Red dots are Ca2+. 
 
1.3.2 Lysosomal Ca2+ homeostasis  
Lysosomes are acidic organelles (pH 4.5-5) that play a central role in degrading and 
recycling macromolecules delivered by phagocytosis, endocytosis and autophagy. The 
degradative function of lysosomes relies on lysosomal hydrolases such as cathepsins [116]. 
32 
 
Lysosomal distribution has been shown to vary depending on nutrient availability; from a 
peripheral cellular location in nutrient-rich conditions to perinuclear clustering during 
nutrient starvation [117]. Aside from their role in degradative pathways, lysosomes are 
implicated in many cellular processes such as cell death and plasma membrane repair 
following cell injury.   
Lysosomes are also regarded as important intracellular Ca2+ stores [118, 119]. Within the 
endolysosomal system, Ca2+ is important for maintaining normal trafficking, recycling, and 
vesicular fusion events [120]. The Ca2+ concentration inside lysosomes can reach up to 600 
µM Ca2+ [121], a concentration similar to that of the ER and greater than the typical ER 
luminal Ca2+ concentration (~200-500 µM). Since the total volume of lysosomes in the cell 
is smaller than that of the ER, the amount of Ca2+ available for release from this store is 
lower than that from the ER. Therefore cytosolic Ca2+ signals arising from lysosomes are 
modest in comparison [120].  
Ca2+ can be released from lysosomes by a potent intracellular Ca2+ -releasing second 
messenger, nicotinic acid adenine dinucleotide phosphate (NAADP). The potential of 
NAADP to release Ca2+ was first demonstrated using sea urchin egg homogenates [122]. 
NAADP was later established as an intracellular messenger that acts upon stores other than 
the ER [123]. Ca2+ release by NAADP can be amplified by Ca2+ -induced Ca2+  release (CICR) 
from neighbouring RYRs and InsP3Rs [124]. Ca2+ released from the ER can also be taken up 
by the lysosomes, and the Ca2+ transfer between lysosomes and the ER is bi-directional [16]. 
This bi-directional communication is facilitated by the close proximity of the two 
organelles. Electron microscopy studies have shown that ~80 % of lysosomes in human 
fibroblasts are located less than 20 nm from the ER [125] , facilitating them functioning as 
a signalling microdomain. 
33 
 
It has been a matter of long debate which lysosomal Ca2+ channel NAADP acts upon. Most 
evidence shows that NAADP activates Ca2+ release via the two-pore channel (TPC) family of 
proteins [124]. It has been shown that NAADP does not directly bind to TPCs, but to 
currently unidentified small molecular-weight proteins which then modulates the TPC 
channel action [126]. However, other lysosomal Ca2+ channels have been discussed as 
target of NAADP. Besides TPCs, the main other lysosomal Ca2+ release channels are TRPML1 
(transient receptor potential cation channel) and TRPM2 [127-129]. TRPML1, the first Ca2+ 
channel identified on lysosomes, is sensitive to NAADP but studies have not fully confirmed 
this finding and so its regulation by remains poorly understood [130]. TRPM2s are mostly 
found in the plasma membrane where they are activated by NAADP [129], but can also be 
found on the lysosomes where they are activated by cytosolic ADP-ribose [131].  
TPCs are localised on endosomes and lysosomes, and do not bind directly to NAADP. Three 
TPC isoforms exist (TPC1-3) and have been shown to have different functions [132, 133]. 
TPC1 is important for endosomal trafficking to the Golgi, and TPC2 is important for 
endosomal trafficking to lysosomes [134]. TPC1 and TPC2 interact with a variety of proteins 
that are important for cellular Ca2+ homeostasis (e.g., Ca2+-binding proteins such as 
calreticulin and annexins, InsP3R-interacting proteins and STIM), and with trafficking 
regulators (e.g., Rab GTPases and syntaxins) [135]. Studies have also found that TPCs co-
immunoprecipitate with mammalian target of rapamycin (mTOR) [136], with evidence that 
mTOR binds to TPCs under nutrient-rich conditions consequently inhibiting channel 
opening. However, when cellular ATP concentrations are low, mTOR is released from TPCs 
consequently stimulating Ca2+ release. mTOR kinase activity is important for this effect but 
there is dispute about whether mTOR acts upstream of TPCs, as shown in myoblasts [137], 
or downstream of TPCs, as shown in macrophages [138]. TPCs also interact with leucine-
rich repeat kinase 2 (LRRK2), which can stimulate autophagy [136]. TPCs, and NAADP-
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induced Ca2+ release can increase both autophagy and apoptosis in cells overexpressing 
LRRK2 [138, 139]. 
Lysosomes are involved in a secretory pathway known as lysosomal exocytosis, common 
to all nucleated cell types [140]. Lysosomal exocytosis is important in many processes such 
as immune responses, cell signalling and plasma membrane repair [141]. Lysosomal 
exocytosis is a two-step process, where firstly lysosomes relocate from the perinucleus to 
the close vicinity of the plasma membrane [142]. At the plasma membrane the lysosomes 
fuse, firstly with each other then with the plasma membrane. This process takes place in 
response to a rise in intracellular concentration of Ca2+ [140]. ATP (found in large amounts 
in the lysosomes) is released to the extracellular space during lysosomal exocytosis [143] 
and participates in communication between cells which is mediated by a range of different 
ATP binding (purinergic) receptors [144]. 
Transcription factor EB (TFEB), a master gene important for the biogenesis of lysosomes, 
regulates lysosomal function in order to meet the need of degradation capacity. In nutrient 
rich conditions, mTOR is associated with the lysosomal membrane and interacts with TFEB 
to prevent its nuclear translocation. However in nutrient starvation conditions, mTOR-
dependent phosphorylation of TFEB is disrupted and TFEB is translocated to the nucleus to 
drive the transcriptional regulation of genes encoding proteins for autophagosome 
formation [145]. 
1.4 Autophagy 
Autophagy (derived from the Greek words auto, meaning "self" and phagein, "to eat", “self-
eating”), is a catabolic process by which cellular material is degraded. It is important in the 
maintenance of cellular homeostasis in eukaryotic organisms [146].  It is one of two main 
routes by which proteins are degraded within the cell, the other being the ubiquitin 
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proteasome system (UPS). The UPS deals with the rapid removal of short-lived proteins 
whereas, autophagy deals with long-lived proteins, organelles and non-protein targets 
(such as lipids, carbohydrate) [147] [148]. The UPS consumes ATP in the degradation 
process while autophagy generates energy from the degradation of macromolecules [148]. 
The generation of energy through autophagy is important in the maintenance of cellular 
homeostasis.   
1.4.1 Autophagy in the cell 
Autophagy occurs constitutively at basal levels in nutrient-rich, healthy cells, and is 
stimulated when cells are exposed to stressors. Basal and stimulated autophagy exhibit 
common characteristics, suggesting the same underlying mechanism [149]. Common 
cellular stressors include nutrient starvation, mitochondrial depolarization, toxic protein 
aggregates, infection and mechanical damage [150]. Depending on the nature and duration 
of the stress and the cell type, cells can display either protective or destructive autophagic 
responses [151]. The initial response of a cell to a stressful stimulus is often the promotion 
of pro-survival actions [151]. If these are unsuccessful, destructive pathways such as 
apoptosis, necrosis and pyroptosis are activated, which eliminate these damaged cells 
[151]. Autophagy is a key adaptive response to cellular stress, and is largely regarded as a 
pro-survival process, although it can lead to cellular demise. Autophagy can be divided into 
three types: macroautophagy, microautophagy and, chaperone-mediated autophagy. 
Within the literature, ‘autophagy’ usually refers to macroautophagy unless otherwise 
stated [152]. Macroautophagy, hereafter called autophagy, is the focus of this study. 
1.4.2 Mechanism of autophagy 
The process of autophagy involves the formation of a double membraned vesicle called an 
autophagosome, which encapsulates cellular components earmarked for degradation 
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[153-155] (Figure 1.3). The double membrane vesicle, resembling a ring-like structure, is a 
hallmark of autophagy and consists of two distinct lipid bilayers (one inner and one outer 
bilayer), where the source is still debatable [153-155]. This process is modulated by a family 
of proteins termed 'autophagy-related' proteins (Atgs). To date, over thirty Atg genes have 
been identified in yeast, the orthologues of which are well conserved throughout 
eukaryotes [156, 157].  
Autophagy induction takes place when signalling pathways trigger the formation of a 
membrane invagination described as an omegasome, mainly observed on the surface of 
the ER. However other membranes such as the plasma membrane have been shown to act 
as sites of initiation [158]. This structure enlarges into a phagophore (either independently 
of, or associated to, the ER) and targets cellular material in close proximity for digestion. 
The phagophore elongates and eventually forms the autophagosome [159]. The mature 
autophagosome then becomes acidified following fusion with a lysosome in a Ca2+-
dependent manner, to produce autolysosomes [160]. Unlike autophagosomes, 
autolysosomes are single-membrane vesicles [161].  The fusion unites the degradative acid 
hydrolases with the captured cell material. Following breakdown of the cellular material,   
nutrients such as amino acids and fatty acids are exported back into the cytoplasm by 
lysosomal permeases [162]. Autophagosomes, (which are neutral in pH) travel towards the 
smaller lysosomes (0.1 - 1.0 μm, compared to autophagosomes which are 0.5- 1.5 μm) 
[163]. Since lysosomes are smaller than autophagosomes, autolysosomes produced as a 
result of fusion undergo functional adjustments in order to maintain the acidic pH for their 
hydrolytic function to degrade contents [163]. However the exact mechanism of this 
functional adjustment is unknown. As with other intracellular trafficking events, 
autophagosomes move through cytoskeleton-dependent action. This movement involves 
microtubule-associated proteins such as LC3 and actin microfilaments. Interestingly, actin 
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filaments have been involved in selective types of autophagy in the yeast S. cerevisiae, but 
are not regarded as necessary for non-selective (bulk) autophagy in the same organism 
[164]. 
 
 
 
 
 
 
Figure 1.3 The process of autophagy from nucleation to degradation. The process starts 
with the formation of an isolation membrane, followed by the formation of a double 
membrane names the autophagosome which targets cellular constituents to be degraded. 
Following fusion with a lysosome, cell components in the autolysosome are degraded and 
recycled as nutrients and metabolites back into the cytosol. 
 
1.4.3 Core autophagy machinery 
Autophagy is involved in differentiation, development and tissue remodelling in various 
organisms [165]. It is upregulated in cells undergoing remodelling in the course of 
differentiation, and was first observed in newborn mice [166]. The morphology of 
autophagy was first characterized in mammalian cells, however, the molecular 
components involved in the regulation of autophagy were initially described in yeast [167-
169]. The Atg proteins involved in autophagy are frequently classified in six distinct 
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functional groups, which cooperate to perform important roles in the overall process 
(Figure 1.4).  The functions of these proteins are summarised below [156, 170]. 
First, UNC-51-like kinase 1 (ULK1, a yeast Atg1 homolog) stimulates autophagy by 
phosphorylating Beclin-1 and activating VPS34 lipid kinase. ULK1 is a stable cytosolic 
kinase complex comprised of ULK1, FIP200 (focal adhesion kinase family-interacting 
protein of 200 kDa), Atg13L and Atg101. 
Second, a pathway upstream of mTORC1 involves Vps34 (see section 1.4.4), or PI3-kinase 
(phosphoinositide 3-kinase, class III), which is a lipid kinase that is conserved throughout 
eukaryotes. The Vps34 kinase complex is comprised of Vps34, Vps15, Beclin-1 (see sections 
1.6.3 and 1.7), and Atg14 or UVRAG.  These proteins bind Beclin-1 exclusively. Since Beclin-
1 has a vital role in the induction of autophagy, it is often used as a marker of autophagy 
whereby its expression levels increase upon induction of autophagy [171, 172]. 
Third, Phosphatidylinositol 3-phosphate (PtdIns3P or PI3P) binding proteins are important 
in membrane dynamics and the regulation of trafficking. The majority of PI3P are 
connected with endosomal membranes and with the autophagosome preassembly 
machinery, most probably at the endoplasmic reticulum [173].  
Fourth is the Atg5-Atg12 ubiquitin-like conjugation system, including the E3-ligase-like 
complex comprised of Atg5-Atg12- Atg16L. The Atg5-Atg12 complex is involved with the 
expansion of autophagosomal membranes. 
Fifth is the microtubule-associated protein 1-light chain 3 (LC3) phosphatidylethanolamine 
(PE) conjugation system, where PE is conjugated to LC3 by the Atg5-Atg12- Atg16L complex. 
LC3 has been used as an autophagosome marker in autophagy studies, where cytosolic LC3-
I is transformed to a membrane-bound form, LC3-II [174] (see section 1.5). 
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Sixth, Atg9a is a multi-spanning transmembrane protein and the only transmembrane 
protein among the Atg proteins that is essential for autophagosome formation [175]. 
Figure 1.4 reproduced with permission from InvivoGen (www.invivogen.com): Core 
autophagy proteins involved in the different stages of the autophagy process. The ULK1, 
Atg13 & FIP200 complex forms to initiate phagophore formation. The Atg5-Atg12 complex 
is important in the elongation of the phagophore membrane. 
 
1.4.4 Control of autophagy by mTOR  
A major regulator for starvation-induced autophagy (in mammalian systems) is the mTOR 
pathway. mTOR is a highly conserved serine/threonine kinase with a large molecular size 
(c. 300 kDa). It belongs to the phosphatidylinositol kinase-related kinase (PIKK) family [176] 
and  is capable of responding to signals from many stimuli (including amino acids, oxygen, 
growth factors and stress) to coordinate cell growth and maintain metabolic homeostasis 
[177]. As mTOR has been linked to many cellular events it has been linked to a variety of 
pathological states, including cancer and neurodegenerative diseases [178, 179].  
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mTOR binds many proteins forming two distinctive protein signalling complexes, mTORC1 
(mTOR complex 1) and mTORC2 (mTOR complex 2). mTORC1 contains raptor (KOG1 
ortholog), GβL/mLst8, PRAS40 and DEPTOR, and mTORC2 (mTOR complex 2) contains rictor 
(Avo3 ortholog), GβL/mLst8, Sin1 (Avo1 ortholog), PRR5/protor and DEPTOR [150]. The 
activation of mTOR occurs downstream of Akt/PKB (a pathway commonly dysregulated in 
human cancers including breast cancer) [180]. Biochemical approaches in mammals led to 
the discovery of mTOR as the physical target of rapamycin, which forms a gain-of-function 
complex with the intracellular FK506-binding protein (FKBP12). The complex directly 
interacts with, and inhibits mTORC1, but not mTORC2 [181]. 
mTORC2 is involved in the regulation of phosphorylation and activation of Akt/PKB, PKC, 
serum- and glucocorticoid induced protein kinase 1. The inhibition of mTORC2 triggered 
autophagy and atrophy in skeletal muscle cells under fasting conditions [176].However, the 
autophagy induction by mTORC2 inhibition is mediated mainly by FoxO3, a transcription 
factor downstream of Akt that is involved in autophagy gene expression.   
The mTORC1 complex is sensitive to both growth factors and nutrients, and the presence 
of amino acids has been shown to be crucial for activation of the mTORC1 kinase  [150]. 
Cellular stress leads to negative regulation of mTORC1 activity, which in turn leads to the 
stimulation of autophagy. In growth promoting conditions, mTORC1 phosphorylates and 
inhibits ULK1 downstream, inhibiting autophagosome formation.  
Aside from nutrient starvation, other common methods of inducing autophagy via the 
mTOR pathway involve treatment with pharmacological agents such as rapamycin, Torin 
and PP242. The classical mTOR inhibitor rapamycin suppresses mTORC1 activity when 
applied acutely [182]. Since the activation of mTOR is involved in stimulating cell growth 
and protein synthesis, mTOR inhibitors such as PP242 and rapamycin have potential uses 
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as drugs for molecular-targeted therapy against many malignancies such as leukaemia 
[183]. These inhibitors have been shown to have different potencies in different cell lines 
[184]. For example, PP242 was shown to suppress cell growth more potently than 
rapamycin in several leukaemia cell lines such as T-Lymphoblastic and Jurkat cells. 
The yeast orthologue of mTOR (TOR) is regulated by the availability of nutrients such as 
nitrogen and carbon. TORC1 and mTORC1 containing raptor, are important regulators of 
translation and ribosome biogenesis in both yeast and mammalian cells, and are also 
responsible for autophagy stimulation [169][171] in response to starvation .  
Vps34 has been shown to regulate autophagy in response to nutrients by producing and 
accumulating PI(3)P, at specific locations during early steps of autophagy induction [150]. 
Deficiency of the mammalian Vps34 suppressed leucine responsive activation of mTORC1, 
proposing that Vps34 may act upstream of mTORC1 signalling [176]. In agreement with this 
finding, it has been shown that Ca2+ and CaMdependent signalling regulate mTORC1 via 
Vps34 in HeLa cells in response to leucine [185]. However, the relationship between 
mTORC1 and Vps34 appears to be complex since Vps34 is not essential for TORC1 signalling 
in Drosophila [186]. The complexity of this relationship could be due to the difference 
between the mammalian and Drosophila systems [187]. It is possible that some of the 
Vps34 complexes function upstream and others downstream of mTORC1. Further 
investigation is necessary to clarify the relation between mTORC1 and Vps34 complexes 
and their crosstalk throughout the whole autophagy processes.  
1.4.5 Induction of autophagy 
A common method for induction of autophagy in vitro is to remove growth factors and 
amino acids from the extracellular medium of cells. These starvation conditions lead to the 
inhibition of mTOR kinase and the subsequent induction of autophagy through well-
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characterised mechanisms [188] [189]. Not all autophagy signals are dependent upon 
mTOR transduction; some amino acid (leucine) signalling can suppress autophagy in an 
mTOR-independent manner [190, 191]. Autophagy can also be induced independently of 
mTOR by small-molecule enhancers of the cytostatic effects of rapamycin (SMERs) [192]. 
The absence of essential amino acids (specifically leucine) is believed to be a particularly 
important in the induction of autophagy [193]. Depletion of amino acids induces autophagy 
in variety of cultured cell lines, however the sensing mechanism is not fully understood. 
Individual amino acids have been shown to exert differing effects on autophagy; for 
example leucine, tyrosine, phenylalanine, glutamine, proline, histidine, tryptophan, 
methionine, and alanine have been shown to suppress autophagy in ex vivo perfused liver 
[194]. These profiles are likely related to differences in amino acid metabolism between 
tissues. Additionally to insulin and amino acid signalling, many other factors are involved in 
autophagy regulation [195]. These include Bcl-2, reactive oxygen species (ROS) [196-198], 
Ca2+ [199] and AMP-activated protein kinase (AMPK) [200]. 
1.4.6 Selective autophagy 
Autophagy was initially considered to be an essential but non-selective process. Bulk 
autophagy, which takes place during nutrient starvation, is thought to be non-selective 
toward its substrates. Recently evidence has shown that autophagy can also be selective. 
This allows for the specific targeting and elimination of of  abnormal protein aggregates, 
lipid droplets, dysfunctional organelles and invading pathogens [201]. The mechanisms of 
cargo recognition in such cases are not yet fully understood [202], but what is known is that 
this process involves ubiquitination. Many autophagy-specific receptors such as 
P62/SQSTM (hereafter referred to as p62) control the selective autophagy by tethering 
cargo to the site of autophagosomal engulfment [203]. P62 is a scaffold protein for atypical 
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PKC, extracellular signal-regulated kinase (ERK)1, nuclear factor-κB and caspase-8. The p62 
receptor possesses multiple domains, including an LC3-interacting region (LIR).  Most p62 
protein in the cell is found in the cytoplasm and the nucleus, as well as the autophagosomes 
and lysosomes.  It is also localised to autophagy substrates such as protein aggregates and 
damaged organelles [204]. Before autophagic clearance, p62 ‘tethers' the ubiquitinated 
cargo to the nascent autophagosome, which carries ubiquitin-like modifiers (UBL) proteins 
such as LC3 on its surface [205]. Defects in autophagy results in accumulation of p62. Many 
types of selective autophagy have been identified and include xenophagy (microbes and 
viruses), ribophagy (ribosomes), mitophagy (mitochondria) and reticulophagy (ER).  
1.4.6.1 Mitophagy 
Since mitochondria are essential for regulating cellular energy homeostasis, mitophagy has 
been the subject of extensive research and has been recently proposed to play critical roles 
in diseases [206].  As the name suggests, mitophagy is the selective degradation of 
mitochondria by autophagy. In addition to quality control, mitophagy is important for the 
maintenance of mitochondrial number [207] and the elimination of mitochondria during 
the development of specialized cells such as reticulocytes [208].  
Lemasters et al., initially found that mitochondria are selectively targeted for autophagy 
following a loss in their membrane potential. This suggests that the process of mitophagy 
is key to the removal of damaged mitochondria [209].  A number of factors interact 
specifically with damaged mitochondria; notably PTEN-induced kinase 1 (PINK1). PARKIN, 
a protein implicated in autosomal recessive monogenic Parkinson’s disease (PD), has also 
been found to bind selectively to damaged mitochondria [210], and it has been suggested 
that PARKIN may therefore have a role in this selective autophagy process.  
PARKIN and Pink-1 act together through a complex interplay of phosphorylation and 
ubiquitination [211]. A number of groups have reported that the recruitment of PARKIN to 
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impaired mitochondria requires PINK1 expression and its kinase activity [208, 212, 213]. 
Following translocation to the mitochondrial surface, PARKIN ubiquitylates many OMM 
proteins, such as VDAC and some components of the translocase of the OMM (TOM) 
complex (TOM70, TOM40 and TOM20)[208]. These consequently recruit other proteins to 
mitochondria to initiate mitophagy [214]. Overexpression of PARKIN is typically used to 
induce mitophagy and can be employed as a tool to identify mitochondrial E3 ligase 
substrates as endogenous PARKIN expression is low in many cell lines. Mitophagy can be 
confirmed by flow cytometry using mitochondrial dyes [215]. It is vital to confirm that 
changes in mitochondrial mass are truly as a consequence of autophagy and not because 
of reduced mitochondrial biogenesis. 
1.4.6.2 Ribophagy 
Ribosomes constitute half of the cell’s protein mass [216] and so represent an important 
source of amino acids. Studies of nutrient starvation conditions in S.cerevisiae have 
revealed that ribosomes are degraded faster than other cytoplasmic components. This is 
suggestive of a selective degradation process [217]. The transport of ribosomes to the 
degradative organelles in yeast relies on core autophagy proteins such as Atg1 and Atg7. 
Catalytically inactive mutants of ubiquitin protease (Ubp3) exhibit defects in the 
degradation of ribosomes resulting in cell death. This study reveals that ubiquitination plays 
a key role in this process and, also that ribosomal turnover is important for cell survival 
under conditions of nutrient starvation [218]. Additionally, ribophagy is a significant 
process as has been shown to contributes to the downregulation of protein translation, a 
process that relies on large amounts of energy and the availability of amino acids [218]. 
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1.5 Methods for measuring autophagy 
 
Tools employed for studying autophagy include immunoblotting and fluorescence 
microscopy. Biochemical detection of the membrane-associated form of LC3-II can be 
carried out by immunoblotting. LC3-I is conjugated to PE following autophagy activation to 
form LC3-II and consequently recruited to the autophagosomal membrane. The ratio of 
LC3-I and LC3-II can be detected using immunoblotting.  A band with a different molecular 
weight is observed after modification of LC3-II (LC3-I: 18 kDa, LC3-II: 16 KdA). LC3 is 
expressed as three isoforms in mammalian cells, LC3A, LC3B and LC3C, but only LC3B-II is 
linked with increased levels of autophagic vesicles. The use of anti-LC3B specific antibodies 
are employed for such analysis [215]. 
Endogenous LC3B-II protein can be quantified by immunofluorescence [215]. In addition, it 
can be visualised via the use of fluorescent markers into the cell system, such as green 
fluorescent protein (GFP) and red fluorescent protein (RFP).  GFP-tagged LC3, in which GFP 
is expressed as a fusion protein at the amino terminus of LC3, is a common marker used to 
monitor autophagy in such systems. Since GFP-LC3 will be localised to, autophagosomes 
and autolysosomes, these structures can be visualised as punctate or ring structures 
(autophagosomes and autolysosomes that are 0.5-1.5 µm in diameter). The lipidated form 
of LC3 (LC3-II) is observed as bright green punctae associating with phagophore and 
autophagosomal membranes. As vesicles mature, LC3-II present on the outer 
autophagosome membrane is delipidated and released for recycling back to LC3-I [219]. 
When autophagosomes fuse with lysosomes the acidic content of the lysosomes quench 
the GFP fluorescence and therefore punctae are no longer apparent. Determination of the 
number of autophagosome by fluorescence is one method by which cellular autophagy can 
be quantified.  An increased number of autophagosomes usually reflects an increase in 
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autophagic activity. However, it is important to note that autophagosomes are 
intermediate structures in a dynamic pathway. An accumulation of autophagosomes may 
result from either autophagy induction, or suppression of degradation steps. A block of any 
step downstream of autophagosome formation will result in an increase of the number of 
autophagosomes.  
Systems such as those described above are widely used to gain insight into the process of 
autophagy. Counting GFP-positive punctate is, however, a laborious and potentially 
subjective task. This can be somewhat ameliorated by the use of computer software. In 
addition, over-expressed GFP–LC3 has the potential to be incorporated into protein 
aggregates or endosomal vesicles independent of autophagy.  
LC3 tagged to both GFP and a red fluorescent protein (mRFP or mCherry), called ‘tandem 
reporter’, provides an alternative method to visualise autophagy processes [220]. The red 
fluorescence is not quenched at low pH. This tandem tool allows the visualisation of 
phagophores and autophagosomes with both green and red fluorescence that can be 
overlaid. Since the green fluorescence is quenched in mature autophagosomes, these 
appear as red fluorescent punctae. 
Other proteins such as WD repeat domain, phosphoinositide interacting 1 (WIPI-1, a 
mammalian ortholog of Atg17) can be fluorescently tagged and used to detect autophagy. 
WIPI-1 is more rapidly recycled and enables more proximal events such as the development 
of nascent phagophore membranes to be observed [221]. WIPI-1 also co-localizes with LC3-
positive membranes therefore WIPI-1-positive punctae can be used together with LC3-II 
staining as a measure of autophagy.   
Recent research has shown that autophagy does not depend solely on LC3 but also relies 
on GABARAPs, a subfamily of Atg8 proteins [222], and in these instances, alternative 
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methods must be employed. To analyse autophagic flux in such conditions, cytosolic 
proteins such as lactate dehydrogenase (LDH) can be analysed. A sequestration assay can 
be employed to measure the transfer of the autophagic cargo marker enzyme LDH from 
the cytosol to autophagic vesicles, which is later degraded by the lysosome [223].  
Measuring flux through the autophagic pathway in its entirety – from autophagosome 
production through to lysosomal degradation – may therefore be regarded as a more 
reliable representation of autophagic activity [224] [225]. Measuring long-term protein 
degradation (for example of p62) by e.g. Western Blotting has been used as a means of 
measuring autophagy. However, factors other than autophagy could be influencing the 
degradation of proteins, for instance the UPS is also active during inhibition of mTOR by 
rapamycin [226] [224]. Autophagic flux can be measured by selectively inhibiting the 
specific stages of autophagy using pharmacological agents. Lysosomal activity can be 
blocked using lysosomal protease inhibitors, such as bafilomycin A1 (BafA1) and 
chloroquine (CQ) [215, 227]. These compounds inhibit autophagosome degradation, 
resulting in an accumulation of autophagosomes.  
In addition to the use of BafA1 to inhibit the autophagic flux, inhibitors of autophagy 
induction such as Chloroquine (CQ), 3-Methyladenine (3-MA) and Wortmannin can be 
employed to exert influence upon specific points of the pathway (Figure 1.5). CQ is a 
lysosomotropic agent commonly used to neutralise lysosomal pH and inhibit lysosomal 
degradation [163]. 3-MA inhibits the Vps34 complex and consequently the production 
ofPI3P, which is needed for nucleation of phagophores. One limitation of this approach is 
that chronic incubation with 3-MA can induce autophagy through via the inhibition of class 
I PI3-kinases [228]. Wortmannin is another inhibitor of PI3-Kinase [228] that is commonly 
used to inhibit the nucleation step of autophagy. 
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Other methods for detecting selective types of autophagy (such as mitophagy) also exist.  
These are described in section 1.4.6.  
 
 
 
 
 
 
 
 
Figure 1.5. Schematic representation of the autophagy process and common inhibitors 
used to modulate different stages of autophagy. 3-MA: 3-methyladenine, BafA1: 
Bafilomycin A1, CQ: Chloroquine 
 
1.6 Autophagy in health and disease  
Autophagy is implicated in many human diseases ranging from neurodegenerative 
disorders, cardiovascular diseases and various forms of cancer [229, 230].   
1.6.1 Neurodegenerative diseases 
Alzheimer’s disease (AD) is characterized by the presence of the hallmark extracellular 
amyloid-beta (Aβ) plaques and accumulations of abnormally processed tau (the 
neurofibrillary tangles) in the brain. Compared to non-neuronal cells, neurons are 
dependent on high basal autophagy for survival. It is the major degradative pathway in 
neuronal cells [231]. There is evidence to suggest that defects in the autophagy-lysosomal 
pathway occurs before any signs of pathological hallmarks [229]. Therapeutic targeting of 
the autophagy network in this context has focused upon promoting autophagy [232]. 
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Factors such as ageing and metabolic/oxidative stress contribute to the accumulation of 
materials including multivesicular bodies, dense bodies, and autophagosomes. The latter 
have shown to contain greater levels of amyloid precursor protein (APP), and processing 
enzymes required for Aβ generation. Neurons grown in cell culture and transgenic mice 
deficient of Beclin-1 show accumulation of APP and Aβ. However, Beclin-1 over-expression 
reduces Aβ accumulation. Beclin-1 deficiency has been shown to impair late stages in the 
autophagosomal-lysosomal pathway, and promote neurodegeneration in mice. Beclin-1 
levels are also reduced in affected grey matter of patients with early stages of AD [233].  
Lysosomal proteases such as cathepsin are important in autophagy and are involved 
directly in substrate clearance. Inhibiting these proteases has been shown to increase 
amyloid pathologies and memory deficits in an AD mouse model [234]. Other therapeutic 
studies have shown that rapamycin reduces Aβ and Tau pathology resulting in an 
improvement in cognition [235], if treatment precedes the onset of plaque and tangle 
accumulation. Moreover rapamycin treatment of Drosophila over-expressing wild-type 
and mutant tau showed an increased tau clearance. Arctigenin, can inhibit both Aβ 
production and stimulate its clearance through mTOR inhibition (thereby autophagy 
stimulation) in APP transgenic AD model mice. This study also showed that memory 
impairment was reduced in these mice [10]. Enhancing lysosomal production or function 
(or both) could be another therapeutic approach. Yang et al. [236] showed that increasing 
lysosomal activity in the brain of a transgenic AD mouse model of reduced Aβ levels and 
deposits. While some evidence points to defective autophagic clearance, irregular 
autophagy induction can also lead to accumulation of autophagosomes containing Aβ and 
APP [10]. 
Autophagy is also implicated in Huntington’s disease (HD) and Parkinson’s disease (PD). In 
PD autophagy is vital for the clearance of α-synuclein (α-syn), a major component of Lewy 
50 
 
bodies that characterize PD [237]. Over-expression of Beclin-1 reduces the accumulation of 
α-syn and enhanced neuropathological features in the mouse model [238]. HD is linked to 
the expansion of the polyglutamine (polyQ) tract in huntingtin (Htt). Autophagy enhances 
the turnover of Htt [239], and studies of Atg knockout (autophagy deficient) Caenorhabditis 
elegans worms have shown increases in the formation of Htt aggregates and toxicity [240]. 
1.6.2 Cardiovascular diseases 
Autophagy occurs at low levels under normal conditions in the myocardium, and defects in 
autophagy can lead to cardiac dysfunction and heart failure. A build-up of autophagosomes 
was observed in myocardial biopsy samples from patients with cardiovascular diseases 
(such as hypertension and congestive heart failure) [241]. Induction of autophagy in cardiac 
myocytes reduced the accumulation of misfolded proteins known to contribute to cardiac 
diseases [242]. mTOR inhibitors have been shown to promote the stabilization of 
atherosclerotic plaques [243]. Deficiency of LAMP2 in mice has been shown to result in 
autophagosome accumulation and defective degradation of long-lived proteins, which may 
contribute to the incidence of cardiomyopathy [244]. 
Verapamil, an L-type calcium channel blocker used in the treatment of hypertension and 
cardiac arrhythmia, induces autophagy and is antiproliferative in cultured vascular smooth 
muscle cells (VSMC). Moreover, commonly used cardiovascular drugs such as β-receptor 
agonists and β-receptor blockers have also been shown to alter autophagy levels in the 
cardiovascular system but a better understanding of their autophagic mechanism of action 
is required [243]. 
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1.6.3 Cancers 
Autophagy has been shown to have a dual role in cancer with evidence showing that 
autophagy may act as a tumour suppressor, particularly in the early stages of tumour 
initiation, while it can also enhance cancer cell survival in harsh conditions such as nutrient 
deficiency and hypoxia (common to many established and solid tumors) [245].  In addition, 
autophagy has been linked to the therapeutic resistance of breast cancer [246]. Elevated 
autophagy is often seen in cancer cells exposed to radiation and chemotheraptic agents 
[227]. Attempts to inhibit autophagy in order to ameliorate such effects have therefore 
attracted great interest. A number of studies have also suggested that autophagy inhibition 
by genetic or chemical means has the potential to induce apoptotic cell death and inhibit 
tumour cells growth [247, 248]. 
Cancer cells have a re-modelled phenomenon termed the ‘Warburg effect’, a metabolism 
where ATP is produced through increased glycolysis and reduction of lactic acid, rather than 
ATP production via oxidation of pyruvate within the mitochondria [249]. A variety of cancer 
cell lines have been shown to be addicted to the ER-mitochondrial Ca2+ fluxes to keep up 
with their uncontrolled proliferation, whereas non-tumorigenic cells slow down their cell 
cycle in when mitochondrial metabolism is limited so that failed cytokinesis and necrosis 
do not occur [250, 251]. Metastatic cancer cells are also sensitive to InsP3R inhibition. For 
example, when breast cancer cells were treated with the InsP3R inhibitor 2-APB, or 
following InsP3R knockdown, cell death was increased and was linked to amplified 
activation of autophagy involving Atg5 upregulation. Knockdown of Atg5, or the inhibition 
of autophagy repressed the breast cancer cell death [252].  
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1.6.3.1 Autophagy as a tumour promotor 
Mechanisms by which autophagy promotes tumorigenesis include the inhibition of p53 
tumour suppressor protein and supporting the metabolic function of mitochondria. Cancer 
cells have been shown to be more dependent on autophagy than normal cells and tissue, 
mostly due to unique characteristics of the tumour microenvironment and the increased 
metabolic demands as a consequence of deregulated proliferation [253].  
Autophagy is elevated in RAS-transformed cancer cells and enhances their growth, survival 
[254] and metastasis [255]. Moreover findings have shown that that RAS-driven cancers 
may be “autophagy addicted”, relying upon elevated levels of autophagy for survival [254]. 
The essential autophagy gene Atg7 was deleted alongside with KRASG12D activation in 
mouse models to study role of autophagy in spontaneously arising lung cancer. Tumour-
specific Atg7 deficiency caused the accumulation of dysfunctional mitochondria with an 
induction of p53, proliferative arrest, and cell death reducing tumour size. In spite of the 
reduction in tumour size and the generation of benign instead of malignant neoplasms, 
animals with Atg7-deficient tumours didn’t extend their life span because the mice died of 
pneumonia instead of cancer. Autophagy defects in tumours, have been shown to trigger 
inflammation, which may trigger pneumonia. These studies propose that inactivating 
autophagy can divert progression of lung carcinomas to a benign disease, which could be 
an advantage if it can be achieved in the clinic with an autophagy inhibitor [253]. RAS-driven 
cancers not only rely on autophagy for survival, RAS activation also promotes cell signalling 
events involved in autophagy induction by upregulating Beclin-1 expression and BNIP3 
expression through the RAS/RAF/ERK pathway [256].  
The tumour microenvironment contributes to cancer cell survival and metastasis and is a 
complex system composed of a variety of cells including adipocytes, immune cells, 
fibroblasts, vascular endothelial cells, mesenchymal stems cells (MSCs), and many 
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cytokines [257]. The characteristics of the tumour microenvironment can induce autophagy 
by activating various pathways. For example autophagy is upregulated by activating the 
AMPK pathway to protect cancer cells against nutrient starvation by providing their 
nutrients. In response to hypoxia, hypoxia inducible factor HIF-1α is translocated to the 
nucleus and causes a rapid induction of the BH3-only proteins which displace Beclin1 from 
Bcl-2, leading to the induction of autophagy [188]. 
1.6.3.2 Autophagy as a tumour suppressor 
Studies have shown that that the essential autophagy gene Beclin-1 is mono-allelically lost 
in up to 75 % of human prostate, breast, and ovarian cancers [253]. The death-associated 
protein kinase (DAPK), a Ca2+-activated protein kinase that phosphorylates Beclin-1 and 
therefore disrupts Beclin-1/BcL-2 complex and induces autophagy, is commonly silenced in 
many human cancer types [256]. Beclin-1 protein levels have also been shown to be 
reduced in many brain cancers.  
A crucial connection between autophagy and tumour suppression is through the regulation 
of reactive oxygen species (ROS) [258]. Increased ROS production stimulates 
carcinogenesis. Since mitochondria are the main source of intracellular ROS, mitophagy 
helps to minimise damage. Inhibition of autophagy in different animal models leads to 
accumulation of defective mitochondria. Defects in the autophagic process are linked with 
the accumulation of protein aggregates and the autophagy substrate p62/SQSTM1 
(commonly elevated in human tumours). Such factors are associated with increased 
production of ROS and ER stress. In fact studies have shown that genetic inactivation of p62 
in various models have reversed tumorigenic development observed in autophagy-
deficient cells. An anti-inflammatory role of autophagy has also been suggested [256]. 
Degenhardt et al., have shown that autophagy inhibition in apoptosis-deficient tumour 
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cells promote necrotic cell death, local inflammation, and tumour growth [245]. These 
results suggest that autophagy restricts tumour necrosis and local inflammation. 
Autophagy is mainly regarded as a pro-survival process but, under certain conditions, an 
increase in autophagic flux may cause cell death in part due to the tumour suppressor 
effects of autophagy [256]. Studies in an ovarian cancer cells showed that ectopic 
expression of Ras stimulates autophagic cell death through the upregulation of Beclin-1 
and Noxa, a BH3-only protein [259]. Autophagy also has a role in cell senescence, which 
can be a major barrier to malignant transformation. This role might explain its tumour 
suppressor effects. Studies in fibroblasts showed that autophagy is activated during RAS-
induced senescence and inhibition of autophagy delayed the oncogene-facilitated 
senescence [260].  
 
1.6.4 Therapies, clinical trials and challenges 
Many methods exist for measuring autophagy in vitro, however few methods exist for the 
assessment of this dynamic process in a living organism (especially in humans). This raises 
questions such as how can one be sure that autophagy was indeed inhibited or stimulated 
in patient treatments. Therefore there is a need to develop reliable biomarkers for 
autophagy assessment in clinical trials. Anticancer drugs such as hormonal agents, DNA 
damaging agents, microtubule-targeted drugs, death receptor agonists, antimetabolites, 
antiangiogenic agents, histone deacetylase inhibitors, and kinase inhibitors have all 
demonstrated an effect  on autophagy [261].  
HCQ, a derivative of the anti-malarial chloroquine (CQ), and an inhibitor of lysosomal 
acidification, is the only autophagy inhibitor that is clinically-approved [13]. Preclinical trials 
show that HCQ (which is less toxic than CQ) leads to tumour shrinkage alone or in 
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combination therapy. For example, in breast cancer cells, HCQ and tamoxifen were more 
effective at inhibiting autophagy than the monotherapy in oestrogen receptor-positive 
breast cancer cell lines [262]. HCQ nanocarriers have also been used to improve the 
pharmacokinetic properties. However studies of HCQ have shown that high doses of the 
drug (up to 1200 mg/day) only show modest inhibition in vivo and are not always 
consistent.  HCQ has also been shown to contribute to defective lysosomal function, which 
can consequently cause lysosomal storage disease [263]. Therefore there is a demand for 
more active autophagy inhibitors and an understanding of mechanism of action [13]. 
1.7 Autophagic cell death 
Apoptosis, a form of programmed cell death (PCD), is well characterised. However, there is 
substantial evidence suggesting that there may be other forms of PCD for example 
autophagic PCD, a type II programmed cell death process. Unlike apoptosis, autophagic 
PCD does not require DNA fragmentation or caspase activation [264].Autophagic cell death, 
termed autosis, is morphologically different from apoptosis and results from sustained 
excessive levels of cellular autophagy [265]. Autosis is accompanied with increased 
autolysosomes in dying cells that lack features of apoptosis and necrosis. Autosis has been 
shown to be regulated by Na+,K+-ATPase [266]. The process has been mainly observed from 
morphologic studies (i.e. cell death associated with autophagosomes/autolysosomes). This 
observation stems from evidence suggesting cells with autophagic features in regions 
where PCD is occurring.  A lack of appropriate experimental systems to study autophagic 
PCD is one of the reasons why the mechanism remains poorly defined [267]. 
Evidence has shown that apoptotic death is faster than autophagic death and that 
autophagic cell death acts as an alternative to apoptosis. For example, growth factor–
deprived wild-type cells go through a rapid apoptotic death whereas growth factor–
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deprived bax–/–, bak–/– cells, which are unable to undergo apoptosis, undergo slow death 
characterized by progressive self-cannibalization[264]. Deficiency in apoptosis due to the 
absence of Bax and Bak allows autophagy to progress to such an excessive extent that cells 
eventually die. 
These observations raise the question whether autophagic activity in such cells is the cause 
of death or, an attempt to prevent it [268]. In situations where cell death occurs following 
sustained periods of autophagy, genetic or pharmacological inhibition of the autophagy 
process should prevent cell death. Indeed, in vitro inhibition of autophagy has been shown 
to prevent cell death. For example, the pharmacologic inhibitor of autophagy 3–MA, 
partially inhibits death in populations of starved hepatocytes derived from carcinogen-
treated rats, in serum-deprived PC12 cells, and in TNF-treated human T lymphoblastic 
leukaemia cells. However, in a number of these studies, autophagy was observed in cells 
thought to die by apoptosis, and it was presumed that autophagy triggered apoptosis 
instead of having a direct role in cell death [264]. 
Additionally, studies have shown Atg5, Atg6 and Atg7 are involved in both autophagic cell 
death and in pro-survival autophagy. However their expression levels vary between the 
two events. In pro-survival autophagy their levels remain low whereas in autophagic death 
the proteins are upregulated [267].   
The molecular connections between autophagy and apoptosis are complex. The 
therapeutic potential of autophagy for treating cancers and other diseases relies on the 
complicated interactions between the apoptotic and autophagic mechanisms [268]. Most 
cancer therapeutics induce cytotoxic stress on cancer cells that eventually trigger 
programmed cell death [269] and research has shown that autophagy can protect cells 
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against treatment with anti-cancer drugs [11]. Understanding these connections is 
therefore critical to know when and how to modulate autophagy for therapeutic gain.  
During nutrient starvation, autophagy is usually the dominant process stimulated in the cell 
to provide energy in form of ATP, thereby achieving a metabolic state which is anti-
apoptotic [270]. Other stimuli may promote an apoptotic response, and many molecules 
can stimulate both process.   
At the root of autophagy-apoptosis interactions are two autophagy proteins, p62 
(important for RAS-induced tumorigenesis) and the tumour suppressor Beclin-1 [268]. p62 
is important in the selective autophagy of many proteins and interacts directly with many 
apoptotic and survival pathway proteins including ERK, TRAF6 (this regulates NF-kB survival 
pathways) and caspase-8 [271]. Beclin-1 interacts directly with anti-apoptotic Bcl-2. When 
Bcl-2 and Beclin-1 are bound, Beclin-1 is unable to trigger autophagy. The process is only 
triggered when Beclin-1 is released from Bcl-2 by pro-apoptotic BH3 proteins, when Beclin-
1 is phosphorylated by DAPK or when Bcl-2 is phosphorylated by JNK [272]. Studies have 
shown that overexpression of DAPK in tumour cell lines (such as HeLa, MCF-7, or HEK 293T 
cells) leads to cell death displaying characteristic autophagic features [273]. 
Overexpression of Bcl-2 or Bcl-XL can hinder autophagy. Apoptosis can also inhibit 
autophagy through caspase-3-dependent cleavage of Beclin-1, resulting in a truncated 
protein that is unable to stimulate autophagy. These results show that apoptotic 
components regulating Beclin-1 can either stimulate or inhibit autophagy depending on 
BH3 proteins and caspase activities [272]. 
The pro-apoptotic BH3-only proteins, Bim and Bid directly trigger oligomerisation of Bax 
and Bak on the outer membrane of the mitochondria, leading to release of cytochrome c. 
Other members of the pro-apoptotic BH3-only proteins are Bad and Bik. In this case, the 
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BH3 domain of these proteins binds and antagonises anti-apoptotic Bcl-2 proteins 
and sensitises cells to apoptosis.  BH3-only proteins can also regulate autophagy, for 
example the over-expression of Bnip3 (a hypoxiainducible, BH3 domain containing protein) 
increased autophagy levels and non-apoptotic cell death [274].  
DAPK also acts as a mediator of ER stress-induced caspase activation and autophagic cell 
death in primary fibroblasts. Loss of DAPK reduces the accumulation of the active form of 
caspase-3, and the accumulation of LC3-II, thereby partially inhibiting cell death.  Loss of 
DAPK has not been shown to affect ER stress or the unfolded protein response (UPR) 
signalling pathway.  This suggests that DAPK acts downstream of the ER stress response to 
facilitate apoptosis and autophagy [275]. 
Calpains, a family of Ca2+-dependent cysteine proteases localised in the cytosol, have also 
been shown to be involved in both apoptosis and autophagy processes. Increased levels of 
cytosolic Ca2+ allow calpains to translocate to the intracellular membrane, where they are 
activated by autocatalytic hydrolysis. Calpain-mediated cleavage of anti-apoptotic proteins 
such as Bcl-2 promotes apoptosis [273]. Calpains can also trigger necrosis by cleaving the 
Na+/Ca2+ exchanger in the plasma membrane. This results in sustained 
secondary intracellular Ca2+ overload [276]. In relation to autophagy, loss of the calpain 
small 1 regulatory subunit (CAPNS1) resulted in the inhibition of autophagy under 
conditions of nutrient starvation, rapamycin treatment, and etoposide treatment. This 
inhibition of autophagy sensitises cells to apoptotic cell death events, suggesting that 
calpain-mediated autophagy plays a protective role against apoptosis [273]. Caspase 
inhibition have also been reported to induce autophagic cell death; chemical inhibition of 
cysteine proteases with z-VAD-fmk (a broad spectrum caspase inhibitor) can cause 
autophagic cell death in L929 mouse fibrosarcoma and the human Jurkat T cell lymphoma 
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cell types. This effect is likely to involve the combined inhibition of one or more caspases, 
including caspase-8, as well as other proteases such as a calpain [270]. 
Although autophagy is able to specifically degrade components of the apoptotic machinery 
(such as mitochondria and caspase-8), the significance of these events in relation to 
modifying the extent of cell death in a physiological or disease setting is unclear. For 
example, only mitochondria recognised as damaged or defective are thought to be 
targeted specifically by mitophagy. Therefore a question that remains unanswered is: even 
with autophagy being upregulated in a cell, why would an apoptotic stimulus still not cause 
cytochrome c release from the mitochondria untargeted by autophagy to induce 
apoptosis? One suggestion is that in a population of cells where some die and some survive, 
the molecular mechanisms (such as Beclin-1 or p62 cleavage), only take place in those cells 
that do eventually die and, these cells have lower levels of autophagy. Therefore, a clear 
mechanistic understanding of how autophagy can inhibit apoptosis for any defined 
apoptotic pathway is still lacking. Gaining knowledge on how proteins involved in 
autophagy and apoptosis can control the balance between cell death and survival can 
potentially help determine the approach in targeting autophagy in disease [268]. It is likely 
that cells have different sensitivity thresholds and can influence whether autophagy or 
apoptosis will occur. In some situations, a mixed phenotype of both apoptosis and 
autophagy is observed at the single-cell level [270].  
 
1.8 Autophagy and ER stress 
The ER is a site of synthesis, folding and post-processing of proteins in the cell.  
Genetic and environmental factors that disrupt the function of the ER cause misfolded and 
unfolded proteins to accumulate in the ER lumen.  This accumulation results in ER stress. 
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Factors disrupting ER function include Ca2+ depletion from the ER, viral infections, high 
protein demand, increased concentration of ROS and inflammatory cytokines. ER stress-
mediated cell dysfunction and death has been implicated in many disorders, including 
diabetes and neurodegeneration. Ogata et al., have also shown that tumour cells stimulate 
autophagy for survival to avoid ER stress-induced toxicity [277].  
Eukaryotic cells respond to ER stress by triggering the unfolded protein response (UPR); a 
signalling network which acts to alleviate this stress and restore ER homeostasis, promoting 
cell survival. Depending on the severity and duration of the ER stress, the UPR branches 
into two streams, survival or programmed cell death. The Bcl-2 family of proteins is 
essential to the cell death arm of the UPR pathway. It is usually under irrecoverable ER 
stress conditions that the UPR promotes apoptosis through intrinsic and extrinsic pathways 
[278]. Three ER transmembrane proteins initiating the UPR are Inositol Requiring 1 (IRE1), 
PKR-like ER kinase (PERK), and Activating Transcription Factor 6 (ATF6). In normal cell 
conditions, the ER chaperone immunoglobin binding protein (BiP) (which ensures correct 
folding of newly synthesised proteins) binds to the luminal domains of these master 
regulators rendering them inactive. However upon ER stress, BiP dissociates from these 
sensors [279]. 
Once activated, the UPR regulates downstream effectors resulting in adaptive response, 
feedback control, and cell fate regulation. The adaptive response includes upregulation of 
molecular chaperones and protein processing enzymes thereby increasing folding and 
handling efficiency. Translation is also attenuated for a few hours to minimise ER workload 
and reduce additional accumulation of unfolded proteins. An increase in ER-associated 
protein degradation (ERAD) and autophagy occur to clear unwanted proteins. ERAD 
involves translocation of misfolded or aggregated ER proteins to the cytoplasm where they 
are degraded by the ubiquitin proteasome system [280].  
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In the canonical ERAD system, terminally misfolded proteins are ubiquitylated and targeted 
for degradation by the ubiquitin–proteasome system (UPS). However, activation of 
autophagy by UPR transducers functions as a non-canonical ERAD pathway. Autophagic 
degradation was originally considered as a secondary response to ER stress, and activated 
only when the canonical UPS was overwhelmed by an excess of ubiquitylated proteins 
[281]. However, recent evidence shows that autophagy removes misfolded proteins that 
either form aggregates or are not efficiently processed by the canonical ERAD system [281]. 
In general it is now known that autophagy-dependent ERAD deals with both soluble and 
insoluble forms of misfolded proteins, whereas UPS-dependent ERAD targets only soluble 
misfolded proteins [282]. ER stress activates autophagy, however prolonged or excessive 
autophagy is often associated with cell death [283]. ER stress mediated autophagy 
induction can take place through varying mechanisms depending on cell types and stimuli 
in question. A link between autophagosome formation and ER expansion induced by ER 
stress has been shown by electron microscopy studies in yeast, revealing that ER volume 
increases 5-fold under ER stress and with a concomitant increase in autophagosome 
formation [278]. Evidence has shown that the UPR and autophagy are dynamically 
interconnected, and that ER stress can either stimulate or inhibit autophagy. However the 
molecular signals that control the changeover between induction and inhibition of 
autophagy remained undefined. Additionally, mitochondrial function is also associated 
with the UPR and autophagy in ER stress conditions with emerging roles by E3 ubiquitin 
ligases in regulating these processes by fine-tuning their magnitude and duration [281]. 
RIPK1, an emerging determinant of cell fate in response to cellular stress, was also shown 
to have a role in autophagy in response to ER stress. RIPK1 was found to be upregulated in 
melanoma cells treated with ER stressors tunicamycin (TM) and thapsigargin (Tg) along 
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with upregulated autophagy. RIPK1 has been shown to be important for protecting 
melanoma cells from TM- or Tg-induced apoptosis by increasing autophagy.  Knockdown 
of RIPK1 inhibited autophagy and rendered the cells sensitive to cell death by TM or Tg 
[284]. Targeting the RIPK1 autophagy mechanism may therefore be valuable in order to 
enhance sensitivity of melanoma cells to therapeutic agents that induce ER stress. 
1.9 The complex role of Ca2+ in autophagy 
Differing spatiotemporal patterns of Ca2+ have been shown to both promote autophagy as 
well as suppress autophagy process. On the one hand, evidence indicates that intracellular 
Ca2+ signals, arising mainly from InsP3Rs, suppress autophagy. Conversely, elevated 
cytosolic Ca2+ concentrations have also been shown to promote autophagic process [285]. 
Figure 1.6 represents some of the ways Intracellular Ca2+ regulates autophagy. 
 
Figure 1.6 Intracellular Ca2+ signalling regulates autophagy. In basal conditions, IP3R-
mediated Ca2+ release towards mitochondria enhances mitochondrial ATP production and 
consequently inhibits autophagy through inactivation of AMPK. Centre: once Ca2+ 
mobilising agents, like thapsigargin, are added, the ER Ca2+ store is emptied causing a 
gradual increase in cytosolic Ca2+, leading to autophagy activation through the 
calcium/calmodulin kinase (CaMKK-β) and AMPK pathway. Upon rapamycin addition (an 
inhibitor of mTOR) or nutrient starvation, the InsP3R becomes sensitised through Beclin 1 
and increased ER Ca2+ store content, enhancing InsP3R mediated Ca2+ signalling and 
essentially triggering autophagy (Decuypere, et al., 2013). 
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1.9.1 Ca2+ inhibits autophagy 
Many studies reporting Ca2+ as an inhibitor of autophagy focus on InsP3Rs [286-288]. 
Elevations in cytosolic InsP3 concentrations produced in cells occur after stimulation by (for 
example) hormones, growth factors or antibodies. This causes InsP3R mediated Ca2+ release 
from the ER into the cytosol [4]. InsP3-mediated inhibition of autophagy has been studied 
in InsP3R triple knock out (TKO) chicken DT40 B lymphocytes, which showed higher 
autophagy levels than their wild-type counterparts [288]. Expressing type 1 or 3 InsP3R 
reduced autophagy levels in TKO cells. In contrast, ryanodine receptor expression, another 
ER Ca2+ release channel, does not reduce the elevated autophagy levels found in the TKO 
cells. However, although it is clear that InsP3Rs are important, the mechanisms involved are 
still debated. Other groups have shown decreased mTOR activity in TKO cells while AMPK 
activity did not change, and have demonstrated that cytosolic Ca2+ elevation acts to 
maintain elevated mTORC1 activity and thereby inhibiting autophagy [289]. 
Antagonists of voltage-operated Ca2+ channels (VOCC) and of InsP3 signalling enhance 
autophagy by inhibiting calpain (Ca2+-sensitive proteases) activity [290]. Inhibition of 
calpains activated an mTOR-independent autophagic clearance of aggregated proteins in 
neuronal cells [291]. It was suggested that Ca2+ influx was necessary for constitutive 
calpain-mediated cleavage of Atg5, thereby preventing induction of autophagy.   
Resveratrol, a natural polyphenol, causes cell cycle arrest and cancer cell death by 
apoptosis and was found to inhibit SOCE in prostate cancer cells, causing ER stress and 
autophagy [292]. Tg, widely used to induce long lasting cytosolic Ca2+ signals and depleting 
ER Ca2+, was shown to stimulate autophagy [293]. Other studies have shown that Tg 
blocked autophagic flux by preventing the maturation of autophagosomes into 
autolysosomes. In another study, Tg did not block autophagosome formation, but it 
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inhibited the fusion of autophagosomes with lysosomes. Tg has also been shown to inhibit 
nutrient starvation-induced autophagy [294]. These results show that Tg has a dual role in 
autophagy with more evidence for it activating autophagy. It could be that these dual roles 
are a consequence of a balance between cellular responses to elevated cytosolic Ca2+ 
concentration versus loss of ER Ca2+ stores.  
SOCE, a major route of Ca2+ influx in many excitable and non-excitable cells, also has a role 
in autophagy. Inhibition of SOCE led to colorectal cancer cell death through apoptosis [295]. 
However, inhibition of SOCE also evoked a concomitant triggering of autophagy that 
delayed the onset of apoptosis by preventing cytochrome c release from mitochondria. 
Blocking autophagy increased colorectal cancer cell death. In this context, Ca2+ influx via 
SOCE prevented the triggering of autophagy via a Ca2+/CaMKII/AKT pathway [295]. 
1.9.2 Ca2+ activates autophagy 
Studies reporting Ca2+ as an activator of autophagy mostly make use of the SERCA inhibitors 
such as Tg or Ca2+ mobilising agents like ionomycin, ATP or resveratrol that all lead to 
elevated cytosolic Ca2+ levels and consequently elevated levels of autophagy [296]. 
However, exactly how these elevations lead to autophagy activation has not been fully 
elucidated, with data implicating many Ca2+ sources. 
The importance of cytosolic Ca2+ in autophagosome formation was shown in one of the first 
studies where adding BAPTA-AM, a potent intracellular cytosolic Ca2+ chelator (more 
potent for Ca2+ than magnesium), prevented the induction of autophagy in MCF-7 cells. 
Høyer-Hansen et al. further demonstrated that autophagy occurred by the Ca2+-dependent 
activation of AMP activated protein kinase, which required upstream activation of the 
CaMKK-β [199].  
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Sakaki et al. showed that Tg, used to deplete intracellular Ca2+ stores, induced autophagy 
in hepatocytes due to ER stress and the misfolding of proteins  [293]. Autophagy in this 
study was shown to act as a pro-survival process, since the application of 3-MA reduced 
cell survival following Tg treatment.  While these treatments have either directly or 
indirectly lead to an increase in Ca2+ in the cytosol, data showed that nutrient starvation 
induced autophagy was also inhibited by BAPTA-AM, suggesting that nutrient starvation 
might also lead to autophagy through enhanced Ca2+ signalling. Additionally, BAPTA-AM 
loading reduces the number of autophagosomes at basal levels (in cells kept in a medium 
replete with nutrients) and also prevents the formation of new ones in response to 
stimulation. This implies that a Ca2+ signal is important for maintaining the basal level of 
autophagic flux and for autophagy induction when mTOR is inhibited. The origin of such 
signals and the effectors involved are not fully known. BAPTA-AM was shown to prevent 
endosome/lysosome fusion, revealing that BAPTA-AM not only prevents the triggering of 
autophagy but also inhibits the processing of autophagosomes. 
Studies on autophagy induced by amino acid starvation (through the inhibition of mTORC1) 
have shown that withdrawing essential amino acids lead to an increase in cytosolic Ca2+ 
deriving from both intracellular stores and the extracellular medium. An induction of AMPK 
via CaMKK-β (important for mTORC1 inactivation) was presented and the inactivation of 
AMPK has shown that induction of autophagy was attenuated [297]. AMPK was also shown 
to evade mTORC11 inhibition and can induce autophagy by phosphorylating ULK1 [298]. 
Furthermore, the Ca2+/CaMKK-β/ AMPK signalling pathways has been commonly proposed 
in the involvement of increased autophagy in a variety of cell lines. Experimental conditions 
such as stimulation with ionomycin, vitamin D and InsP3 generating agonists in cancer cells 
[199] and in neuronal cells treated with resveratrol, promoted autophagic clearance of 
amyloid-beta peptide via CaMKK/AMPK [296]. Other studies involving the CaMKK/AMPK 
66 
 
pathway include the induction of autophagy in endothelial progenitor cells by oxidized low-
density lipoproteins through SOCE [299]. 
Further evidence of Ca2+ acting as an inducer of autophagy was the finding from Gao et al. 
[300] that Ca2+  phosphate precipitates could induce autophagy in a concentration 
dependent manner when transfected into HEK293 and MEF cells. This autophagy induction 
is also inhibited by BAPTA-AM. They also show that autophagy mediated by Ca2+ phosphate 
was Beclin-1 dependent and not dependent on CaMKK-B as the use of STO-609 (inhibitor 
of CaMKK-B) did not block autophagy. 
TRPML3 Ca2+channels located at the plasma membrane and intracellular vesicles, were also 
shown to have role in induction of autophagy. Knockdown of TRPML3 by siRNA reduced 
autophagy in response to many stimuli such as tunicamycin, nutrient starvation and SERCA 
inhibition in HeLa cells [301]. 
Many of the reports of Ca2+ stimulating autophagy stem from imposition of Ca2+ signals by 
treatments such as ionophores and SERCA inhibitors. Only a few reports have examined 
the role of natural agonist stimulation such as ATP, given that ATP is an agonist of purinergic 
receptors on many cell types. ATP is released from cells through connexin hemichannels 
for paracrine signalling [302]. It can also be released from dying cells to act as a pro-
inflammatory molecule. Studies have shown that ATP can induce autophagy through G-
protein coupled P2Y receptors [303] and ionotropic P2X receptors [304]. Autophagy 
induction through P2X receptors enhanced inflammatory signalling in hepatocytes but in 
macrophages, autophagy induction in response to ATP was very fast due to a Ca2+ influx, 
which helped in the clearance of mycobacteria from cells [305]. Evidence also showed that 
the concentration of extracellular ATP has a role in the fate of hepatoma cells, either 
autophagic or apoptotic [306].The role of InsP3Rs has been studied fairly well in relation to 
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autophagy, however Less is known about the role of RyRs in autophagy in comparison with 
InsP3Rs. Autophagy induced by knockout of InsP3Rs was reversed by re-expression of 
functional InsP3Rs, but not by functional RyRs [115]. Insulin withdrawal leads to cell death 
via autophagy in neural stem cells alongside cytosolic Ca2+ signals arising from type 3 RyRs 
[307]. Stimulation of RyR activity amplified cell loss also. In neonatal cardiac myocytes, 
InsP3R-mediated Ca2+ release but not RyR InsP3R-mediated Ca2+ release inhibits autophagy 
[308]. However, in adult cardiac myocytes, where type 2 RYRs expression is reduced, 
increased autophagy was linked to decreased mitochondrial metabolism [286]. This is 
similar to the effect of reduced InsP3R expression in other cell types. Expression of type 3 
RyRs in HEK293 cells inhibited autophagic flux, however pharmacological inhibition of 
ectopically expressed RyRs in HEK293 cells, increased autophagic flux [309]. It was 
proposed that RyR-mediated Ca2+-release inhibited autophagic flux by preventing 
autophagosome-lysosomal turnover.  
1.9.3 Mitochondrial Ca2+ uptake and autophagy 
Ca2+ uptake into mitochondria has been shown to prevent AMPK-activated autophagy 
[310]. Ca2+ stimulates the citric acid cycle within the mitochondrial matrix by activating 
pyruvate dehydrogenase, α-ketoglutarate dehydrogenase and isocitrate dehydrogenase 
and increasing electron flow through the electron transport chain for ATP production. 
Therefore it is unsurprising that the inhibition of mitochondrial Ca2+ uptake renders cells 
susceptible to bio-energetic crisis [311]. Studies where InsP3Rs have been inhibited 
(pharmacologically or genetically) show that autophagy can be induced independent of 
mTORC1 [286]. Moreover, in support of these findings, reduced expression of MCU 
upregulated autophagy in HeLa cells [312]. However, mitochondrial depolarisation, 
thought to inhibit Ca2+ uptake did not show elevated autophagy using autophagic markers 
[286]. 
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The Bax inhibitor-1 (BI-1/TMBIM6), a member of the transmembrane Bax-Inhibitor Motif-
containing protein family (TMBIM) is an ER membrane protein with important cell death 
functions [313] and was found to promote autophagy by reducing InsP3R-mediated Ca2+ 
transport to the mitochondria [314]. BI-1/TMBIM6’s ability to lower the ER Ca2+ store 
occurs by forming a Ca2+-permeable channel [315] and/or directly sensitizing InsP3Rs 
(outside the MAMs) [316]. SERCA overexpression, to restore normal ER Ca2+ loading 
suppressed BI-1/TMBIM6-induced autophagy and mitochondrial energetics. The InsP3R 
antagonist xestospongin B (XeB) was found to stimulate autophagy in various cell lines, but 
not in DT40 cells that had a triple knockout of all InsP3R isoforms (DT40 TKO) [287]. In breast 
cancer cells, the induction of autophagy by inhibiting InsP3Rs led to cell death and reduction 
of tumour growth [252]. 
Evidence has also shown that InsP3Rs are necessary for the induction of autophagy. For 
example, incubating cells with XeB can not only induce autophagy, but when applied to 
cells under nutrient starvation conditions, it inhibits autophagy [317]. InsP3Rs associate 
with Beclin 1, an important protein for phagophore formation, and inhibit autophagic flux 
by limiting Beclin 1 availability for Vps34-complex formation. In response to rapamycin and 
starvation, InsP3Rs scaffolding with Beclin 1 cause a direct sensitization of InsP3R that is 
required to induce autophagy [317]. Moreover, expression of the InsP3-binding domain of 
InsP3Rs (prevents InsP3R activation/opening) abolished autophagy induced by XeB or 
nutrient starvation [287]. Additionally, the knockout of all three InsP3R isoforms in HEK 
cells, which inhibits all agonist-induced Ca2+ release prevented resveratrol-induced 
autophagy [318]. 
Tumour cells which rely on autophagy for proliferation can involve InsP3R-mediated Ca2+ 
signalling. In renal cancer cells, upregulation of type 1 InsP3R increased autophagy and 
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consequently tumour survival [319]. However, inhibiting InsP3R-mediated Ca2+ release was 
demonstrated to kill tumour cells in higher numbers than non-tumorigenic cells although 
both cell types are able to induce autophagy similarly [320]. Autophagy was not responsible 
for tumour cell death in that study; inhibiting autophagy in fact instead caused an increased 
cell death. InsP3R inhibition in cancer cells causes a bio-energetic crisis resulting in failure 
to complete mitosis, leading to necrotic death when tumour cells undergo division. The 
effect of InsP3R inhibition could be overcome by incubating cells with a membrane 
permeant form of pyruvate to stimulate the citric acid cycle, consistent with a metabolic 
defect downstream of IP3R inhibition due to a decreased rate of mitochondrial respiration. 
1.10 Aims 
Given the contradicting literature on the role of Ca2+ Signalling in Autophagy, one aim in 
the thesis was to study the regulation of autophagy by cytosolic and mitochondrial Ca2+ 
signals. Specifically, the aim was to understand the spatial and temporal characteristics of 
Ca2+ signals that regulate autophagy in two mammalian cell lines. The relevant sources of 
Ca2+ that lead to the generation of these Ca2+ signals will also be investigated. The first 
chapter presented establishes robust cellular systems as tools to study the regulation of 
autophagy by Ca2+, whilst ensuring viability, without extruding Ca2+ indicators, or triggering 
unwanted autophagy or other cellular processes. Tools include fluorescence and electron 
microscopy and using Ca2+ indicators to record Ca2+ signalling in parallel with autophagy 
measurements. 
The second chapter investigates the regulation of autophagy by Ca2+ release from InsP3Rs. 
The aim is to inhibit Ca2+ signalling from the ER across to mitochondria with the expression 
of InsP3 5’‐phosphatase. By doing so, we aim to explore putative links between preventing 
InsP3R function and mitochondrial Ca2+ uptake, cellular ATP concentration, and ER stress, 
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which have all been suggested to regulate autophagy. Moreover, the role of InsP3R activity 
for cell cycle progression and sensitivity towards apoptotic stimuli will be examined.  
The last chapter investigates the role of Ca2+ influx via store-operated Ca2+ entry (SOCE) on 
autophagy with the use of Cyclopiazonic acid (CPA), an inhibitor of SERCA. Using CPA, 
intracellular Ca2+ stores become depleted and SOCE takes place. This tool will enable the 
distinction between Ca2+ signals arising from intracellular stores and SOCE and will 
hopefully reconcile some of the contradictory data on SOCE in literature. Where there is a 
link between Ca2+ and autophagy upregulation/downregulation, cellular pathways such as 
CaMKK2 will be investigated. 
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Chapter 2: Materials & methods 
2.1 Chemicals and solutions 
 
 
Chemical or solution 
 
Supplier 
 
Catalogue number 
2-Aminoethoxydiphenyl borate  
(2-APB) 
Sigma D9754-5G 
2-Deoxy-D-glucose (2-DG) Calbiochem 25972 
3-Methyladenine (3-MA) Sigma M9281-100 MG 
Ampicillin Thermo Fisher 11593027 
Antimycin A Sigma A8674-25MG 
ATP determination kit Molecular Probes A22066 
Bafilomycin A1 (BafA1) LC Labs B-1080 
BAPTA-AM  AAT Bioquest 21001 
Cyclopiazonic acid (CPA) Sigma C1530-5 MG 
Cyto-ID autophagy kit Enzo Life Sciences ENZ-51031-0050 
DharmaFECT Dharmacon T-2001-01 
Dimethylsulfoxide (DMSO) Sigma 276855-100ML 
Dithiothreitol (DTT) Sigma D-9163 
Dulbecco's Modified Eagle Medium 
(DMEM) 
HyClone SH30022.02 
EGTA Sigma E-0396 
Ethanol, absolute Fisher Scientific E/0650DF/17 
Foetal bovine serum (FBS) Gibco 10500 
Fura-2-AM Thermo Fisher F1221 
Geneticin, powder (G-418 sulfate) Thermo Fisher 11811-023 
Gö 6983 (PKC inhibitor) Sigma G1918-500UG 
Hydrogen peroxide- 30 % (w/w) in H2O Sigma H1009-5ML 
Ionomycin, free acid Sigma I9657 
jetPEI DNA transfection reagent Source Bioscience 101-01N 
Kanamycin  Thermo Fisher 11815024 
KN-92  Calbiochem 422709 
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Chemical or solution 
 
Supplier 
 
Catalogue number 
KN-93 (CaMKII inhibitor) Calbiochem 422708 
Laminin Sigma L2020-1MG 
L-glutamine Thermo Fisher 25030081 
Luciferase from Photinus pyralis 
(firefly) (for use with the ATP kit) 
Sigma L9506-2MG 
MCU antibody Sigma HPA016480 
Menadione Selleckchem S1949 
Methyl pyruvate Sigma 371173-25G 
Minimal Essential Medium (MEM) 
amino acids (50X) 
Thermo Fisher 11130051 
MTT (thiazolyl blue tetrazolium 
bromide) 
Sigma M2128 
 
Nocodazole Sigma M1404 
Non-essential amino acids (100 X) Thermo Fisher 11140050 
NuPAGE LDS sample buffer (4X) Thermo Fisher NP0007 
Oligomycin A Sigma 75351-5MG 
Paraformaldehyde (PFA) Sigma P6148 
Penicillin-Streptomycin Thermo Fisher 15140122 
Phosphate-buffered saline (PBS) Sigma P3813 
PierceTM BCA protein kit Thermo Scientific 23225 
PierceTM ECL Thermo Scientific 32109 
Pluronic F-127 Thermo Fisher P-3000MP 
Power SYBR®Green PCR Master Mix  Thermo Fisher 4367659 
Propidium iodide Sigma P4170-10MG 
Protease Inhibitor Cocktail Set III, 
EDTA-Free 
Calbiochem 539134 
QIAprep Spin Miniprep Kit Qiagen 27104 
Rapamycin Enzo Life Sciences BML-A275- 0025 
Rhod-2-AM, ultrapure AAT Bioquest  21062 
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Chemical or solution 
 
Supplier 
 
Catalogue number 
RNA extraction kit 
High-Capacity RNA-to-cDNATM Kit 
Thermo Fisher 4387406 
RNase A Alfa Aesar J62232 
RNeasy kit  Qiagen 74104 
RU360 Santa-Cruz sc-222265 
SB 216763  Selleckchem S1075 
siRNA MCU  
(ON-TARGETplus Human MCU siRNA 
SMARTpool) 
Dharmacon L-015519-02 
 
siRNA control  
(ON-TARGETplus Non-targeting siRNA) 
Dharmacon D-001810-10 
Sodium pyruvate Thermo Fisher 11360070 
STO-609  Stratech C17-900-SGC 
Tali® cellular analysis slides Tali® T10794 
Thapsigargin Thermo Fisher T7458 
ThioflavinT Sigma T3516 
Tissue culture inserts (0.4 µm) Greiner 665641 
Trypsin-EDTA solution Gibco 25200-056 
U-73122 hydrate Sigma U6756  
Wheat Germ Agglutinin (WGA) Thermo Fisher W11262 
Table 2.1 List of chemicals or solutions used, with their relevant supplier and catalogue 
number. The name of the chemical and its acronym or abbreviation used in the text are 
shown. 
 
2.2 Cell culture 
2.2.1 Cell lines used 
HeLa cells 
HeLa cells are an immortalised human epithelial cervical cell line that proliferate as 
attached cells. With regard to ER Ca2+ release channels, HeLa cells mainly express InsP3R1 
and InsP3R3. Some RYR2 expression has been shown [321]. Early studies have shown that 
these cells can be transiently activated by histamine through H1 receptors [322]. 
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HEK-293 cells 
HEK-293 cells (hereafter denoted ‘HEK cells’) are immortalised human embryonic kidney 
cells that were developed by Frank Graham [323], and have since been an important cell 
line for use in biology, virology and molecular biology research. HEK cells are epithelial cells 
that mainly express InsP3R2 and InsP3R3 [324].  
GFP-LC3 HEK cells and GFP-LC3 HeLa cells 
HeLa and HEK cell lines stably expressing GFP-LC3 were a gift from The Katholieke 
Universiteit (KU), Leuven and The Babraham Institute respectively. The GFP-LC3 HeLa cells 
were initially observed to be heterogenous in GFP-LC3 expression, which made it difficult 
to find appropriate settings for imaging. The GFP-LC3 HeLa cells were therefore sub-cloned 
to obtain a population of cells with a more homogenous GFP-LC3 expression. Cells were 
seeded onto glass coverslips at 4 x 104 cells /mL in 12 well plates for 48 hours before use.  
GFP-LC3 HEK cells were grown on laminin-coated glass coverslips 48 hours before imaging. 
The laminin coating was applied by adding a 25 µg/mL laminin solution (made up in PBS) to 
ethanol- and PBS-washed coverslips for one hour at 37°C. After removal of the laminin the 
coverslips were left to air dry before seeding with cells. 
RFP-GFP-LC3 HeLa cells  
This cell line was created by stably transfecting RFP-GFP-tagged LC3 in HeLa cells during 
this project. RFP-GFP-tagged LC3 is a tandem sensor that was used for monitoring the 
various stages of autophagy. Compared to GFP-LC3 expressing cells, where it is only 
possible to monitor autophagosome activity, the RFP-GFP-LC3 cell line can be used to 
assess the full autophagic flux and distinguish between autophagosomes and 
75 
 
autolysosomes. Cells were seeded on glass coverslips at 4 x 104 cells /mL in 12 well plates 
for 48 hours before use. 
Two-pore channel null (TPC) 1/2 (WT and -/- ) MEF cells  
TPC 1/2 -/- MEF cells and their corresponding wild type MEF cells were obtained from 
Professor Antony Galione (University of Oxford). Ruas et al. (2015) first showed that TPC 
1/2-/-   knockout in MEF cells abrogates NAADP-induced Ca2+ signals. Although there is still 
some debate about the role of NAADP, it has been shown to play a role in many 
physiological contexts such as smooth muscle contraction, autophagy and cardiovascular 
physiology [325]. We used TPC1/2-/- cells, and their corresponding control TCP-expressing 
MEF cells, were used to study the role of these channels have in the regulation of 
autophagy. The TPC1/2-/- cells and their corresponding controls were seeded onto glass 
coverslips at 3 x 104 cells /mL in 12 well plates, then transiently transfected with GFP-LC3 
24 hours later, and used in experiments 24 hours following transfection. 
2.2.2 Growth of cells 
 
All the cell types described above were maintained in DMEM supplemented with 10% FBS, 
50 U/mL penicillin and 50 µg/Ml streptomycin in a standard cell culture incubator (i.e. 
humidified environment with 5% CO2 at 37°C). For those cell lines that needed continual 
selection (i.e. HeLa or HEK cells stably expressing GFP-LC3 or RFP-GFP-LC3), 400 µg/mL or 
800 µg/mL geneticin was added to the cell culture medium. Cells were passaged every 2 or 
3 days depending on confluency, with the aim of keeping them sub-confluent at all times. 
For passaging, the DMEM surrounding the cells was aspirated, and the cells were 
superfused with PBS and then incubated with a 0.05% trypsin/0.2% EDTA solution at 37°C 
for a maximum of 2 minutes. Following dissociation of the cells from their cell culture 
substrates, the action of trypsin was terminated by addition of fresh DMEM with the 
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supplements described above. The cells in suspension were counted using a 
haemocytometer. To obtain the number of cells per mL, the number of cells in a 1 mm2 
square of the haemocytometer grid was multiplied by 10,000. Subsequently, cells were re-
suspended in DMEM at the desired density and plated onto 16 mm coverslips (for imaging) 
or into 25 cm2 flasks (for perpetuation).  
2.2.3 Cell storage and recovery 
 
For long-term storage, cells were re-suspended in freezing media (10% DMSO, 90% FBS 
v/v), placed in cryo-vials in 1 mL aliquots and frozen at a rate of 1oC per hour to –80oC in a 
pre-cooled freezing tub, and then kept within in a –80oC freezer or in a liquid nitrogen 
cryopreservation container. Cells were resuscitated from frozen by thawing at 37 °C and 
then re-suspended in 4 mL warm complete medium before being transferred to a 25 cm2 
flask. Once the cells were adherent, their surrounding medium was aspirated and replaced 
with fresh DMEM plus supplements in order to remove the DMSO present in the freezing 
medium. 
2.2.4 Sub-cloning 
 
In order to obtain a population of HeLa cells that expressed a homogenous level of GFP-
LC3, cell cloning by serial dilution was carried out in a 96 well plate. The protocol was 
adapted from the article "Cell cloning by Serial Dilution in 96 Well Plates” (Corning). First, 
HeLa cells expressing heterogeneous levels of GFP-LC3 were plated at 4,000 cells/200 µL in 
the first well of a plate (well A1). 100 µL of cell culture medium was added to all wells except 
for well A1. Using a single channel pipette, 100 µL of the cell solution in well A1 was 
transferred to well B1, mixing gently and avoiding bubbles. These 1:2 dilutions were 
sequentially carried out across the columns of wells (i.e. wells A1 – H1) discarding 100 µL 
from well H1 so that it ended up with the same volume as all the wells above it. 100 µL of 
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cell culture medium was added to all wells in column 1, giving a final volume of 200 µL for 
each. Quickly after, 100 µL from the wells in column 1 were transferred to column 2 and all 
the way across the plate to the last column. As before, 100 µL medium was added to all 
wells to give a final volume of 200 µL. The plate was placed in a cell culture incubator under 
standard conditions. Colonies were detectable by microscopy 5 days after plating. Wells 
that contained a single colony were selected and the cells were sub-cultured into one well 
of a 12 well plate. Following a few days of growth, 3 wells from the plate were checked for 
populations where >95% of the cells expressed the fusion protein of interest (GFP-LC3) at 
approximately the same level.  The colonies checked were passaged in T25 flasks 
individually. Clones displayed stability with time and were expanded and frozen for later 
use.  Autophagy studies, such as inducing cells with rapamycin and nutrient starvation, 
were also carried out and results showed the same effects with all 3 clones. Transient 
transfection with InsP3 5’-phosphatase showed the 3 clones transfected at the same 
efficiency. Altogether results demonstrated that any of the 3 clones were suitable for use. 
2.3 Molecular biology 
2.3.1 Transformation of E.coli 
 
100 µL of competent cells (DH5α) (thawed on ice) were added to a cold, sterile tube with 1 
- 5 µL DNA. The mixture was heat shocked at 42oC for 2 minutes and returned on ice. 600 
µL of LB media (without antibiotics) was added to each tube and incubated at 37oC in an 
orbital shaker for 1 hour. 100 or 200 µL of the transformation mix was spread onto 
antibiotic-containing LB agar plates (ampicillin or kanamycin) and incubated at 37oC for 16-
24 hours.  
 
 
78 
 
2.3.2 Plasmid DNA preparation 
 
Single colonies were picked from the agar plates and used to inoculate 10 mL aliquots of 
LB media containing the required antibiotic. The colonies were grown at 37oC with gentle 
agitation in an orbital shaker at 220 rpm overnight until the mixture was cloudy. Bacteria 
were collected in 5 mL aliquots and plasmid DNA was isolated using a miniprep kit (Qiagen) 
following the manufacturer’s protocol. The resultant plasmid DNA was re-suspended in TE 
buffer and stored at -20 oC. 
2.4 Transfection 
2.4.1 Expression vectors 
 
The following expression vectors are gifts from: 
RFP-GFP-LC3:  Laboratory of Molecular and Cellular Signaling, KU Leuven Belgium. 
GFP-LC3: Laboratory of Molecular and Cellular Signaling, KU Leuven Belgium. 
mCherry InsP3 5’phosphatase: The Babraham Institute, Cambridge. 
GFP InsP3 5’phosphatase: The Babraham Institute, Cambridge. 
The mCherry and GFP InsP3 5’-phosphatase constructs were a gift from Professor Llew 
Roderick (KU Leuven, Belgium). Sequence information was not given, although the cloning 
and sequence were verified. The InsP3 5’-phosphatase was originally cloned by Professor 
Christophe Erneux [326] and incorporated in a mammalian expression vector. The inactive 
InsP3 5’-phosphatase has a D232A mutation, which is known to make the enzyme 
catalytically inactive [327]. 
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The constructs used encode kanamycin resistance for selection in bacteria and neomycin 
resistance which allows cells expressing the construct to be selected for using geneticin in 
mammalian cells.  
2.4.2 Transient transfection 
 
Cells were seeded either onto 16 mm glass coverslips in 12-well plates (for imaging 
experiments), or into 6-well dishes for PCR and transfected at 70 - 80% confluency 24 hours 
post seeding, and 12 – 24 hours prior to imaging experiments. JetPEI® transfection reagent 
was used for DNA transfection in all studies in accordance with the manufacturer’s 
instruction. In brief, DNA encoding the gene of interest and NaCl, and similarly JetPEI and 
NaCl, were mixed together and vortexed. The JetPEI/NaCl mix was added to the DNA/NaCL 
mix, vortexed and incubated for 15-30 minutes at room temperature (the amount of DNA 
and solution volumes are shown in Table 2.2). Following incubation, ~100 µL of the 
resulting solution was added dropwise to the DMEM surrounding the cells. 
  
 
 
 
 
 
Table 2.2 Ratio of Jetpei to DNA (per well of a 12-well plate). 
 
2.4.3 Stable transfection  
 
The RFP-GFP-LC3-expressing HeLa cells were generated by initially following the transient 
transfection protocol, but then selecting test clones using the colony isolation procedure 
described in section 2.2.4. To maintain the RFP-GFP-LC3 expression, a ‘kill curve’ of 
 DNA mix Transfection reagent mix 
HeLa and HEK cells DNA NaCl (150 mM) Jetpei NaCl (150 mM) 
1 µg 50 µL 2 µL 50 µL 
MEF cells 1 µg 50 µL 8 µL 50 µL 
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geneticin-dependent cell death was established to determine the minimal antibiotic 
concentration at which non-transfected cells would die. For this, HeLa cells were seeded in 
a 24-well plate and incubated for 72 hours with geneticin concentrations ranging from 50 
µg/mL to 1,000 µg/mL. Clones were selected and amplified, and then tested with 
rapamycin and bafilomycin to ensure that the RFP-GFP-LC3 reporter construct was 
sensitive to inducers of autophagy. 
2.4.4 siRNA transfection 
HeLa and HEK cells were seeded in 6-well plates in antibiotic-free complete medium 
(DMEM+FBS) and were transfected with siRNA solutions 48 hours post seeding. 
DharmaFECT (Dharmacon) was used to facilitate siRNA transfections, using the 
manufacturer’s protocol. In brief, in separate tubes, the siRNA (Tube 1) and the appropriate 
DharmaFECT transfection reagent (Tube 2) were diluted with serum-free medium and 
incubated for 5 minutes at room temperature.  Contents of tube 1 were added to tube 2, 
mixing carefully. The mix was incubated for 20 minutes at room temperature. Antibiotic-
free complete medium was added to the mix for a final MCU siRNA concentration of 25 
nM. Culture medium from wells of the 6-well plate were replaced with the appropriate 
transfection medium to each well. Cells were incubated for 72 hours before lysates were 
collected for western blotting analysis using antibodies directed against the MCU and to 
confirm inhibition of gene expression. Control transfections were performed in parallel 
using a negative control siRNA (non-silencing). siRNA sequences are shown in Table 2.3. 
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siRNA Sequence 
non-targeting UGGUUUACAUGUCGACUAA 
UGGUUUACAUGUUGUGUGA 
UGGUUUACAUGUUUUCUGA 
UGGUUUACAUGUUUUCCUA 
 
Human MCU siRNA GAUCAGGCAUUGUGGAAUA 
GUUUUGACCUAGAGAAAUA 
ACUGAGAGACCCAUUACAA 
GUAAUGACACGCCAGGAAU 
Table 2.3 siRNA sequences used in transfection experiments. 
 
2.5 Quantification of ATP in cells 
2.5.1 Solutions used 
 
2-deoxyglucose solution: this solution is similar to complete imaging medium (section 2.10), 
but with replacement of D-glucose by 5.5 mM 2-deoxyglucose. 
To determine ATP concentration in cells, a luciferase-based luminescence assay was used. 
HeLa and HEK cells were seeded at a density of 40,000 cells per well in 12-well plates. 
Where necessary, cells were transfected (e.g. with InsP3 5’-phosphatase) 12 hours post 
seeding. Various treatments (e.g. oligomycin, antimycin and 2-deoxyglucose solution) were 
added to cells within a well, and the cells further incubated for 1 hour. At the appropriate 
sampling time, the media surrounding the cells was carefully aspirated and cells were 
washed twice with PBS, before the addition of 0.5 mL boiling distilled water. This boiling 
water method (adapted from Hu et al.) was used to lyse cells and extract ATP instead of 
other methods that involve chemicals such as perchloric acid or Tris-borate, which were 
found to interfere with the luciferin-luciferase system. Additionally, the boiling water 
method of ATP extraction was found to be effective in inhibiting ATPases, and thereby 
prevent post-lysis degradation of ATP. Following lysis, cells were suspended by repeated 
pipetting and then centrifuged at 12,000g for 5 minutes at 4°C. 10 µL of the supernatant 
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was used for luminescence measurement using the ATP Determination Kit (Molecular 
Probes). The ATP measurement protocol was carried out as per the manufacturer’s 
instructions in a 96 well plate. This involved the addition of 90 µL of a reaction solution that 
consists of Luciferin, DTT, Luciferase and a reaction buffer provided in the kit. The reaction 
buffer consists of 500 mM Tricine buffer, pH 7.8, 100 mM MgSO4, 2 mM EDTA and 2 mM 
sodium azide. 10 µL ATP standard solution and sample supernatants were added to the 
reaction buffer for a final volume of 100 µL. The plate was then placed in an OPTIMA 
FluoStar plate reader for luminescence detection at 560 nm. 
Luciferase solution (purchased as a powder separately from Sigma) was prepared by 
diluting the powder in 1 M Tris-buffer (composition: 6.05g TrisBase in 30 mL dH20, pH 
adjusted to 7.3 using HCl then made up to 50 mL with dH20). A standard curve of ATP 
concentrations (spanning 50 to 2,000 nM) was generated by serial dilutions from a stock 
solution containing 10 µM ATP. This standard curve was used to relate luciferase output 
from the cell samples to ATP concentration.  
2.6 Determining cell viability using an MTT assay  
 
To determine potential changes in cell viability or metabolism, the colorimetric MTT 
metabolic activity assay was carried out on cells cultured in 96 well plates. HEK and HeLa 
cells were cultured at 1 × 104 cells/well overnight in a cell culture incubator under standard 
conditions. Where indicated, cells were transfected (e.g. with InsP3 5’-phosphatase) for 12 
hours. To induce cell death, 100 µM menadione (a pro-apoptotic agent) was added to some 
cells, but not the cells in the control wells, and they were returned to the incubator for a 
further 12 hours. Subsequently, the cell culture medium surrounding the cells was 
aspirated, and was replaced with 60 µL/well of MTT solution (5 mg/mL constituted in dH20,) 
and incubated for 2 to 4 hours in a cell culture incubator under standard conditions. After 
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incubation, the MTT solution was aspirated and 100% DMSO (100 μL/well) was added to 
dissolve the purple formazan precipitate formed in the assay. The plate was then placed in 
an OPTIMA FluoStar plate reader, and the absorbance of each well was measured at 540 
nm.  
2.7 Measuring endoplasmic reticulum stress 
 
WT HeLa cells were seeded onto 16 mm glass coverslips in 12-well plates for 48 hours 
before use. Some cells were transfected with InsP3 5’-phosphatase 12 hours post seeding 
and on the day of experimentation, some coverslips were treated with hydrogen peroxide 
for 1.5 or 3 hours, or with DTT for 1, 2 or 4 hours for use as positive controls. Cells were 
incubated with 0.5 µM thioflavin T in the last 10 minutes of treatment and visualised in the 
GFP mode on the Leica wide-field microscope for measuring overall fluorescence intensity. 
DTT, which causes ER stress by interfering with disulfide bond formation, was made up 
fresh on each day of experimentation. 
Quantitative reverse transcription PCR (qRT-PCR) (section 2.8) was carried out as another 
tool for measuring ER stress in HEK cells. 
2.8 Quantitative real-time PCR 
HEK and HeLa cells were seeded at a density of 8 x 104/mL in 6-well plates and were either 
transfected with InsP3 5’-phosphatase the next day for 24 hours or incubated with other 
treatments such as H202 for 3 hours two days post-seeding. Following the experimental 
treatments, total RNA was extracted from both cell types using an RNeasy kit (Qiagen). RNA 
was quantified using a Nanodrop (NanoDrop™ One, Thermo Scientific) and 0.5 µg RNA was 
transcribed into cDNA using a High-Capacity RNA-to-cDNATM Kit (Thermo Fisher). cDNA was 
used at a 1/20 dilution, and qRT-PCR was performed using Power SYBR®Green PCR Master 
Mix (Thermo Fisher) in a reaction volume of 25 μl on an BioRad DNA Engine Opticon 2 Real-
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Time Cycler. Primer sequences (synthesised by Eurofins Genomics) are shown in Table 2.4. 
Thermal cycling conditions were 95°C for 5 minutes following PCR Master Mix addition, 
followed by 40 cycles comprising: 95°C for 30 seconds, 58°C for 30 seconds and 72°C for 30 
seconds. At the end of the PCR cycling, melting curves were investigated to determine the 
amplification of a single product and the absence of primer dimers. A melting curve shows 
the change in fluorescence detected when double-stranded DNA (dsDNA) with an 
incorporated dye dissociates, or “melts” into single-stranded DNA (ssDNA) as the reaction’s 
temperature is raised. For example, when double-stranded DNA bound with SYBR Green I 
dye is heated, a sudden decrease in fluorescence is detected when the melting point (the 
temperature at which 50% of DNA is denatured) is reached. This is due to dissociation of the 
DNA strands and a consequent release of the dye. SYBR®Green dye is able to detect any 
double-stranded DNA including primer-dimers, contaminating DNA and PCR products from 
mis-annealed primers therefore by viewing the melting curve, one can ensure that the 
desired amplicon is detected. 
 
2.8.1 Analysis of real-time PCR 
Ct (threshold cycle) values, which show the number of cycles taken to detect a real signal 
from the samples, are obtained at the end of the PCR assay and are used for quantification. 
Results were calculated and normalised against GAPDH as endogenous control using the 
2^-ΔΔCt method [328]. . The fold change in mRNA was calculated using the following 
equations: 
2^-ΔΔCt , where ΔΔCt = ΔCTE – ΔCTC  
 (Δ represents change, CTE are Ct experimental values, and CTC are Ct control values). 
ΔCTE = TE-HE  
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(TE: gene tested experimental, HE: housekeeping gene experimental)  
ΔCTC = TC-HC (TC: gene tested control (untreated), HC: housekeeping gene control).  
One-way ANOVA or one-sample t-tests were applied to determine the differences in mRNA 
expression between samples using a hypothetical value of 1 (control). A P value < 0.05 was 
considered as the threshold for statistical significance. 
Gene Primer sequence (5’ to3’) 
GAPDH Forward AGGGCTGCTTTTAACTCTGGT 
GAPDH Reverse CCCCACTTGATTTTGGAGGGA 
GRP78/BiP Forward ACGTGGAATGACCCGTCTGT 
GRP78/BiP Reverse AACCACCTTGAACGGCAAGA 
Table 2.4 Oligonucleotides primers used for PCR with their relevant sequence. 
 
2.9 Western blotting 
2.9.1 Western blotting solutions 
 
Running buffer: contains 190 mM Glycine, 0.1% SDS and 25 mM Tris-HCL (pH 8.3).                                 
Stripping buffer: contains 2% SDS, 62.5 mM Tris (pH 6.7) and 100 mM β-mercaptoethanol. 
TRIS-buffered saline (TBS) (pH 7.6): contains 10 mM TRIS-HCL and 150 mM NaCL                                   
TRIS-buffered saline + Tween (TBST): contains 0.05% Tween-20 and TBS. 
Laemmli sample buffer: contains 3% SDS, 4 mM EDTA (pH 8.0), 500 nM sucrose, 0.005% 
Bromophenol blue and 80 mM Tris/HCL (pH 7.0).                                                                                   
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Transfer buffer: contains 192 mM Glycine, 25 mM Tris-HCL and 20 % Methanol. 
Ponceau-S: contains 0.1% w/v Ponceau-S and 1% v/v Glacial acetic acid.                                          
Blocking buffer: contains 8% w/v non-fat dry milk in TBST. 
Lysis buffer: this solution was used for preparing cell lysates for western blotting. Lysis 
buffer contained 40 mM Na3VO4, 20 mM Tris-HCL (pH 7.6), 140 mM NaCl, 1% Triton X-100 
and a cocktail of protease inhibitors (freshly added at 1/100 to the lysis buffer before use). 
2.9.2 Preparation of cell lysates 
Cells were grown in 25 cm2 flasks to obtain sufficient amounts for immunoblotting (or 6-
well plates for MCU siRNA (section 2.4.4)). Cell lysates were prepared on ice, with reagents 
at ice-cold temperatures and centrifuges pre-cooled to 4°C. The medium surrounding the 
cells was aspirated, and the cells were washed. Cells were displaced from culture flasks 
using a cell scraper and then centrifuged 10,000 RPM for 5 minutes. The pellet was washed 
with PBS and re-suspended in 500 µL lysis buffer, placed on a shaker for 30 minutes, and 
centrifuged again for 5 minutes at 10,000 rpm. The supernatant was kept and analysed for 
protein content. 
2.9.3 Protein determination  
To quantify the amount of protein in cell lysates, a protein assay kit involving bicinchoninic 
acid (BCA) was used in a 96-well plate format with 10 µL Bovine serum albumin (BSA) 
standard and 2 µL samples in duplicates. The BCA reagent was prepared by adding 4% 
copper (II) sulphate to BCA at a ratio of 1:50. BCA reagent was added to each well of the 
plate and incubated at 37°C for 30 minutes, during which time a change of colour took 
place. Absorbance values were obtained by reading the plate at 562 nm on either the 
OPTIMA or FLEXSTATION plate readers. Protein concentration in the lysates was calculated 
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by reference to a standard curve obtained by adding the BCA mix to wells in the 96-well 
plate that contained a range of BSA Concentrations (0, 0.025, 0.125, 0.5, 0.75, 1, 1.5 and 2 
mg/mL).  
2.9.4 Gel Electrophoresis  
Pre-cast gels were used to resolve proteins within the cell lysates. The gels used were 4-
12% Bis-Tris (NuPAGE) or 4-20% Tris-glycine (NOVEX). To prepare for Western blotting, cell 
lysates (1µg/µL in 15µL) were diluted in 4x NuPAGE LDS (for Bis-Tris gels) or Laemmli sample 
buffer (for Tris-glycine gels) and heated to 75°C for 5 minutes. The comb associated with 
the pre-cast gels was removed, and the wells were washed to remove any bubbles or 
residue. The electrophoresis chamber was filled with running buffer (or MES 20x for Bis-
Tris gels; NOVEX) and the heated samples were loaded onto wells alongside molecular 
weight protein standards (Novex Sharp Pre-stained protein standard, Thermofisher). Once 
assembled in the electrophoresis system (Invitrogen), gels were subjected to 125 - 180 V 
until the sample buffer had reached the bottom of the gel. 
2.9.5 Transferring proteins from the gel to membranes for staining 
Gels were carefully removed from their associated glass plates. The proteins within the gels 
were subsequently transferred to either Immobilon-P polyvinylidine difluoride (PVDF) or 
nitrocellulose membranes transfer. The gel and appropriate membrane were sandwiched 
between sponges and filter papers soaked in transfer buffer. PVDF membranes were 
soaked in methanol for 15 seconds, followed by dH20water for 2 minutes, and then pre-
soaked along with the sponges in transfer buffer. Nitrocellulose membranes were only 
briefly soaked in transfer buffer before sandwiching. The sandwich was then placed in a 
Novex Mini-cell system (Invitrogen). The inner chamber was filled with transfer buffer and 
the outer chamber with water. Proteins were transferred from gel to membrane by 
88 
 
application of 100 V for 1 hour at 4°C (PVDF) or 30 V for 2.5 hours at room temperature 
(nitrocellulose). 
2.9.6 Immunodetection  
Following the transfer step described above, the membranes were stained with Ponceau-S 
to visualise protein transfer and to ensure equal transfer of samples. The membranes were 
consequently washed in distilled water, and incubated for 1 hour in blocking buffer at room 
temperature on a rocking plate. The membranes were then incubated overnight at 4°C in 
blocking buffer with primary antibody. The primary antibodies used in this study are listed 
in Table 2.5. The following day, the antibody solution was replaced with TBS-T, and the 
membrane was placed on a rocking plate for 1 hour at room temperature, with the TBS-T 
exchanged every 10 minutes. The membranes were then incubated in the appropriate 
horse radish peroxidase (HRP)-conjugated secondary antibody in TBS-T-milk for 1 hour at 
room temperature on a rocking plate. This was followed by washes in TBS-T for 1 hour with 
the TBS-T exchanged every 10 minutes. The secondary antibodies used in this study are 
listed in Table 2.6. An additional wash was carried out in TBS without tween just before the 
protein detection step. Finally, the membranes were incubated in enhanced 
chemiluminescence (ECL) reagent for 2 minutes. Excess reagent was drained before 
detecting protein bands using a G:BOX gel doc system (Syngene) running Genesys software 
or ChemiDoc imaging system (BIO-RAD). Analysis was carried out using either ImageJ 
software or BIO-RAD Image Lab. 
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Table 2.5. Primary antibodies used in Western blotting. 
 
Antibody Supplier Catalogue number Source Dilution 
peroxidase-conjugated 
anti-mouse IgG 
Thermo 
Fisher 
R-21455 Rabbit 1/2500 
peroxidase-conjugated 
anti-rabbit IgG 
abcam ab6721 
 
Goat 1/5000 
Table 2.6. Secondary antibodies used in Western blotting. 
 
Antibody Supplier Catalogue 
number 
Source immunogenic 
protein/peptide 
Dilution 
Beclin-1 Santa Cruz sc-48341 mouse amino acids 1-300 of 
BECN1 of human origin 
1/500 
Calreticulin 
(CRT) 
Abcam ab92516 rabbit amino acid sequence is in 
the first 100. 
1/1000 
GAPDH Sigma G8795 mouse full length from  rabbit 
GAPDH 
1/50,000 
LC3  Nanotools 0231-100/ 
LC3-5F10 
mouse peptide conjugated to 
hemocyanin. epitope: N-
terminus of LC3-B. 
1/200 
MCU Sigma HPA016480 rabbit Coiled-coil domain-
containing protein 109A 
recombinant protein 
epitope signature tag 
(PrEST) 
1/200 
P62 CST 5114 rabbit the epitope surrounding 
Gly410 is ~10-20 amino 
acids long 
1/10,000 
SERCA2 CST 9580 rabbit 
 
residues near the amino 
terminus of human 
ATP2A2/SERCA2  
1/500 
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2.10 Calcium recording 
2.10.1 Solutions used 
 
Complete imaging medium and starvation medium 
During the experiments described in this study, cells were either maintained in culture 
medium in a cell culture incubator (i.e. humidified environment with 5% CO2 at 37°C), or 
when they were removed from the incubator, cells were superfused with an extracellular 
solution based on a formulation that has been used in my lab for a number of years [329].  
‘Complete imaging medium’ was designed to support the long-term survival of cells outside 
the cell culture incubator, whilst ensuring that autophagy was not activated. Complete 
imaging medium contained 121 mM NaCl, 5.4 mM KCl, 0.8 mM MgCl2, 1.8 mM CaCl2, 6 mM 
NaHC03, 5.5 mM D-Glucose, 25 mM Hepes (adjusted to pH 7.35 using 5 M NaOH), plus 
nutrients (10 % FBS, 2 mM L-glutamine, 1 x amino acids, 1 mM sodium pyruvate). As shown 
in the Results, the omission of these nutrients caused the activation of autophagy. In which 
case, this solution was denoted ‘starvation medium’. It is important to note that each cell 
line required different types of amino acids in the complete imaging medium. For example, 
non-essential amino acids were used for HeLa cells, however HEK cells required both non-
essential and essential amino acids (MEM).  
Ca2+-free solutions 
Where it was necessary, solutions were configured to be Ca2+ free by omitting CaCl2 during 
their preparation, and addition of 1 mM EGTA to chelate contaminating Ca2+ from the 
double distilled water. Care was taken to ensure that the solution was still at pH 7.35 after 
the addition of EGTA.  
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2.10.2 Fluorescent calcium dyes 
Cytosolic and mitochondrial Ca2+ changes were tracked using fluorescent indicator dyes. 
Fluorescent Ca2+ indicators are negatively charged, hydrophilic compounds that cannot 
easily cross the plasma membrane. To overcome this problem, acetoxymethyl (AM) ester 
groups are added to mask the negative charges on the carboxyl groups, therefore allowing 
the molecule to cross the plasma membrane. The AM form of indicators such as Fura-2 is 
not Ca2+ sensitive. Once inside the cell, endogenous esterases cleave the AM ester groups 
leaving a charged Ca2+-sensitive molecule remaining in the cell. The indicators used in these 
studies were Fura-2 and Rhod-2. Fura-2 AM was synthesised in 1985 in Professor Roger 
Tsien’s laboratory [330] and has the substantial benefit of being a ‘ratiometric indicator’. 
In essence, the ratiometric capability of Fura-2 was ideal for the long-term imaging 
experiments presented in this study. Ratiometric measurements account for differences in 
indicator loading between cells in a field of view, as well as the progressive loss of indicator 
due to indicator leakage or photobleaching [331]. Rhod-2 AM was also synthesised in 
Professor Tsien’s laboratory [330] and is a single-wavelength indicator that can be used in 
conjunction with Fura-2 as it has different excitation and emission spectra. Rhod-2 is a 
cationic molecule and therefore preferentially accumulates with the matrix of actively 
respiring mitochondria due to the potential difference across the inner mitochondrial 
membrane. Rhod-2 has been widely used for measurement of mitochondrial Ca2+ uptake. 
Both indicators can be co-loaded into cells, allowing simultaneous recording of the cytosolic 
and mitochondrial Ca2+ concentration. 
BAPTA-AM (10 µM), used to chelate intracellular Ca2+ (Figure 3.24), was loaded into cells 
for 1 hour prior to imaging at room temperature. 
92 
 
To prepare cells for imaging experiments, following tryspinisation cells were re-suspended 
in DMEM and plated onto 16 mm diameter glass coverslips for 48 hours prior to use at 70-
80% confluency. Prior to imaging, the 16 mm glass coverslips with adherent cells were 
mounted in a circular imaging chamber that was designed to fit on the stage of the Leica 
DMI6000 microscope that was used in these studies. Cells were loaded with either 1 µM 
Fura-2 AM and/or 5 µM Rhod-2 in complete imaging medium for 30 minutes at room 
temperature. Subsequently, the Ca2+ indicator was aspirated, and the cells were superfused 
with fresh complete imaging medium and left for another 30 minutes to allow the ester 
groups on the fluorescent indicator to hydrolyse. Fura-2 stock solutions were made at 1 or 
2 mM in DMSO containing 20% F-127 pluronic, aliquoted into single-use aliquots and kept 
at -20 ˚C. An aliquot was diluted in complete imaging immediately prior to use.  
To record Ca2+ signals, a field of cells on the coverslip was selected based on an even 
indicator loading and healthy appearance. A vacuum aspirator was set up in the imaging 
chamber to facilitate superfusion of the cells with experimental solutions. Imaging 
parameters such as excitation/emission light wavelength, exposure time, rate of image 
capture and pixel binning, were set using the Leica proprietary software. At the beginning 
of every recording, the basal fluorescence of Fura-2- or Rhod-2-loaded cells was recorded 
for 1 minute (unless otherwise stated in the figure legends) followed by addition 
experimental treatments (e.g. CPA, ionomycin, etc). A wash off period was sometimes 
incorporated (where stated in the figure legends) before any agonist additions. Fura-2 was 
alternately excited at 340 nm and 380 nm wavelengths (ultraviolet filter set), and emitted 
light >500 nm was recorded. Rhod-2 was excited at 540-552 nm (red filter set), and emitted 
light was recorded at 580-620 nm. For most experiments a 63x objective oil immersion was 
used (NA = 1.25). Fluorescence images (464 by 364 pixels) were captured using a 12-bit 
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DFC360 FX Digital Camera on the Leica DMI6000 light microscope which uses a halogen 
lamp as a light source. 
2.10.3 Analysis of Fura-2 and Rhod-2 recordings 
Video recordings were analysed using ImageJ software. Cells were outlined individually, 
and their raw fluorescence pixel intensity values at both 340 nm and 380 nm excitation 
were sampled and exported into a Microsoft Excel spreadsheet. A non-cellular area was 
used to sample the background signals at both the 340 nm and 380 nm excitation 
wavelengths. The 340 nm/380 nm ratio for each cell was calculated in Excel using the 
formula: 
Ratio = (fluorescence recorded from cell X with 340 nm excitation – background fluorescence at 340 
nm excitation)/ (fluorescence recorded from cell X with 380 nm excitation – background 
fluorescence at 380 nm excitation) 
The background-subtracted 340 nm/380 nm ratio was then used in GraphPad Prism to plot 
graphs, and to calculate outcomes such as the percentage of responding cells, peak 
response amplitudes and percentage of oscillating cells. 
2.11 Measuring autophagy and autophagy vesicles  
2.11.1 Solutions used 
 
Complete imaging medium and starvation medium 
During the experiments described in this study, cells were either maintained in culture 
medium in a cell culture incubator (i.e. humidified environment with 5% CO2 at 37°C), or 
treated with a complete imaging medium (see section 2.10) at room temperature to ensure 
that autophagy was not activated. As shown in the Results, the omission of  nutrients (10 
% FBS, 2 mM L-glutamine, 1 x amino acids, 1 mM sodium pyruvate) caused the activation 
of autophagy. In which case, this solution was denoted ‘starvation medium’. It is important 
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to note that each cell line required different types of amino acids in the complete imaging 
medium. For example, non-essential amino acids were used for HeLa cells, however HEK 
cells required both non-essential and essential amino acids (MEM).  
2.11.2 GFP-LC3 punctae quantitation  
Prior to use, GFP-LC3 HeLa or HEK cells were seeded on 16 mm coverslips and allowed to 
adhere and grow for 48 hours in a standard cell culture incubator before use. To visualise 
GFP-LC3 punctae, the glass coverslips with adherent cells were mounted in the imaging 
chambers described earlier and placed on the stage of the Leica DMI6000 light microscope. 
GFP was excited using 450-490 nm light, and emission of 500-550 nm. Autophagosome 
numbers in all autophagy studies were counted manually or using Image J (using the cell 
counter plugin or the manual thresholding function) and were from time to time verified in 
blind fashion by an independent observer. Punctae are dot like structures that are brighter 
in fluorescence than the overall background of the cell. Punctae were shown to be of similar 
size across the cells. Punctae were displayed as single dots and aggregations were very 
rarely seen. Using this criteria, the number of punctae per cell were counted and used a 
measure for analysing data. Expressing data in this manner is generally the preferred in 
autophagy research compared to for example “percentage of cells with GFP-LC3 punctae”.  
2.11.3 Cyto-ID reagent detection kit 
Cyto-ID dye (Enzo Life Sciences), is a cationic amphiphilic tracer fluorophore that was used 
in this study to assess numbers of autophagic vesicles in situations where GFP-LC3 
expression was not appropriate (e.g. with MEF cells). The protocol was followed as per the 
manufacturer’s instructions. In summary, cells were exposed to various treatments then 
washed twice with the assay buffer provided with the Cyto-ID kit. 5% FBS was added to the 
assay buffer to preserve cells and prevent the induction of autophagy, since autophagic 
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cells can be easily dislodged during washing. Subsequently, a solution containing Hoechst 
33342 Nuclear Stain and the autophagosome-specific Cyto-ID indicator was added to cells 
for 30 minutes at 37 °C.  The cells were then washed with fresh assay buffer before being 
mounted in an imaging chamber and placed on the stage of the Leica DMI6000 microscope.  
The Cyto-ID-labelled punctae were visualised using a 63x objective and the same 
experimental settings as described earlier for imaging GFP-LC3-labelled punctae. 
2.11.4 RFP-GFP-LC3 HeLa cells 
The RFP-GFP-LC3 tandem reporter was used to assess autophagic flux where 
autophagosomes are evident as punctae with both green and red emission (from GFP and 
RFP, respectively), and autolysosomes are evident as punctae solely with red emission 
(from RFP only). The RFP-GFP-LC3-expressing cells were imaged using the Leica DMI6000 
light microscope using the 63x objective using similar conditions to those employed for 
monitoring GFP-LC3, but with the addition that RFP was simultaneously monitored.  RFP 
was excited using 590-650nm light, and the emitted light >660 nm was recorded.   
2.11.5 Electron microscopy 
2.11.5.1 Solutions used: 
0.2 M Sörenson’s phosphate buffer: 18 mM NaH2PO4, and 82 mM Na2HPO4 (pH7.4). 
Transmission electron microscopy was used to study the structure and size of autophagic 
vesicles in HEK cells. First, HEK cells were seeded into the top of transwell inserts (1 cm2, 
Corning Costar) in a 12-well plate. The transwell system consists of a top chamber 
containing porous membrane (pores of 0.4 µm) on which cells grow, and is filled with 0.5 
mL of cell culture medium, and a bottom chamber that contains 1.5 mL of PBS. The cells 
were seeded at a density of 100,000 cells per insert and incubated for 2 days in a standard 
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cell culture incubator (37°C with 5% CO2). Transwell inserts were coated with laminin 
before seeding HEK cells.  
Following cell incubation, the liquids from both parts of the transwell were removed and 
the cells were washed three times using Hanks’ balanced salt solution (Sigma). The cells 
were then fixed by application of a 2.5% glutaraldehyde solution for 1 hour at room 
temperature. The fixative was removed by washing the filter three times with 0.1 M 
Sörenson’s phosphate buffer (PB) and stored in this buffer at 4°C. Samples were then 
processed by Drs Igor Kraev and Radka Gromnikova in The Open University’s electron 
microscopy facility. The processing included post-fixation, dehydration and embedding in 
resin. Cultures were post-fixed in a solution containing 1% osmium tetroxide and 1.5% 
ferricyanide (to enhance membrane labelling) in 0.1 M PB for 1 hour. They were then 
washed three times in 0.1 M PB. The membrane of the transwell insert that contained cells 
was removed and dehydrated in series of ethanol solutions as follows: 30% ethanol for 5 
minutes, 50% for 5 minutes, 70% for 10 minutes, 100% for 10 minutes twice, and 100% 
ethanol with a molecular sieve (type 3A, Sigma) for 10 minutes. The molecular sieve 
dehydrates ethanol since atmospheric water absorbed when the ethanol bottle is open can 
decrease the percentage of ethanol. The membranes were then incubated in a mixture of 
100% ethanol and epon resin in 1: 1 ratio overnight. After that, the membranes were 
embedded in epon resin and formed blocks were polymerized at 60°C for 48 hours. The 
blocks were then microsectioned at 80 nm thickness with a diamond knife (Diatome). The 
sections were mounted onto pioloform-coated copper grids and counter stained in 3.5% 
uranyl acetate and lead citrate. The grids were imaged using a transmission electron 
microscope JEM 1010 (Jeol, Japan) Using an 80 kV electron beam gun for excitation and a 
spot size of 2 µm. A XR40 camera (Advance microscopy techniques; AMT, Woburn, MA, 
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USA) was used for capturing images and the software used for capturing images was AMT 
Image Capture Engine (AMT, Woburn, MA, USA). 
 
2.12 Analysis of cell cycle progression 
 
HEK cells were seeded in 12-well plates, and transiently transfected with DNA constructs 
as described in the Results. The positive control for cell cycle arrest (G2-M arrest) was 
nocodazole (100 nM for 12 hours).  24 hours post transfection, the medium surrounding 
the cells was aspirated, and the cells were fixed using a 4% paraformaldehyde (PFA) 
solution for 30 mins at room temperature. The cells were then scraped, centrifuged and 
washed with PBS. A mix of RNAse A (10 µg/mL), 0.1 % Triton X-100 and propidium Iodide 
(1 µg/mL) was added to the cells and incubated for 30 minutes in the dark. Subsequently, 
25 µL of the cell solution was aliquoted into the slots on slides compatible with a Tali 
cytometer (Invitrogen). Data analysis was performed on the cytometer itself, firstly by 
gating debris and aggregates out of the analysis by setting the correct size of HEK cells (5 - 
20 µm). Threshold gates were set for each phase of the cell cycle using the untreated 
sample (normal cell cycle histogram) and these settings were held constant across treated 
samples and the Relative fluorescence units (RFU) were displayed with their corresponding 
numbers and percentages of cells for each phase of the cell cycle. The data were analysed 
with a Two-way ANOVA using Tukey’s post-hoc multiple comparisons test. A P value < 0.05 
was considered as the threshold for statistical significance. 
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Chapter 3: Validating autophagic flux measurements using HeLa and HEK cell lines, and 
examining the necessity of cellular Ca2+ signalling for autophagy. 
 
3.1 Introduction 
 
Over the past decades there has been extensive research focusing on understanding the 
causes and mechanisms underlying autophagy, such as the discovery of evolutionarily-
conserved genes that regulate autophagy. Numerous techniques have been established to 
monitor dynamic autophagic flux, and to modulate it at various stages in order to 
understand its function and regulation [225]. The first methods in autophagy research 
(dating back to the 1950s) largely involved the use of electron microscopy [152]. 
Autophagosomes could be identified using this technique due to their obvious double 
membrane. However, this is not the case with autolysosomes, which are delimited by a 
single membrane (as described in detail in Chapter 1: Introduction). The use of fluorescence 
microscopy, enzyme assays and Western blotting and, molecular tools such as expression 
of fluorescently-tagged proteins and organelle markers, as well as techniques for 
preventing expression of particular proteins have increasingly been used to complement 
electron microscopy studies. Many of these techniques have the added advantage that 
they enable the investigation of the process in live cells [152, 332].  
A common approach for studying the induction of autophagy is to monitor the formation 
of autophagosomes by following the coalescence of GFP-tagged LC3 (GFP-LC3). GFP-tagged 
LC3 shows a largely diffuse distribution in resting cells, with a few brightly fluorescent spots 
(‘punctae’), which range from ~0.5 to ~1.5 µm in diameter. These punctae reflect LC3 
molecules coupling with the nascent phagophore and autophagosomal vesicles [333]. The 
few GFP-LC3 punctae in resting cells reflect a constitutive basal level of autophagy, whereas 
the number of GFP-LC3 punctae increases upon induction of autophagy [152]. Counting the 
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number of punctae can provide a quantitative assay for autophagic induction providing that 
certain control experiments are performed to ensure that autophagic flux, and not a 
blockage of vesicle processing, is being measured [334].  
The studies described here used HeLa and HEK cell lines that stably express GFP-LC3, in 
addition to other cell lines when required. Both HeLa and HEK cells were employed in this 
study in order to establish whether the responses seen were somewhat generic, or whether 
there was a cell type-dependence to the relationship between Ca2+ signalling and 
autophagy. Since the published literature describing the regulation of autophagy by Ca2+ is 
contradictory in places, it was considered that using two independent cell lines might help 
establish some consistent mechanisms. HeLa cells are ideal for this project because they 
are well understood from the perspective of Ca2+ signalling [335], they have highly 
reproducible responses to various agonists, and they can be readily transfected using 
standard cationic lipid reagents [336]. HEK cells are widely studied in the autophagy field, 
they have been widely used for studying various aspects of Ca2+ signalling, and they can 
also be readily transfected [337]. 
The work presented in this Chapter describes the characterisation of HEK and HeLa cells as 
tools to study the regulation of autophagy by Ca2+. It is essential to characterise the 
robustness of the cellular systems that were going be used in order to establish conditions 
in which the cells could be maintained on a fluorescence imaging microscope whilst 
ensuring viability, without extruding Ca2+ indicators, or triggering unwanted autophagy. 
The primary goal here was to determine experimental conditions where autophagic flux 
and cellular Ca2+ signals could be measured in real time, whilst analysing both processes 
simultaneously in the same cells. Moreover, cells can react to prolonged Ca2+ signals by 
remodelling their signalling toolkits [19] triggering stress responses and/or dying [338]. It 
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was therefore considered that an ideal experimental approach would be one where cells 
were investigated for a minimal duration whilst still yielding statistically significant 
outcomes for both autophagy and cellular Ca2+ signals. To be able to quantify autophagic 
flux in response to changes in cellular Ca2+ signalling and homeostasis, it was important to 
establish the response of HEK and HeLa cells to known activators and inhibitors of 
autophagy. Finally, the data in this chapter examines the necessity of cellular Ca2+ signals 
for triggering of autophagy in different conditions.  
3.2 Results 
Imaging medium contains Ca2+ 
 
(complete imaging medium) 
Imaging medium does not contain Ca2+ 
 
(Ca2+ -free medium) 
All figures (Figure 3.1 to 3.24) none 
Table 3.1 Experiments of Chapter 3 which were carried out in either complete imaging  
medium or Ca2+ -free medium. 
 
3.2.1 GFP-LC3-expressing HeLa and HEK cells remain viable, and autophagy is not 
activated in an extracellular medium that mimics their cell culture environment.   
 
Initial experiments sought to establish a medium whereby HeLa and HEK cells could be 
imaged on the stage of the fluorescence microscope for a prolonged period, but did not 
undergo cell death, and maintained basal levels of autophagy. Standard culture medium 
was not suitable for this purpose as it contains phenol red, which would have interfered 
with fluorescence recordings, and the pH buffering would not have been stable outside the 
environment of a gassed incubator. Therefore a supporting medium was established, based 
on standard HEPES-buffered imaging medium (Chapter 2: Materials and Methods) 
compatible with fluorescence imaging [294, 339, 340].  
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To begin imaging experiments, glass coverslips bearing growing cells were removed from 
the gassed incubator and the cell culture medium surrounding the cells was replaced with 
the medium used for imaging experiments. The glass coverslips were then transferred to 
imaging chambers, and the cells were superfused with fresh HEPES-buffered imaging 
medium. The solution change was performed as rapidly as possible so that there was no 
period in which the cellular integrity could be affected (e.g., due to drying out or a pH 
change), but without causing mechanical damage to the cells. The data presented in Figure 
3.1 show that HeLa cells suspended in HEPES-buffered medium supplemented with non-
essential amino acids (NEAA), 10% FBS, 2 mM L-glutamine and 1 mM sodium pyruvate 
(hereafter referred to as ‘complete imaging medium’) maintained basal levels of GFP-LC3 
punctae for up to 4 hours. The GFP-LC3 punctae could be readily quantified by manual 
counting (Chapter 2: Materials and Methods), and elaborated below. Superfusion of cells 
with imaging medium that did not contain the supplemented nutrients provoked a 
significant increase in the number of GFP-LC3 punctae following 1- or 4-hour incubations, 
consistent with an increase in autophagy.  
All four supplements were required to suppress the increase in GFP-LC3 punctae (Figure 
3.2). Sodium pyruvate was added to the medium due to its common addition to cell culture 
medium as an additional source of energy. FBS was also added to the medium, as studies 
have shown that serum starvation induces autophagy in many cell lines including 
astrocytes. Reports have shown that L-glutamine deprivation induces autophagy [341, 342] 
and was therefore added to the complete imaging medium. L-glutamine is a NEAA, which 
is not present in the NEAA solution used in this study. It was therefore necessary to add L-
glutamine to the complete imaging medium. Given that DMEM contains a mixture of non-
essential and essential amino acids, we added amino acids to the complete imaging 
medium to ensure that autophagy was not activated. HeLa cells required addition of NEAA, 
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whereas HEK cells also required the addition of essential amino acids.Since the purpose of 
this study was to examine the role of Ca2+ signalling in autophagy, no further investigations 
were made into medium constitution or different supplement combinations. Media in 
which all four supplements were omitted (hereafter termed ‘starvation medium’) was used 
in this study to trigger starvation-induced autophagy.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
103 
 
 
 
 
 
 
 
Figure 3.1.  The phenol red–free ‘complete imaging medium’ used for live cell imaging 
prevented the accumulation of GFP-LC3 punctae. The column graph is a quantitative 
representation of the effect of the nutrient-replete extracellular medium, which was used 
in this study, on GFP-LC3 punctae accumulation in HeLa cells. The complete imaging 
medium is similar to the medium in which the cells were cultured (i.e., containing NEAA, 
sodium pyruvate, L-glutamine and 10% FBS), but with HEPES and without phenol red. It was 
critical to this project that the complete imaging medium supported long-term survival of 
the cells and did not lead to the induction of autophagy. Removing the four nutrients led 
to elevated numbers of GFP-LC3 punctae in a time–dependent manner. The data are mean 
± S.E.M of 3 - 5 experiments (35 - 60 cells per condition). The data were analysed with a 
one-way ANOVA test. *** indicates p < 0.001 and **** indicates p < 0.0001.  
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Figure 3.2.  Optimisation of the composition of a phenol red–free medium for live cell 
imaging and to prevent induction of autophagy. The column graph is a quantitative 
representation of the effect of removing specific nutrients from HeLa cells suspended in a 
HEPES-buffered phenol red–free medium on GFP-LC3 punctae accumulation in HeLa cells. 
A nutrient-replete extracellular medium (complete imaging medium; black and dark grey 
bars), similar to the medium in which the cells were cultured, maintained the basal level of 
GFP-LC3 punctae. Removing any of the nutrients led to elevated numbers of GFP-LC3 
punctae. The data are mean ± S.E.M of 3 experiments (40 - 60 cells per condition). The data 
were analysed with a one-way ANOVA test. ** indicates p < 0.01. 
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To ensure that the complete imaging medium could suppress the accumulation of GFP-LC3 
punctae and maintain cell viability over a longer period of time, and to establish that the 1- 
and 4-hour time points analysed for the data presented in Figures 3.1 and 3.2 were not 
nearing the end of cell viability, both HeLa and HEK cells were incubated in the complete 
imaging medium for 12 hours. As shown by the cell images in Figures 3.3A and 3.4A, there 
was no obvious deterioration of the cells: they remained firmly attached with no evident 
morphological changes such as membrane blebbing, which could indicate a loss of viability. 
In addition, there was no increase in GFP-LC3 punctae accumulation in either cell type 
following the 12-hour incubation in complete imaging medium (Figures 3.3 and 3.4). These 
data indicate that the complete imaging medium was able to adequately support the cells’ 
long term nutritional needs, whilst also being compatible with fluorescence imaging.  
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Figure 3.3. Complete imaging medium maintained HeLa cell viability and basal levels of 
GFP-LC3 punctae for up to 12 hours. Panels A and B show representative images of HeLa 
cells incubated in complete imaging medium, which contained the same supplements as 
the usual cell culture environment (i.e., amino acids, sodium pyruvate, L-glutamine and 
10% FBS). Panels A and B show GFP-LC3 fluorescence (Ai and Bi) and bright field images (Aii 
and Bii) of cells at the start of incubation with complete imaging medium, and following a 
12-hour incubation, respectively. Similar numbers of GFP-LC3 punctae were observed at 
both time points. The images in panels Aii and Bii illustrate that the cells appeared 
comparable in terms of shape, size and attachment. Panel C is a quantitative representation 
of GFP-LC3 punctae in the cells following incubation with complete imaging medium. The 
data are mean ± S.E.M of 3 experiments (40 - 45 cells per condition). The data were 
analysed with an unpaired t-test. The scale bars in Panels A and B represent 10 µm. 
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Figure 3.4.  Complete imaging medium maintained HEK cell viability and basal levels of 
GFP-LC3 punctae for up to 12 hours.  Panels A and B show representative images of HEK 
cells incubated in complete imaging medium, which contained the same supplements as 
the usual cell culture environment (i.e., amino acids, sodium pyruvate, L-glutamine and 
10% FBS). Panels A and B show GFP-LC3 fluorescence (Ai and Bi) and bright field images (Aii 
and Bii) of cells at the start of incubation with complete imaging medium, and following a 
12-hour incubation, respectively. Similar numbers of GFP-LC3 punctae were observed at 
both time points. The images in panels Aii and Bii illustrate that the cells appeared 
comparable in terms of shape, size and attachment. Panel C is a quantitative representation 
of GFP-LC3 punctae in the cells following incubation with complete imaging medium. The 
data are mean ± S.E.M of 3 experiments (50 - 70 cells per condition). The data were 
analysed with a paired t-test. The scale bars in Panels A and B represent 10 µm. 
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3.2.2 The induction of autophagy by nutrient starvation 
Nutrient starvation is a key physiological stimulus for induction of autophagy [150]. Images 
of HeLa cells showing an increase of GFP-LC3 punctae following incubation in starvation 
medium are depicted in Figure 3.5. HEK cells also showed an increase in the number of 
GFP-LC3 punctae following incubation in a starvation medium (Figure 3.6). However, HEK 
cells had a lower basal number of GFP-LC3 punctae, a lesser accumulation of punctae 
following starvation, and reached a maximal punctae accumulation within 1 hour of 
incubation in starvation medium. 
The visualisation of GFP-LC3 punctae is a convenient way to monitor autophagy and is 
compatible with Ca2+ imaging, which also requires recording of fluorescence. 
Autophagosomes are normally short-lived vesicles that form and undergo degradation 
within tens of minutes [162]. However, several reports have demonstrated that 
accumulation of autophagosomes can arise not only from the induction of autophagy, but 
also from the artificial blockade of autophagic degradation [152, 334]. If autophagic 
degradation is blocked, GFP-LC3 punctae may progressively accumulate within cells solely 
due to on-going basal autophagy and the lack of processing of GFP-LC3-labelled 
autophagosomes, rather than increased levels of autophagy. It is therefore essential to 
establish that an increased accumulation of GFP-LC3 punctae is due to the induction of new 
autophagosome formation (i.e., increased ‘autophagic flux’), and is not caused by the 
blockade of autophagic vesicle processing. Application of bafilomycin A1 (BafA1), an 
inhibitor of vacuolar-type H+-ATPases that prevents the fusion of autophagosomes with 
lysosomes, is commonly used for this purpose [343, 344]. In this study, where formation of 
GFP-LC3 punctae was used to monitor autophagy, it would be expected that BafA1 would 
cause an increased number of GFP-LC3 punctae under conditions in which there was an 
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increased autophagic flux. In contrast, if an observed accumulation of GFP-LC3 punctae 
reflected the blockade of autophagic flux, BafA1 would not be expected to cause any 
further increase in the number of GFP-LC3 punctae. Importantly, incubation of either HeLa 
or HEK cells in starvation medium that included BafA1 (0.1 µM) had a greater number of 
GFP-LC3 punctae compared to cells in starvation medium only (Figures 3.7 and 3.8). These 
observations support the notion that counting GFP-LC3 punctae can reflect a genuine 
induction of autophagic flux in both cell types.  
Another control experiment that allows genuine autophagy induction to be distinguished 
from aberrant accumulation of LC3-II is the use of 3-methyladenine (3-MA) [152, 345, 346]. 
3-MA inhibits Vps34 (a class III PI3-kinase) and thereby prevents the production of PI3P 
necessary for forming nascent autophagic vesicles. However, care has to be taken in the 
use of 3-MA, since long term treatment can trigger autophagy due to its additional 
inhibition of class I PI3-kinases [228]. In this study, 3-MA was used to confirm that the 
various treatments caused the accumulation of GFP-LC3 punctae due to the activation of 
the canonical autophagy pathway. An example of the effect of 3-MA on GFP-LC3 puncta 
accumulation in HEK cells incubated in starvation medium is shown in Figure 3.9. The 
inclusion of 3-MA during incubation of the cells in starvation medium suppressed the 
accumulation of GFP-LC3 punctae (Figure 3.9). 
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Figure 3.5. Induction of GFP-LC3 accumulation in HeLa cells following incubation in 
starvation medium. Panel A is a representative image of cells in complete imaging medium. 
Panels B and C are representative images of cells in starvation medium following a 1- or 4-
hour incubation, respectively. The green (GFP-LC3) punctae represent autophagosomes 
within the cells. Relatively few GFP-LC3 punctae, due to a basal level of autophagy, are 
visible in A. Whereas, more GFP-LC3 punctae are visible in Panels B and C. Panel D is a 
quantitative representation of the effect of starvation on autophagy; the number of GFP-
LC3 punctae per cell increased progressively with time. The data are mean ± S.E.M of 3 
experiments (55 - 90 cells per condition). The data were analysed with a one-way ANOVA 
test. ** indicates p < 0.01 and **** indicates p < 0.0001. The scale bars in Panels A-C 
represent 10 µm.  
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Figure 3.6. Induction of GFP-LC3 punctae accumulation in HEK cells by incubation in 
starvation medium. Panel A is a representative image of HEK cells maintained in complete 
imaging medium. Panel B is a representative image of the same cells as in Panel A, but 
following a 1-hour incubation in starvation medium. Relatively few GFP-LC3 punctae (due 
to basal autophagy) are visible in Panel A. Greater numbers of punctae are visible in Panel 
B (following starvation). Panel C is a quantitative representation of the effect of starvation 
on autophagy. The number of GFP-LC3 punctae per cell significantly increased after 1 hour 
and remained elevated for a further 3 hours. The data are mean ± S.E.M of 3 - 9 experiments 
(25 - 60 cells per condition). The data were analysed with a one-way ANOVA test. **** 
indicates p < 0.0001. The scale bar in Panel B indicates 10 µm. 
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Figure 3.7. Nutrient starvation increased GFP-LC3 punctae accumulation in HeLa cells. 
Panel A is a representative image of cells in complete imaging medium. Panels B and C are 
representative images of cells following a 1-hour incubation in starvation medium, in the 
absence or presence of BafA1 (0.1 µM) respectively. Panel D is a quantitative 
representation of the effect of nutrient starvation on accumulation of autophagosomes; 
more GFP-LC3 punctae were observed following starvation, with greater punctae 
accumulation in the presence of BafA1 indicating that starvation increased autophagic flux. 
The data are mean ± S.E.M of 3 experiments (55 - 70 cells per condition). The data were 
analysed with a one-way ANOVA. **** indicates p < 0.0001. The scale bars in Panels A - C 
indicate 10 µm.  
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Figure 3.8. Nutrient starvation increased GFP-LC3 punctae accumulation in HEK cells. 
Panel A is a representative image of cells in complete imaging medium. Panels (B) and C 
are representative images of cells following a 1-hour incubation in starvation medium, in 
the absence or presence of BafA1 (0.1 µM) respectively. Panel D is a quantitative 
representation of the effect of nutrient starvation on accumulation of autophagosomes; 
more GFP-LC3 punctae were observed following starvation, with greater punctae 
accumulation in the presence of BafA1 indicating that starvation had increased autophagic 
flux. The data are mean ± S.E.M of 3 experiments (50-70 cells per condition). The data were 
analysed with a one-way ANOVA. *** indicates p < 0.001 and **** indicates p < 0.0001. 
The scale bars in panels A - C indicate 10 µm. 
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Figure 3.9.  3-MA, an inhibitor of class III PI3-kinase, inhibited induction of GFP-LC3 
punctae accumulation by nutrient starvation in HEK cells. Panels A, B and C are 
representative images that show cells as follows: A in complete imaging medium, B 
following a 1-hour incubation in starvation medium, and C  following 1-hour incubation in 
starvation medium supplemented with 3-MA (5 mM). Panel D is a quantitative 
representation of the effect of nutrient starvation, and nutrient starvation + 3-MA, on 
autophagy; the number of GFP-LC3 punctae per cell was increased by nutrient starvation, 
but was suppressed to near basal levels by 3-MA. The data are mean ± S.E.M of 2 - 3 
experiments (40 – 50 cells per condition). The data were analysed with a one-way ANOVA. 
** indicates p < 0.01 and **** indicates p < 0.0001. The scale bars in Panels A - C represent 
10 µm. 
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3.2.3 The triggering of autophagy by rapamycin occurred over the same time course as 
the induction of autophagy by nutrient starvation 
In addition to nutrient starvation, a commonly used method of inducing autophagy is 
application of rapamycin [152, 347, 348]. Rapamycin is an antifungal agent that inhibits the 
mechanistic target of rapamycin (mTOR) [349, 350]. Since rapamycin is a well-known 
activator of autophagy, it was used in this study to verify that the accumulation of GFP-LC3 
punctae within the HeLa and HEK cells represented an autophagic response. In addition, 
rapamycin was used as a positive control to establish that cells were viable and displayed 
increased autophagy before carrying out various experimental conditions on the same day. 
Initial experiments determined the optimal rapamycin concentration and incubation time 
to use for inducing autophagy in HeLa and HEK cells.  
Addition of rapamycin to cells maintained in complete imaging medium triggered the 
accumulation of GFP-LC3 punctae (Figure 3.10). Similar to the effect of nutrient starvation, 
rapamycin induced an increase in GFP-LC3 punctae over 1 to 4 hours.  As shown in Figure 
3.10, an increase in GFP-LC3 punctae was observed following incubation of cells with 0.1 
and 1 µM rapamycin, with more GFP-LC3 punctae being evident at the higher rapamycin 
concentration. These data indicate that rapamycin induced GFP-LC3 punctae accumulation 
in a time- and concentration-dependent manner. 
 As described in Chapter1: Introduction, LC3 (or LC3-I) is a cytosolic protein that is converted 
to LC3-II prior to membrane association, and is upregulated on induction of autophagy. 
Although sometimes difficult to interpret [225], Western blotting of LC-I and LC3-II has 
been used in many studies to assess activation of autophagy. Autophagic responses can 
typically be validate by calculating either the ratio of LC3-I to LC3-II, or the ratio of LC3-II to 
an endogenous protein such as GAPDH [215]. Western blotting experiments were 
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therefore carried out to determine LC3 protein modification following treatment of cells 
with rapamycin (1 µM, 1 hour) (Figure 3.10B). Rapamycin treatment caused an increase of 
LC3-II compared to the control levels. 
Similarly to nutrient starvation, the addition of rapamycin in the presence of BafA1 (0.1 
µM) caused a greater number of GFP-LC3 punctae per cell compared to treatment with 
rapamycin only (Figure 3.11). The effect of BafA1 supports the idea that rapamycin induced 
an increase in autophagic flux. Moreover, addition of 3-MA during the incubation of cells 
with rapamycin significantly reduced the increase in GFP-LC3 punctae accumulation in both 
HeLa and HEK cells (Figures 3.12 and 3.13).  
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Figure 3.10. Rapamycin (an inhibitor of mTOR) stimulated GFP-LC3 punctae accumulation 
in a time- and concentration-dependent manner in HeLa cells maintained in complete 
imaging medium. Panel A shows a quantitative representation of the effect of rapamycin 
concentration, and incubation time, on GFP-LC3 punctae accumulation; rapamycin causes 
a progressive increase in GFP-LC3 punctae accumulation in a time- and concentration-
dependent manner. Greater GFP-LC3 punctae accumulation was obtained in the presence 
of BafA1, indicating an increased autophagic flux. The data are mean ± S.E.M of 3 - 5 
experiments (30 - 70 cells per condition). The data were analysed with a one-way ANOVA 
test.  * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001 and **** indicates 
p < 0.0001. Panel B shows a Western blot for LC3-II protein in lysates from rapamycin-
treated (1 hour incubation with 1 µM rapamycin), or untreated cells. GAPDH was used as a 
loading control (n = 1).  
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Figure 3.11. Rapamycin stimulated GFP-LC3 punctae accumulation in HEK cells. Panel A is 
a representative image of cells in complete imaging medium. Panels B and C are 
representative images of cells in complete imaging medium following a 1-hour incubation 
with rapamycin (2 µM) in the absence, or presence, of BafA1; 0.1 µM), respectively. Panel 
D is a quantitative representation of the effect of rapamycin on GFP-LC3 punctae 
accumulation; an increase in GFP-LC3 punctae was caused by rapamycin, with greater 
punctae accumulation in the presence of BafA1. The data are mean ± S.E.M of 3 
experiments (45 - 70 cells per condition). The data were analysed with a one-way ANOVA. 
**** indicates p < 0.0001. The scale bars in Panels A - C indicate 10 µm. 
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Figure 3.12.  3-MA, an inhibitor of class III PI 3-Kinases, inhibited GFP-LC3 punctae 
accumulation in HeLa cells.  Panels A, B and C are representative images that show: A, the 
basal level of GFP-LC3 punctae in cells maintained in complete imaging medium, B, elevated 
levels of GFP-LC3 punctae following a 1-hour incubation with rapamycin (1 µM), and C, low 
levels of GFP-LC3 punctae following 1-hour treatment with rapamycin (1 µM) and 3-MA (5 
mM). Panel D is a quantitative representation of the effect of rapamycin, and rapamycin + 
3-MA, on autophagy; the number of GFP-LC3 punctae per cell increased due to addition of 
rapamycin, but was suppressed to near basal levels by 3-MA. The data are mean ± S.E.M of 
3 experiments (25 - 35 cells per condition).  The data were analysed with a one-way ANOVA. 
**** indicates p < 0.0001. The scale bars in Panels A - C indicate 10 µm. 
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Figure 3.13.  3-MA, an inhibitor of class III PI 3-kinases, inhibited GFP-LC3 punctae 
accumulation induced by rapamycin in HEK cells. Panels A, B and C are representative 
images that show cells as follows: A, in complete imaging medium, B, following a 1-hour 
incubation with rapamycin (2 µM), and C, following 1-hour treatment with rapamycin (2 
µM) and 3-MA (5 mM). Panel D is a quantitative representation of the effect of rapamycin, 
and rapamycin + 3-MA, on GFP-LC3 punctae accumulation; the number of GFP-LC3 punctae 
per cell was significantly increased by rapamycin alone, but suppressed to near basal levels 
by 3-MA. The data are mean ± S.E.M of 3 experiments (30-50 cells per condition). The data 
were analysed with a one-way ANOVA. ** indicates p < 0.01 and **** indicates p < 0.0001. 
The scale bars in Panels A - C represent 10 µm. 
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3.2.4 PP242 (Torkinib), an inhibitor of mTOR, induces autophagy in HeLa cells. 
A newer mTOR inhibitor, PP242, was also used as an inducer of autophagy. Consistent with 
the effect of rapamycin shown above, incubation of HeLa cells in complete imaging medium 
with PP242 (1 µM, 1 hour) resulted in an increase in GFP-LC3 punctae formation (Figure 
3.14).  
 
Figure 3.14. Induction of GFP-LC3 punctae accumulation in HeLa cells by the mTOR 
inhibitor PP242. Panel A is a representative image of cells in complete imaging medium. 
Panel B is a representative image of cells incubated with PP242 (1 µM) for 1 hour. Panel C 
is a quantitative representation of the effect of PP242 on GFP-LC3 punctae accumulation. 
The data are mean ± S.E.M of 3 experiments (30 - 40 cells per condition). The data were 
analysed with an unpaired t-test. ** indicates p < 0.01. 
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3.2.5 The induction of autophagy in HEK and Hela cells is quantitatively similar at 37°C or 
room temperature 
The bulk of imaging experiments presented in this thesis were performed at room 
temperature. It is challenging to maintain cells at 37 °C on the stage of an epifluorescence 
microscope (such as that used here) when solutions are being changed, and because the 
objective lens is a significant heat sink. Ca2+ signals in both HeLa and HEK cells have been 
extensively characterised at room temperature, and Ca2+ indicator dyes (such as Fura-2) 
are known to be sequestered into organelles or extruded when cells are warmed above 
room temperature [329, 351, 352]. It was therefore considered that conducting 
experiments at room temperature would prevent issues observed with temperature 
changes/gradients and preserve Fura-2 loading. However, it was important to ensure that 
basal autophagy and the altered accumulation of GFP-LC3 punctae in response to nutrient 
starvation, rapamycin, BafA1 and 3-MA were not affected by the lower temperature.  
The data presented in Figures 3.15 and 3.16 shows results obtained from cells examined 
on the same day, and using the same experimental solutions, but at either room 
temperature (approximately 20 – 22°C) or 37°C. Similar numbers of GFP-LC3 punctae were 
evident in control cells before any experimental manipulations at either temperature. 
Incubation of cells in starvation medium or with rapamycin, caused a comparable increase 
of GFP-LC3 punctae in cells maintained at room temperature or 37°C. Moreover, BafA1 
augmented the number of GFP-LC3 punctae observed during incubation of cells with 
rapamycin, whilst 3-MA prevented an increase in GFP-LC3 punctae number at either 
temperature. These observations indicate that the induction of autophagy by 
pharmacological or physiological means, and the actions of BafA1 and 3-MA, are similar at 
room temperature or 37°C. 
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Figure 3.15. The induction of GFP-LC3 punctae accumulation in HeLa cells is quantitatively 
similar in cells at 37°C or room temperature. Panels A-D represent images of HeLa cells 
following a 1-hour incubation with either starvation medium, rapamycin (1µM), rapamycin 
+ BafA1 (0.1µM), or rapamycin + 3-MA (5mM), respectively, at room temperature or 37°C. 
Panel E is a quantitative representation of the effect of temperature on GFP-LC3 punctae 
accumulation during the various treatments; there were quantitatively similar increases in 
GFP-LC3 punctae caused by nutrient starvation or rapamycin at both temperatures. The 
induction of GFP-LC3 accumulation was blocked by 3-MA with both temperatures. The data 
are mean ± S.E.M of 3 experiments per temperature (25 - 50 cells per condition). The data 
were analysed with a one-way ANOVA test. * indicates p < 0.05, **** indicates p < 0.0001. 
The scale bars in Panels A - D indicate 10 µm. 
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Figure 3.16. Induction of GFP-LC3 punctae accumulation in HEK cells is quantitatively 
similar at 37°C or room temperature. The column graph is a quantitative representation 
of the effect of temperature on GFP-LC3 punctae accumulation during the various 
treatments indicated; there were quantitatively similar increases in GFP-LC3 punctae 
caused by either nutrient starvation or rapamycin (2µM) at both temperatures. The 
induction of GFP-LC3 punctae accumulation was blocked by 3-MA (5mM) at both 
temperatures. The data are mean ± S.E.M of 3 experiments per temperature (40 - 100 cells 
per condition). The data were analysed with a one-way ANOVA test. * indicates p < 0.05, 
** indicates p < 0.01, *** indicates p < 0.001 and **** indicates p < 0.0001. The scale bars 
in Panels A - D indicate 10 µm. 
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3.2.6 Additional methods to measure the induction of autophagy: 
Cyto-ID® green autophagy stain 
Cyto-ID® green, a cationic amphiphilic tracer dye, was recently developed to enable acute 
labelling of autophagic vesicles with minimal staining of lysosomes [353].  The advantages 
of a fluorescent autophagic indicator such as the Cyto-ID autophagy stain are that it is 
compatible for use with flow cytometry, fluorescence microscopy and high throughput 
screening. Moreover, it can stain autophagic vesicles within minutes, so cells do not have 
to be transfected or undergo clonal selection, for example to express a fluorescent protein. 
In this study, Cyto-ID green was used as another method of verifying the induction of 
autophagy by various treatments, and to assess its potential to be used in situations where 
GFP-LC3 expression was not appropriate.  
The Cyto-ID green autophagy stain was found to label discrete punctae within HeLa cells, 
similar in size and distribution to those observed in cells expressing GFP-LC3 (Figure 3.17A). 
Incubation of HeLa cells with starvation medium, or addition of rapamycin, increased the 
number of Cyto-ID green-labelled punctae. Moreover, concurrent application of BafA1 
during the incubation with rapamycin increased the number of Cyto-ID green-labelled 
punctae. Whereas, the addition of 3-MA during the incubation with rapamycin decreased 
the number of Cyto-ID green-labelled punctae. Control experiments, using GFP-LC3-
expressing HeLa cells, were conducted in parallel using the same reagents and solutions, 
and qualitatively similar responses were observed (Figure 3.17B). These observations 
suggest that Cyto-ID green can be used as an alternative to GFP-LC3 for detection of 
autophagic vesicles. However, one notable difference between the Cyto-ID green-labelled 
cells and cells expressing GFP-LC3 was that Cyto-ID consistently indicated a higher number 
of punctae.  
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Figure 3.17. Detection of autophagy in HeLa cells with CYTO-ID®, a selective stain for 
autophagic vesicles. HeLa cells (either wild type, or GFP-LC3-expressing) were incubated in 
complete imaging medium, starvation medium or complete imaging medium 
supplemented with rapamycin, and the other treatments indicated, for 1 hour. The wild 
type HeLa cells were further incubated with CYTO-ID® green autophagy detection reagent 
for 10 min at 37°C. Panels A and B are representative images of wild type HeLa cells in 
complete imaging medium in the absence or presence of CYTO-ID®. Panel D is a 
representative image of GFP-LC3 HeLa cells in complete imaging medium. Panels C and E 
are quantitative representations of the effects of the various treatments on autophagic 
vesicle numbers measured using the CYTO-ID® kit or GFP-LC3, respectively. The data are 
mean ± S.E.M of 3 experiments (30 - 50 cells per condition). The data were analysed with 
one-way ANOVA. * indicates p < 0.05, ** indicates p < 0.01, and **** indicates p < 0.0001. 
The scale bars in Panels A, B and D indicate 10 µm. 
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3.2.7 Electron microscopy 
As discussed at the beginning of this Chapter, electron microscopy has been used in many 
previous studies to establish the presence and form of autophagic vesicles [152, 354]. 
Experiments were therefore undertaken to explore whether electron microscopy could be 
used as a quantitative approach to measuring autophagic flux. As depicted in Figures 3.18 
and 3.19, autophagic vesicles could be clearly identified within cells under nutrient-replete 
conditions, and also following stimulation of autophagy by rapamycin and nutrient 
starvation. The autophagic vesicles were similar in shape and form, but were 
heterogeneous in terms of their contents. With some autophagic vesicles, it was possible 
to identify the contents of the engulfed structures within the lumen of the vesicle (Figure 
3.19). Whilst it was relatively simple to observe autophagic vesicles using electron 
microscopy, it was found to be a labour-intensive method that could only provide 
quantitative data with a significant investment of time. Moreover, distinguishing 
autophagosomal structures from other vesicles was sometimes difficult. The preparation 
for electron microscopy required the transfer of cells from imaging buffer to a fixation 
solution for an hour, thereby making it difficult to match Ca2+ imaging with quantitation of 
autophagy. 
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Figure 3.19. Detection of autophagic vesicles in HEK cells using electron microscopy 
following induction of autophagy with nutrient starvation and rapamycin. Panels A and B 
are electron micrographs showing sections of different cells  that were incubated in 
starvation medium for 1 hour, or complete imaging medium supplemented with rapamycin 
(2 µM, 1 hour). The labels indicate autophagosomes and autolysosomes in various locations 
within the cells, along with mitochondria, ER and lysosomes. Heterogeneity in the contents 
of autophagic vesicles is evident. Panel (Aii) shows an autophagosome containing a 
fragment of rough ER. Panel B shows images with an autophagosome containing traces of 
mitochondrial cristae (i) and pieces of smooth ER (ii). No gross differences in the structure 
or size of the autophagosomes were obvious between the two treatments. AV: 
autophagosome, ER: endoplasmic reticulum, G: golgi, LY: lysosome, M: mitochondria, MVB: 
multivesicular body, N: nucleus. 
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3.2.8 Using mCherry-GFP-LC3-expressing HeLa cells to assess autophagic flux 
Due to its relatively simple use in microscopy and high-throughput screening, GFP-LC3 has 
been employed in many studies of autophagy. A refinement of this approach was the 
development of a mCherry-GFP-LC3 dual-colour reporter construct with both green and 
red fluorescent proteins appended to the LC3 protein [220] . This mCherry-GFP-LC3 tandem 
fluorescent reporter labels nascent autophagosomal membranes and autophagosomes 
with both green and red fluorescence emission. However, when autophagosomes fuse with 
lysosomes the acidic conditions within the lumen of the autolysosome quenches the 
fluorescence from the GFP moiety. In contrast, the red fluorescence from mCherry is not 
quenched by the acidity of the autolysosomes, but eventually disintegrates due to 
autophagic protein degradation. The mCherry-GFP-LC3 tandem fluorescent reporter 
therefore allows visualisation of autophagosomes as punctae with overlapping green and 
red fluorescence, and mature autolysosomes as punctae with red fluorescence only (Figure 
3.20A) [225].  
A stable HeLa cell line expressing mCherry-GFP-LC3 was created in this study (Chapter 2: 
Materials and Methods). As shown in Figure 3.20, the mCherry-GFP-LC3-expressing HeLa 
Cells displayed both green and red punctae when incubated in complete imaging medium. 
Incubation of cells with rapamycin increased the total number of green + red punctae 
indicative of an increase in autophagy (Figure 3.20). Addition of BafA1 increased the 
number of autophagosomes (green + red fluorescence), and decreased the number of 
autolysosomes (red fluorescence only), when applied by itself, or concurrently with 
rapamycin. The increase in the number of autophagosomes caused by BafA1 tallies with 
the results described earlier, which were obtained using the GFP-LC3 construct. The 
decrease in the number of autolysosomes by BafA1 was an expected result, as the 
compound has been shown to block the fusion of autophagosomes with lysosomes, in 
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which case the progression from red + green punctae to red only punctae cannot occur. 
These observations are consistent with the use of fluorescently-tagged LC3 reporter 
constructs to quantitatively monitor the induction of autophagy, and the utility of BafA1 as 
a blocker of autophagic flux. 
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Figure 3.20. Quantitation of autophagy using an mCherry-GFP-LC3 reporter in HeLa cells. 
Cells were stably transfected with a plasmid encoding mCherry-GFP-LC3. Panel A illustrates 
how this reporter can be used to assess autophagic flux. GFP is quenched in the acidic 
autolysosomal compartment, whereas mCherry remains fluorescent. Therefore, 
autophagosomes are evident as punctae with both green and red emission (from GFP and 
mCherry, respectively) and autolysosomes are evident as punctae that have red emission 
(from mCherry only). Panel B shows representative images of (i) cells in complete imaging 
medium, (ii) cells in complete imaging medium supplemented with rapamycin (1 µM) for 4 
hours, and (iii) cells in complete imaging medium supplemented with rapamycin (1 µM) 
and BafA1 (0.1 µM) for 4 hours. Panel C is a quantitative representation of the effects of 
rapamycin and rapamycin + BafA1 on numbers of green and red punctae. Rapamycin and 
BafA1 increased the total number of punctae (whether green or red). BafA1 also reduced 
the proportion of red-only punctae, consistent with a reduced autophagic flux. The data 
are mean ± S.E.M of 3 - 4 experiments (40 - 80 cells per condition). The data were analysed 
with a one-way ANOVA. **** indicates p < 0.0001. The scale bars in Panel B indicate 10 
µm. 
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3.2.9 Quantification of fluorescent autophagic vesicles 
The GFP-LC3 punctae quantitation presented so far have been expressed as ‘punctae per 
cell’. However, whilst counting the number of punctae per cell is a common method 
presented in the published literature, it is important to note that there is some variability 
in the size of cells. It was therefore considered whether cell size could influence the 
quantitation of autophagy. As an alternative to calculating the number of GFP-LC3 punctae 
per cell, the number of GFP-LC3 punctae per cell area was also determined, using the same 
cells in each case to allow a direct comparison. As illustrated in Figure 3.21, both methods 
of calculating GFP-LC3 punctae numbers gave qualitatively similar outcomes. Using either 
method, there was a clear, statistically significant, increase in GFP-LC3 punctae caused by 
treatment of the cells with 1 or 2 µM rapamycin (1 or 2 hours), and an even greater number 
of GFP-LC3 punctae in cells incubated with rapamycin and 0.1 µM BafA1 (1 or 4 hours). 
Since determination of the number of punctae per cell is simpler and less time consuming, 
it was adopted as the method of punctae quantitation in this study. 
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Figure 3.21. Analysis of GFP-LC3 punctae as number of punctae per cell or number of 
punctae per cell area. Panels A and B depict data from the same experiments analysed in 
two different ways. Panel A represents data expressed as the number of punctae per cell 
and panel B represents data expressed as number of punctae per cell area. Both analyses 
show that rapamycin (1 µM) induced a significant increase in the number GFP-LC3 punctae 
in HeLa cells, with a further increase in GFP-LC3-labelled punctae accumulation in cells 
concurrently incubated with rapamycin (1 µM) and BafA1 (0.1 µM). The data are mean ± 
S.E.M of 3 experiments (30 - 40 cells per condition). The data were analysed with a one-
way ANOVA test. **** indicates p <0.0001.  
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An important consideration when capturing images of cells to calculate the number of GFP-
LC3 punctae is that there are different possible focal planes at which images may be 
captured. Since autophagic vesicles are ~500 - 1500 nm in diameter, it is likely that they 
may not be evident in all possible focal planes. Failing to capture all GFP-LC3 punctae within 
a cell through choosing an inappropriate focal plane for image capture could lead to an 
underestimation of the induction of autophagy. Therefore, it was important to determine 
whether quantitation of GFP-LC3 punctae was affected by altering the focal plane for image 
capture. The scatter plots shown in Figure 3.22 depict the identification of GFP-LC3 punctae 
from cell images within the same cells, but captured at three different focal planes. It is 
evident that whilst there was some variability in the numbers of GFP-LC3 punctae 
measured in each cell at the three focal planes, overall it made little difference to the 
calculated average number of punctae.  
In this study, the quantitation of GFP-LC3 punctae was performed manually by counting 
individual discrete fluorescent spots within each cell in a field of view. This was a preferred 
method since it allowed quality control for images and cells that were non-optimal (e.g., 
out of focus images or evidently imperfect cells). However, to establish that the manual 
method of counting was not under- or over-estimating punctae, a comparison with an 
automated analysis was performed. For this purpose, the ImageJ Cell Counter plug-in was 
used to measure the GFP-LC3 punctae within cells, and the data from this automated 
analysis was compared to the quantitation of the same cells using the manual approach. 
The settings used for the Cell Counter Plug-in are described in Chapter 2: Materials and 
Methods. As depicted in Figure 3.23, both the manual and automated methods gave similar 
number of punctae in cells incubated in complete imaging medium, or following incubation 
of cells in complete imaging medium supplemented with rapamycin to simulate autophagy. 
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Figure 3.22. Quantitation of GFP-LC3 punctae at 3 different focal planes within the same 
cells. The scatter plots show the number of GFP-LC3 punctae observed within the same 
field of HeLa cells imaged at three distinct focal planes. Each cell is represented by a dot, 
square or triangle of the same colour. There were no significant differences in the average 
number of GFP-LC3 punctae per cell obtained using any of the focal planes.  
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Figure 3.23. Quantitation of GFP-LC3 punctae in HeLa cells using ImageJ or manual 
counting. Punctae were counted manually by two independent researchers, the cell 
counter ImageJ plugin, or the threshold function in ImageJ. The number of punctae within 
cells incubated in complete imaging medium, or within cells incubated in complete imaging 
medium supplemented with 1 µM rapamycin were similar whether counted manually or 
using an automated approach with ImageJ. The data are mean ± S.E.M of 3 experiments. 
The data were analysed with a one-way ANOVA test. *** indicates p < 0.001. 
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3.2.10 Cytosolic Ca2+ is required for the induction of autophagy by rapamycin in HeLa cells  
The key aim of this study was to investigate the regulation of autophagy by cellular Ca2+ 
signals. Previous reports have shown that loading cells with BAPTA-AM, a high-affinity 
intracellular Ca2+ buffer, prevented the induction of autophagy [297, 355]. BAPTA-AM has 
been commonly used in autophagy studies, and has consistently indicated that cytosolic 
Ca2+ is required for the induction of autophagy, although it is unclear how Ca2+ regulates 
autophagy [2][356]. In agreement with these findings, it was observed that loading cells 
with BAPTA-AM significantly reduced the level of GFP-LC3 punctae observed within cells 
incubated in complete imaging medium, and also prevented the increase in GFP-LC3 
punctae that was usually observed following incubation of cells with rapamycin (Figure 
3.24). These results support the hypothesis that Ca2+ signalling is a vital element of 
canonical mTOR-dependent autophagy. Despite the widespread use of BAPTA-AM to 
explore the role of Ca2+ in autophagy, there are few studies where experiments are 
performed to ensure that the BAPTA-AM loading conditions were actually sufficient to 
suppress cellular Ca2+ signals over the timecourse in which autophagy was measured. As 
depicted in Figure 3.24, the BAPTA-AM loading conditions used in this study were sufficient 
to prevent an increase in cytosolic Ca2+ concentration following the addition of histamine, 
a normally potent agonist for causing Ca2+ signals in HeLa cells [3]. 
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Figure 3.24. Chelating intracellular Ca2+ with BAPTA-AM prevented the induction of 
autophagy in HeLa cells. Panel A is a representative image of cells in complete imaging 
medium. Panel B is a representative image of cells incubated in complete imaging medium 
and that were loaded with 10 µM BAPTA-AM for 1 hour prior to imaging. Panel C is a 
quantitative representation of the effect of BAPTA-AM loading on autophagy in untreated 
cells, and cells incubated with 1 µM rapamycin; the number of GFP-LC3 punctae per cell 
due to basal autophagy was decreased following BAPTA-AM loading. In addition, BAPTA-
AM prevented the accumulation of GFP-LC3 punctae by rapamycin. Panel D is the profile 
of cytosolic Ca2+ in cells pre-loaded with BAPTA-AM before imaging (10 µM for 1 hour). To 
assess the ability of BAPTA-AM to buffer Ca2+, 100 µM histamine was added to the cells for 
the final 5 minutes of the recording. The data are mean ± S.E.M of 3 experiments (15 - 50 
cells per condition). The data were analysed with a one-way ANOVA test. ** indicates p < 
0.01 and **** indicates p < 0.0001. The scale bar in Panel B indicates 10 µm. 
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3.3 Summary  
The work described in this chapter characterised the utility of two cell lines (HeLa and HEK) 
for studying the regulation of autophagy by Ca2+. Emphasis was placed on using the 
accumulation of GFP-LC3 punctae as a real-time, direct assay for induction of autophagy in 
these cell lines. A key advantage of visualising GFP-LC3-labelled punctae formation as an 
assay of autophagy is that that it can be performed simultaneously with Ca2+ imaging. In 
theory, it would be possible to follow autophagy and Ca2+ signals within individual cells in 
a field of view, although that was not performed in this study. Particular attention was 
given to control experiments that are necessary when using GFP-LC3 punctae accumulation 
to distinguish an increased autophagic flux from effects on autophagosome processing. 
Several experimental systems were examined, including recording of GFP-LC3 
fluorescence, tandem mCherry-GFP-LC3 fluorescence, electron microscopy, and labelling 
of autophagosomes with CYTO-ID® green. In addition, preliminary experiments using 
Western blotting for endogenous LC3 protein were performed. 
The key findings in this Chapter are: 
 The accumulation of GFP-LC3 punctae was increased by known activators of 
autophagy (starvation, rapamycin, PP242) (Figures 3.7 and 3.8, 3.10 and 3.11, 3.14 
respectively), and was enhanced by BafA1, which is consistent with an increase in 
autophagic flux. Moreover, the accumulation of GFP-LC3 punctae was inhibited by 
the PI3-kinase inhibitor 3-MA. Similar increases in punctae formation were 
observed with a tandem mCherry-GFP-LC3 fluorescent reporter (Figure 3.20) and 
application of the acute autophagosome stain CYTO-ID® green (Figure 3.17).  
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 An extracellular medium that mimicked the cells’ culture environment maintained 
cell viability, and did not induce an increase in GFP-LC3 punctae accumulation for 
up to 12 hours (Figures 3.3 and 3.4). This medium, termed complete imaging 
medium, required NEAA, 10% FBS, 2 mM L-glutamine and 1 mM sodium pyruvate 
to prevent induction of GFP-LC3 punctae accumulation (Figure 3.1). 
 Nutrient starvation and rapamycin increased GFP-LC3 punctae accumulation in 
HeLa and HEK cells to similar extents at 37°C and room temperature (Figures 3.15 
and 3.16). 
 Simultaneous, real-time recordings of cytosolic Ca2+ and GFP-LC3 punctae 
accumulation are possible (Figure 3.24).  
 GFP-LC3 punctae can be reliably measured using a wide-field microscope despite 
the focal plane chosen perhaps not capturing all GFP-LC3 punctae (Figure.322). 
 Images from electron microscopy reveal autophagic vesicles in HEK cells with 
evidently different cargoes (Figures 3.18 and 3.19). However, this technique is not 
the most efficient for use as a quantitative assay. 
 Loading of cells with BAPTA-AM reduced both the basal and rapamycin-stimulated 
GFP-LC3 punctae accumulation, suggesting that cytosolic Ca2+ is critical for 
autophagy (Figure 3.24). 
3.4 Discussion 
 
The work described in this chapter aimed to characterise assays for studying the induction 
of autophagy, and determining their reliability for use with live cell imaging experiments. A 
key aim was to find experimental conditions that allowed the recording of Ca2+ signals and 
autophagy together within the same cells. Real-time visualization of both activities is an 
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ideal situation, and could potentially simplify some of the complex results reported in 
literature. In addition, the minimal experimental times that allowed both Ca2+ signals and 
autophagy to be measured with statistically significant data sets were a sought. It is 
important to bear in mind that physiological Ca2+ signalling events are usually brief events 
in the cell [19]. Deviation from a physiological pattern may activate autophagy, potentially 
due to cellular stress and adaptive responses [293] and not necessarily because of naturally 
occurring Ca2+ signals. Moreover, since stimuli such as hormones, thapsigargin and 
ionomycin trigger Ca2+ signals within tens of seconds, and the formation and processing of 
autophagic vesicles occurs over minutes, it could be argued that there is no need for the 
extended (e.g., many hours) incubations that that have been reported in the literature.  
To verify that the assays used in this study could reliably detect autophagy, different stimuli 
were employed to induce autophagy in the HeLa and HEK cell lines. In particular, rapamycin 
and nutrient starvation were used to inhibit mTORC1 and thereby activate the canonical 
autophagic pathway (Figures 3.5-3.13). Numerous studies have demonstrated that 
rapamycin [357, 358] and nutrient starvation [359, 360] induce autophagy in various cell 
types. However, the incubation times and concentrations of rapamycin used are not always 
the same. For example, in HeLa cells, rapamycin was shown to cause an increase in 
autophagy following a 2-hour incubation [347], whereas a 24-hour incubation was shown 
to induce autophagy in pancreatic islet cells [361]  
To induce starvation conditions, studies have used serum or amino acid withdrawal to 
induce autophagy [297, 362, 363]. However, as with rapamycin, the incubation times have 
been variable. Moreover, a variety of media are widely used in autophagy research. These 
include Hank's balanced salt solution (HBSS) [364], Earle's Balanced Salt Solution (EBSS) 
[365], PBS [366] and DMEM [341]. Similar to the approach used in the present work, some 
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studies have induced autophagy with Krebs buffer as a starvation medium, however, 
incubation times are longer. For example a 4-hour incubation in Krebs buffer induced 
autophagy in HEK293 cells [367] and a 6-hour incubation was used to induce autophagy in 
HeLa cells [368]. 
Despite the variability in time of incubation and/or concentration of rapamycin, and the 
different types of starvation medium used, there is general consensus that they activate a 
bona fide autophagic response. Moreover, measurement of punctae/autophagic vesicle 
accumulation has been used in significant number of publications to indicate a stimulation 
of autophagy [152, 347, 369, 370]. The results presented in this chapter concur with the 
established evidence for the utility of measuring GFP-LC3 punctae as a microscopy-based 
method for real-time monitoring of autophagic flux. It was considered that using the 
tandem mCherry-GFP-LC3-expressing cells to assess autophagic flux could be 
advantageous because both autolysosomes and autophagosomes could be estimated 
simultaneously. However, it was found to be highly labour intensive to look for overlapping 
red/green punctae within the cell images. Moreover, the essential advantage of using the 
tandem mCherry-GFP-LC3 is evidence of continual autophagic flux, which can readily be 
assessed by the inclusion of BafA1. 
Cytosolic Ca2+ has been shown to have a dual role in the regulation of autophagy [7, 371]. 
However, one of the few consistent findings that emerges from the literature is that loading 
cells with BAPTA-AM blocks autophagy [317, 355]. Indeed, BAPTA-AM appears to be an 
effective inhibitor of autophagy in almost all conditions [290]. Exactly how BAPTA-AM 
blocks autophagy is currently unclear. It has been proposed that BAPTA-AM simply buffers 
Ca2+ signals that trigger autophagy [310]. However, there are observations suggesting that 
a number of different steps within the autophagic pathway may be blocked by BAPTA-AM 
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loading. For example, BAPTA-AM loading of cells (using conditions that inhibited 
autophagy) did not affect the production of PI3P by Vps34, but changed the accumulation 
of the PI3P-binding protein WIPI-1 to nascent phagophore membranes [372]. Also, BAPTA-
AM was found to prevent endosome/lysosome fusion [373]. These results reveal that 
BAPTA-AM does not just inhibit the stimulation of autophagy by experimentally-evoked 
Ca2+ signals, but also inhibits steps in the formation and processing of autophagosomes. 
The source and nature of the Ca2+ signals necessary for these putative Ca2+-sensitive steps 
is unclear [290]. 
The results presented in this chapter indicate that chelating cytosolic Ca2+ with BAPTA-AM 
prevented the induction of autophagy, whether under basal conditions, or when autophagy 
was stimulated via application of rapamycin (Figure 3.22). Although many published studies 
have invoked a role for Ca2+ in the regulation of autophagy through the use of BAPTA-AM 
loading, control experiments are seldom performed to show the effectiveness of BATPA-
AM at buffering cytosolic Ca2+ signals. It is well known that cells can extrude Ca2+ indicators, 
especially at 37°C, most likely through ABC transporters, and they may also be able to 
remove BAPTA-AM from the cytosol too. It was therefore important to show that BAPTA-
AM was buffering cytosolic Ca2+ in this study, over the same experimental time and 
conditions that were used for recording GFP-LC3 punctae formation. A simple test that can 
be performed at the end of an experiment to examine the buffering of cytosolic Ca2+ by 
BAPTA-AM is the stimulation of cells with an InsP3-generating agonist. An example of this 
simple control experiment is depicted in Figure 3.24, which demonstrates that BAPTA-AM 
loading abrogated Ca2+ signals evoked by the InsP3-generating agonist histamine, indicating 
that the Ca2+ chelator was retained inside the cells and was effective.  
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Electron microscopy images showed that autophagic vesicles in cells under nutrient rich 
conditions, and those formed during nutrient starvation or treatment with rapamycin, 
appeared similar in size and shape (Figures 3.18 and 3.19). Clustering of autophagic vesicles 
has been highlighted before, particularly under conditions where autophagic flux was 
blocked [372]. Although the contents of the autophagic vesicles were heterogeneous, there 
were no obvious signs of abnormalities in the size or shape of the vesicles compared to 
other published images. Since, only one, or a few, autophagic vesicles could be detected at 
most in one image, electron microscopy was not deemed suitable for quantitative 
measurements in the present study. 
Cyto-ID® autophagy stain, a recently developed amphiphilic tracer dye, was used to label 
autophagosomes in HeLa cells (Figure 3.17). A notable difference between the Cyto-ID 
green-labelled cells and cells expressing GFP-LC3 was that Cyto-ID consistently indicated a 
higher number of punctae. Plausibly this difference could be accounted for by the labelling 
of autophagic vesicles as well as other acidic organelles, such as lysosomes or endosomes 
etc., which are not detected with GFP-LC3. Although, specific staining for those 
compartments would be required to validate this notion. Despite the increased numbers 
of punctae labelled, the Cyto-ID® green stain indicated a statistically significant increase in 
autophagic flux following either nutrient starvation or treatment with rapamycin (Figure 
3.17). The punctae observed with cyto-ID were similar in size and distribution to those 
observed in cells expressing GFP-LC3. 
An important limitation with use of GFP-LC3 to monitor autophagy is that LC3 can associate 
with ubiquitinated protein aggregates, particularly if LC3 is overexpressed by transient 
transfection [215]. This limitation can lead to misinterpretation of results.  These 
aggregates have been described in many systems and are also referred to as aggresome-
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like induced structures (ALIS), SQSTM1/p62 bodies/sequestosomes and inclusions [374].       
In addition to the LC3 proteins, GABARAP (γ-aminobutyric acid receptor-associated  
protein) are a subfamily of Atg8 proteins that are involved in vesicle processing, and are 
subject to lipidation under autophagy-inducing conditions [375]. GABARAPs have been 
shown to associate with phagophores during closure, and moreover, it was shown that 
cytoplasmic cargo sequestration by autophagy depends on GABARAPs [222]. Therefore, 
analysing autophagic flux by using GFP-LC3 alone may not account for the development 
and processing of all autophagic vesicles. Additional techniques to assess macroautophagic 
cargo sequestration could be helpful, such as using the transfer of the cytosolic protein 
lactate dehydrogenase to autophagic vesicles [223].  
In conclusion, the results presented in this chapter establish that monitoring GFP-LC3 
punctae accumulation is a convenient, reliable method for assaying autophagic flux using 
conditions that are also suitable for measuring cytosolic Ca2+ signals. Other techniques may 
provide some additional advantages, but are ether more labour intensive or cannot be 
performed simultaneously with Ca2+ measurements. Two media were established for these 
experiments. Complete imaging medium supported cell viability and prevented the 
induction of autophagy for at least 12 hours whereas starvation medium induced 
autophagy within an hour. These media were used for the experiments reported in the rest 
of this thesis. The results indicate that factors such as the experimental temperature, focal 
imaging plane or manual/automated method of punctae counting did not alter the ability 
to gather reliable data. Moreover, the results confirmed that BAPTA-AM loading blocks the 
induction of autophagy under conditions in which cytosolic Ca2+ is clearly buffered. The 
source and characteristics of Ca2+ signals that regulate autophagy are unknown, and are 
examined in the following chapters.  
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Chapter 4: Ca2+ flux from InsP3 receptors to mitochondria suppresses autophagy by 
maintaining cellular ATP 
4.1 Introduction 
 
As discussed in Chapter 1: Introduction, various studies have suggested that intracellular 
Ca2+ signals can positively and negatively regulate autophagic flux. Exactly how Ca2+ signals 
switch cells between pro-autophagic and anti-autophagic states is not very clear. It is likely 
that the source and characteristics of Ca2+ signals are critical in determining cellular 
responses. Inositol 1,4,5-trisphosphate receptors (InsP3Rs) are one source of Ca2+ signals 
proposed to control autophagic flux. Studies have shown that a reduction in InsP3 signalling 
can be pro-autophagic. For example, treatment of cells with lithium triggers autophagy in 
a mTOR-independent manner [286, 291]. Lithium gradually depletes the cells’ capacity to 
produce InsP3 through inhibiting the recycling of inositol from inositol monophosphates 
[376]. Evidence has also shown that InsP3Rs are necessary for autophagy. For example, Cd2+ 
-induced autophagy was abolished by InsP3R inhibition with 2-APB [377], and starvation-
induced autophagy was reduced with the addition of xestospongin B, an InsP3R antagonist 
[318]. 
Mitochondrial Ca2+ signalling is an important aspect of Ca2+ signalling (Figure 1.2). The close 
distance of mitochondria to ER Ca2+ stores [100] means that Ca2+ signals arising from RyRs 
and InsP3Rs on the surface of the ER occur near the sites of Ca2+ uptake into the 
mitochondria. ER-mitochondria contact sites termed mitochondria-associated membranes 
(MAMs) [96] are important for a number of physiological processes, including lipid 
synthesis, mitochondrial movement and fission, apoptosis, and autophagy [91, 92]. 
Mitochondrial Ca2+ uptake involves the mitochondrial uniporter complex (MCU), located in 
the inner mitochondrial membrane and the voltage-dependent anion channel (VDAC), 
located in the outer mitochondrial membrane. The local Ca2+ signal within the MAMs (~10 
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µM) [107] is sufficient for activating the MCU despite its low affinity for Ca2+ (Kd 20 - 50 µM) 
[93]. Ca2+ is consequently released from mitochondria through the mitochondrial Na+/Ca2+ 
exchanger (NCLX) [108], and taken back up into the ER via SERCA, restoring the Ca2+ level 
in the ER. 
Ca2+ uptake by mitochondria has been shown to prevent AMPK-activated autophagy [288, 
312, 378]. Mitochondrial Ca2+ uptake has been shown to stimulate the citric acid cycle 
[379]. Furthermore, Ca2+ within the mitochondrial matrix increases the rate of ATP 
production by the ATP synthase [380, 381]. In addition to its role in maintaining of ATP 
production, the Ca2+ transfer from InsP3Rs to mitochondria has been shown to be necessary 
to support the cell cycle of cancer cells. It was demonstrated that inhibition of InsP3Rs 
preferentially killed tumour cells, but not non-tumourigenic cells, due to a metabolic 
catastrophe that resulted in necrotic death [378]. These observations that InsP3R-mediated 
Ca2+ release prevents the induction of autophagy, and plays a role in the survival of cancer 
cells, could be highly significant in terms of developing new therapies to prevent tumours, 
and provided the impetus for the work presented in this chapter.  
4.2 Aims of the chapter 
One aim of this chapter was to investigate the role of Ca2+ signalling between InsP3R and 
mitochondria in regulating autophagy. The principle experimental approached used in this 
study was to prevent InsP3R function in a specific manner, whilst still allowing the cellular 
expression of InsP3Rs since they are a binding site for proteins that are involved in 
autophagy, such as Beclin1 [382] and mTOR [383]. It was therefore considered that 
inhibiting InsP3R expression, for example via the use of siRNA, may alter the expression or 
distribution of InsP3R-associated proteins and thereby affect autophagic responses 
indirectly. Moreover, preventing InsP3R expression has not always proven to be helpful in 
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deciphering the role of these channels in autophagy. For example, DT40 cells that are null 
for InsP3R expression have provided conflicting evidence about the role of these channels 
in both basal and triggered autophagic flux [287, 288].  
To prevent the activation of InsP3Rs cells were transfected with an InsP3 5’-phosphatase; 
an enzyme that dephosphorylates InsP3 into InsP2 and inorganic phosphate [384, 385]. 
Whilst InsP3 is an intracellular messenger that stimulates the release of Ca2+ from InsP3 
receptors on the ER, InsP2 does not activate InsP3 receptors, and consequently, Ca2+ release 
from the InsP3Rs is prevented. The experimental approach of using InsP3 5’-phosphatase to 
elucidate the specific contribution of InsP3Rs to particular cellular processes has been used 
before by my laboratory, for example to reveal the role of InsP3Rs in the response of cardiac 
myocytes to hypertrophic stimuli [386]. In addition to the specificity afforded by using an 
enzymatic approach to prevent InsP3R function, it was possible to use a mutated form of 
the enzyme, which has no catalytic activity, as a control for transfection and expression of 
an exogenous protein.  
Additional results presented in this chapter explored putative links between preventing 
InsP3R function and mitochondrial Ca2+ uptake, cellular ATP concentration, and ER stress, 
which have all been suggested to regulate autophagy. Moreover, the necessity of InsP3R 
activity for cell cycle progression and sensitivity towards apoptotic stimuli was also 
examined. The overall rationale for these studies was to obtain a significant insight into the 
role played by InsP3Rs in autophagy and other cell death-linked phenomena. 
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4.3 Results 
Imaging medium contains Ca2+ 
 
(complete imaging medium) 
Imaging medium does not contain Ca2+ 
 
(Ca2+ -free medium) 
All figures (Figure 4.1 to 4.32) none 
Table 4.1 Experiments of Chapter 4 which were carried out in either complete imaging medium or  
Ca2+ -free medium. 
 
4.3.1 Transfection of HeLa and HEK cells with InsP3 5-’phosphatase 
For the experiments described in this chapter that involved expression of InsP3 5’-
phosphatase, cells were transfected with a plasmid in which InsP3 5’-phosphatase was 
fused in-frame with GFP or a red fluorescent protein called ‘monomeric cherry’ (hereafter 
called GFP-InsP3 5’-phosphatase or mCherry-InsP3 5’-phosphatase, respectively). The green 
or red fluorescent tags were essential to find those cells that had been successfully 
transfected. The plasmids encoding GFP-InsP3 5’-phosphatase or mCherry-InsP3 5’-
phosphatase were transfected into cells using jetPEI, a commercial cell transfection 
reagent, as per the manufacturer’s instructions. The GFP-InsP3 5’-phosphatase or mCherry-
InsP3 5’-phosphatase were used for experiments involving Ca2+ imaging, as described 
below. Both constructs were found to be similarly efficacious. When GFP-LC3-expressing 
HEK or HeLa cells were used for experiments, the mCherry-InsP3 5’-phosphatase was 
transfected. In brief, the GFP-LC3 HeLa cells were incubated for 12 - 24 hours with jetPEI 
reagent mixed with 1 µg of mCherry-InsP3 5’-phosphatase plasmid DNA. A plasmid 
construct that encoded an inactive mCherry-tagged InsP3 5’-phosphatase was used to 
control for transfection. This was important to determine whether transfection itself 
caused any cellular stresses, plausibly upregulating autophagy as a consequence. As shown 
in Figures 4.1 and 4.2, InsP3 5’-phosphatase-transfected HeLa and HEK cells displayed 
increased autophagy. However, expression of the inactive form of the InsP3 5’-phosphatase 
did not evoke any change in GFP-LC3 punctae formation. To confirm the pro-autophagic 
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effect of the InsP3 5’-phosphatase, Western Blotting was used as an alternative technique. 
As shown in 4.1D, intensity of the LC3-II band in InsP3 5’-phosphatase-transfected cells was 
increased compared to that of control conditions. 
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Figure 4.1. HeLa cells transfected with InsP3 5’-phosphatase displayed increased 
autophagy. Panel A represents untransfected HeLa cells, with a basal level of autophagy. 
Panel B depicts cells transfected with mCherry-tagged InsP3 5’-phosphatase (12-hour 
transfection), showing an increased number of GFP-LC3 punctae. Note that the autophagy 
depicted in this figure was solely due to the expression of the InsP3 5’-phosphatase; the 
cells were maintained in cell culture medium whilst in the incubator, and then in complete 
imaging medium for visualisation on the microscope. Panel C is a quantitative 
representation of the effects of transfecting the InsP3 5’-phosphatase, and the inactive 
form of the enzyme, on autophagy. Whereas the InsP3 5’-phosphatase triggered significant 
autophagy, cells expressing the inactive enzyme showed similar numbers of GFP-LC3 
puncate to control cells. The data are mean ± S.E.M of 3 - 7 experiments (30 - 70 cells per 
condition). The data were analysed with a one-way ANOVA. * indicates p < 0.05 and **** 
indicates p < 0.0001. The scale bars in Panels A and B indicate 10 µm. Panel D is a Western 
blot showing the expression of LC3-II protein with GAPDH as a loading control; the intensity 
of the LC3-II band was increased in InsP3 5’-phosphatase-expressing cells (n = 1). 
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Figure 4.2. HEK cells transfected with InsP3 5’-phosphatase displayed increased 
autophagy. Panel A represents untransfected HEK cells, with a basal level of autophagy. 
Panel B shows cells transfected with mCherry InsP3 5’-phosphatase (12-hour transfection), 
with an increased number of GFP-LC3 punctae. Panel C is a quantitative representation of 
the effects of InsP3 5’-phosphatase, and the inactive form of the enzyme, on autophagy, 
with the latter showing similar level autophagy to control cells. The data are mean ± S.E.M 
of 3 - 5 experiments (40 - 55 cells per condition). The data were analysed with a one-way 
ANOVA. **** indicates p < 0.0001. The scale bars in Panels A and B indicate 10 µm. 
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4.3.2 Agonist responses in InsP3 5’-phosphatase-transfected cells and non-transfected cells 
 
To examine how expression of the InsP3 5’-phosphatase affected cellular Ca2+ signalling, 
cells were loaded with Fura-2 and Rhod-2 to monitor cytosolic and mitochondrial Ca2+ 
responses, respectively. To provoke Ca2+ signals the cells were superfused with complete 
imaging medium supplemented with histamine (for HeLa cells), or ATP (for HEK cells). Both 
of these agonists trigger the production of InsP3 and mobilisation of Ca2+ from stores, with 
sub-maximal and maximal agonist concentrations of ~2.5 µM and 100 µM. The averaged 
population results presented in Figure 4.3, and the example single cell traces shown in 
Figure 4.4, indicate that HeLa and HEK cells transfected with the InsP3 5’-phosphatase (GFP 
form) showed substantially reduced cytosolic and mitochondrial Ca2+ responses, compared 
to non-transfected cells. From these data, the percentage of cells that responded to agonist 
stimulation, and showed Ca2+ oscillations, were calculated.  These analyses also confirmed 
that HeLa and HEK cells expressing the InsP3 5’-phosphatase had lesser responses to either 
2.5 µM or 100 µM agonist concentrations compared to non-transfected cells (Figures 4.5 
and 4.6). Expression of a catalytically inactive InsP3 5’-phosphatase did not significantly 
affect the response of HEK cells to ATP (Figure 4.6). 
It is important to note that Rhod-2 can become compartmentalised in both mitochondria 
and the cytosol [387]. Therefore, additional control experiments were carried out to 
determine whether Rhod-2 signals reflected mitochondrial or cytosolic Ca2+ responses, or 
a mixture of both. To this end, cells were incubated with oligomycin (5µM) and antimycin 
A (5 µM) to depolarise mitochondria, and prevent Ca2+ uptake via the mitochondrial 
uniporter. The results presented in Figure 4.7 show that indeed there was some Rhod-2 in 
the cytosol, since oligomycin and antimycin A did not entirely abolish Rhod-2 responses. 
However, there was a significant decrease in Rhod-2 responses following oligomycin and 
159 
 
antimycin A application suggesting that a proportion of the Rhod-2 signal emanated from 
mitochondria. Moreover, although the Fura-2 and Rhod-2 signals were temporally similar, 
they did not exactly mirror each other (Figure 4.4), consistent with the notion that they 
arose from separate cellular compartments. Taken together, these data indicated that 
expression of the InsP3 5’-phosphatase abrogated InsP3R-evoked Ca2+ signals in both the 
cytosol and mitochondria. 
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Figure 4.3. Cytosolic and mitochondrial Ca2+ signals were concomitantly reduced in InsP3 
5’-phosphatase–expressing HeLa and HEK cells. The traces in Panels A and B represent 
recordings from Fura-2- and Rhod-2-loaded HeLa (A) and HEK (B) cells. Cytosolic and 
mitochondrial Ca2+ signals were monitored in untransfected cells (Panels Ai and Bi), or in 
cells transfected with InsP3 5’-phosphatase (GFP form) (Panels Aii and Bii). Ca2+ signals were 
evoked by addition of a submaximal and a maximal agonist concentration (histamine or 
ATP; 2.5 and 100 µM); larger Ca2+ signals were observed in untransfected cells, whereas 
less prominent Ca2+ transients were shown in InsP3 5’-phosphatase-transfected cells. The 
data are representative of 3 experiments for each cell type. The data expressed as mean ± 
S.E.M (total cells: 75 untransfected and 35 transfected HeLa cells; 100 untransfected and 
65 transfected HEK cells). 
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Figure 4.4. Cytosolic and mitochondrial Ca2+ signals were concomitantly reduced in InsP3 
5’-phosphatase–expressing HeLa and HEK cells. The traces in Panels A and B represent 
Fura-2 and Rhod-2 recordings from individual HeLa and HEK cells. Cytosolic (black traces) 
and mitochondrial (red traces) Ca2+ signals were monitored in untransfected cells (Panels 
Ai and Bi), or in cells transfected with InsP3 5’-phosphatase (GFP form) (Panels Aii and Bii). 
Ca2+ signals were evoked by addition of a submaximal and a maximal agonist concentration 
(histamine or ATP; 2.5 and 100 µM); larger Ca2+ signals were observed in untransfected 
cells, whereas less prominent responses were shown in InsP3 5’-phosphatase-transfected 
cells.  
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Figure 4.5. Expression of InsP3 5’-phosphatase reduced histamine-evoked Ca2+ signals in 
GFP-LC3-expressing HeLa cells. Panels A - C show that HeLa cells transfected with an InsP3 
5’-phosphatase (mCherry form) had a lesser response to both 2.5 µM and 100 µM 
histamine compared to non-transfected cells. Panels B and C represent data of responding 
cells only. The data are mean ± S.E.M of 3 experiments. The data were analysed with a one-
way ANOVA. * indicates p < 0.05 and *** indicates p < 0.001. 
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Figure 4.6. Expression of InsP3 5’-phosphatase reduced ATP-evoked Ca2+ signals in GFP-
LC3-expressing HEK cells. Panels A - C show that HEK cells transfected with an InsP3 5’-
phosphatase (mCherry form) had a lesser response to both 2.5 µM and 100 µM ATP 
compared to non-transfected cells, or cells transfected with a catalytically inactive InsP3 5’-
phosphatase. The data are mean ± S.E.M of 3 experiments. The data were analysed with a 
one-way ANOVA. * indicates p < 0.05.  
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Figure 4.7. Mitochondrial depolarisation decreased mitochondrial Ca2+ uptake, but did 
not affect cytosolic Ca2+ signals, in HeLa and HEK cells. Cytosolic and mitochondrial Ca2+ 
signals were simultaneously monitored by loading cells with both Fura-2 and Rhod-2. 
Following indicator loading, cells were either left untreated, or were treated with 5 µM 
oligomycin and antimycin A for 5 minutes prior to imaging. Ca2+ signals were evoked by the 
addition of 100 µM histamine to HeLa cells, or 100 µM ATP to HEK cells (Panels A and B, 
respectively). The column graphs represent the difference between Fura-2 and Rhod-2 
fluorescence signals before histamine/ATP addition and the peak responses observed 
following stimulation of the cells with the agonist. Cells treated with oligomycin and 
antimycin A showed a reduction in Rhod-2 peak fluoresence compared to control cells. 
There was a residual response of Rhod-2 in oligomycin- and antimycin A-treated cells, 
which is likely have been due to Rhod-2 in the cytosol since whole cells, and not just 
mitochondrial regions, were measured in the analysis. The data are representative of 2-3 
experiments for each cell type (100 – 150 cells per condition). The data were analysed with 
a one-way ANOVA. * indicates p < 0.05.  
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4.3.3 InsP3 5’-phosphatase expression did not correlate with GFP-LC3 punctae number 
In order to evaluate any correlation between different levels of protein expression and 
induction of autophagy, HeLa cells showing different intensities of mCherry fluorescence 
(following transfection with 1 µg of the mCherry-tagged InsP3 5’-phosphatase plasmid DNA) 
were evaluated for autophagy levels. It was postulated that greater InsP3 5’-phosphatase 
protein expression (assessed by the intensity of mCherry fluorescence) could result in a 
more substantial number of GFP-LC3 punctae due to increased inhibition of InsP3R-
mediated Ca2+ release. However, no correlation was found between mCherry fluorescence 
and the number of GFP-LC3 punctae (Figure 4.8), suggesting that even low levels of the 
InsP3 5’-phosphatase efficiently inhibited Ca2+ release from InsP3 receptors and triggered 
autophagy. 
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Figure 4.8. Correlation of InsP3 5’-phosphatase transfection and GFP-LC3 punctae in HeLa 
cells. Panel A is a representative image of cells transfected with 1 µg mCherry InsP3 5’-
phosphatase (12-hour transfection). Panel B shows the consequent induction of 
autophagy. The level of InsP3 5’-phosphatase expression is reflected by the mCherry 
fluorescence intensities in individual cells. Panel C is a plot of mCherry-InsP3 5’-phosphatase 
intensity versus induction of autophagy for individual cells (55 cells from 5 independent 
experiments). Line of best fit was plotted using analysis of linear regression (R2 = 0.0006). 
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4.3.4 Inhibition of InsP3Rs with 2-APB induced autophagy 
The data presented above show that transfection of cells with an InsP3 5’-phosphatase 
triggered autophagy. From this result, it would be expected that other blockers of InsP3R 
function would have a similar effect. Therefore, the action of 2-aminoethoxydiphenyl 
borate (2-APB), a well-known inhibitor of InsP3Rs [388], was examined. Consistent with the 
effect of expressing the InsP3 5’-phosphatase, acute application of 2-APB (100 µM for 1 
hour) increased the accumulation of GFP-LC3 punctae and also reduced histamine-evoked 
cytosolic Ca2+ signals (Figure 4.9). 
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Figure 4.9. Inhibition of InsP3Rs with 2-APB induced autophagy in HeLa cells.  Panel A is a 
representative image of cells in complete imaging medium. Panel B is a representative 
image of the same cells following a 1-hour incubation with 2-APB (100 µM). Panel C is a 
quantitative representation of the effect of 2-APB on autophagy. Panel D shows averaged 
Ca2+ signals upon addition of 2.5 µM and 100 µM histamine to cells following 2-APB 
treatment, or to cells that were not treated with 2-APB. Larger Ca2+ signals were observed 
in the untreated cells, whereas less prominent peaks are shown in 2-APB treated cells. The 
data are mean ± S.E.M of 3 experiments (70 - 90 cells per condition). The data were 
analysed with a one-way ANOVA test. **** indicates p < 0.0001. 
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Figure X. Inhibition of InsP3 receptors with 2 -APB induced autophagy in HeLa cells. Panel (A) is a
representative image of cells in amino acid/growth factor-replete medium. Panel (B) is a representative
image of the same cells following a 1-hour incubation with 100 µM 2-APB. Panel (C) is a quantitative
representation of the effect of 2-APB on autophagy. Panel (D) shows calcium signals upon addition of
2.5 µM and 100 µM histamine, following 2-APB treatment. Larger calcium signals were obs rved in
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4.3.5 The phospholipase C inhibitor U-73122 induced autophagy 
Another tool that is widely used for inhibiting Ca2+ release from InsP3Rs is U-73122, an 
inhibitor of phospholipase C. Essentially, this compound prevents the production of InsP3, 
and as a consequence Ca2+ release from InsP3 receptors is abrogated. Incubation of cells 
with U73122 increased the accumulation of GFP-LC3 punctae (Figure 4.10), although the 
effect of the phospholipase C inhibitor was slower, and not as big as that with 2-APB (Figure 
4.9). The accumulation of GFP-LC3 punctae during incubation with U73122 is consistent 
with the results obtained using both the InsP3 5’-phosphatase and 2-APB. The slower action 
of U73122 might point to it giving a weaker inhibition of InsP3R-mediated Ca2+ signals 
compared to the other treatments. 
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Figure 4.10. The phospholipase C inhibitor U73122 induced autophagy in HeLa cells. The 
graph shows a quantitative representation of the effect of 10 µM and 50 µM U73122 on 
autophagy, following a 1- or 2-hour incubation. The number of GFP-LC3 punctae per cell 
increased following a 2-hour incubation with 50 µM U73122. Cells were incubated with 
U73122 in complete imaging medium. The data are mean ± S.E.M of 3 experiments (30 - 60 
cells per condition). The data were analysed with a one-way ANOVA test. *** indicates p < 
0.01.   
Figure….. The phospholipase C inhibitor U73122 induced autophagy in HeLa cells. The graph
shows a quantitative representation of the effect of 10 µ and 50 µM U73122 on autophagy,
following a 1- or 2-hour incubation. The number of GFP-LC3 punctae per cell increased
following a 2-hour incubation with 50 µM U73122. Cells were incubated with U73122 in
complete medium (DMEM + 10% FBS) at 37°C + 5% CO2. The data are mean ± S.E.M of 3
experiments (30 - 60 cellsper condition). The data were analysed with a one-way ANOVA test.
*** indicates p <0.01.
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4.3.6 Rapamycin and InsP3 5’-phosphatase did not show a synergistic or additive effect on 
the induction of autophagy  
The data presented in this Chapter so far has demonstrated that Inhibition of InsP3R-
mediated Ca2+ signalling induced autophagy. To explore if there was an interaction 
between autophagy caused by reduced InsP3R opening and that arising via mTOR 
inhibition, cells were transfected with the InsP3 5’-phosphatase and simultaneously treated 
with rapamycin. For these experiments, two different amounts of mCherry-InsP3 5’-
phosphatase (0.2 µg or 1 µg) were used to transfect the cells, with the intention of evoking 
different levels of autophagic response that might reveal additivity/synergy with 
rapamycin. However, with HeLa cells, both amounts of mCherry-InsP3 5’-phosphatase 
plasmid DNA gave a similar number of GFP-LC3 punctae (Figure 4.11), consistent with the 
data shown in Figure 4.8 that the expression of InsP3 5’-phosphatase has an all-or-none 
effect, rather than being concentration dependent. With HEK cells, 1 µg of the mCherry-
InsP3 5’-phosphatase plasmid DNA gave a robust transfection and induction of autophagy 
(Figure 4.12). Whereas, 0.2 µg of mCherry-InsP3 5’-phosphatase plasmid DNA was not 
sufficient for triggering autophagy. Despite the concentration of mCherry-InsP3 5’-
phosphatase plasmid DNA used to transfect the cells, concurrent application of rapamycin 
did not give any additional increase in GFP-LC3 punctae numbers (Figures 4.11 and 4.12). 
It is plausible that rapamycin and InsP3 5’-phosphatase induced autophagy through the 
same canonical pathway. This would explain why the addition of rapamycin to InsP3 5’-
phosphatase-transfected cells did not increase autophagy to a higher level than the InsP3 
5’-phosphatase alone. 
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Figure 4.11. Rapamycin and InsP3 5’-phosphatase did not have an additive effect on 
autophagy in HeLa cells. The bar graph shows a quantitative representation of the effect 
of rapamycin on autophagy levels in cells that were either untransfected, or transfected 
with an mCherry-InsP3 5’-phosphatase construct. The data are mean ± S.E.M of 3 
experiments (30 - 50 cells per condition) and were analysed with a one-way ANOVA. * 
indicates p < 0.05, ** indicates p < 0.01 and **** indicates p < 0.001.  
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Figure 4.12. Rapamycin and InsP3 5’-phosphatase did not have an additive effect on 
autophagy in HEK cells. The column graph shows a quantitative representation of the 
effect of rapamycin on autophagy in cells that were either untransfected, or transfected 
with an mCherry-InsP3 5’-phosphatase construct. The data are mean ± S.E.M of 3 
experiments (30 - 75 cells per condition) and were analysed with a one-way ANOVA. *** 
indicates p < 0.001 and **** indicates p < 0.0001.  
 
 
 
 
 
 
 
 
 
 
Figure …….Rapamycin and InsP3 5’-phosphatase do not have ann additive effect on
autophagy. The column graph shows a quantitative representation of the effect of rapamycin
on autophagy in HEK cells that were either untransfected, or transfected with an InsP3 5’-
phosphatase construct. The data are mean ± S.E.M of 3 experiments (30 - 75 cells per
condition) and were analysed with a one-way ANOVA. *** indicates p < 0.001 and ****
indicates p < 0.0001.
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4.3.7 BAPTA-AM inhibited autophagy induced by InsP3 5’-phosphatase  
The accumulation of GFP-LC3 punctae following expression of the InsP3 5’-phosphatase, 
suggests that InsP3R-mediated Ca2+ release provides a signal that suppresses autophagy. In 
this situation, Ca2+ signals would be anti-autophagic. However, one of the most consistent 
methods for preventing the induction of autophagy is the buffering of Ca2+ using BAPTA-
AM (Chapter 3, Figure 3.24), and in this context Ca2+ signals would be pro-autophagic. To 
examine the interplay between these Ca2+ signals, the effect of BAPTA-AM loading on InsP3 
5’-phosphatase was examined. For these experiments, cells were pre-incubated with 
BAPTA-AM (10 µM for 1 hour at room temperature), concurrently with Fura-2 loading in 
the final hour of the 12–hour transfection with InsP3 5’-phosphatase. As shown earlier 
(Figures 4.1 and 4.2), transfection of HeLa and HEK cells with the mCherry-InsP3 5’-
phosphatase induced the accumulation of GFP-LC3 punctae (Figures 4.13 and 4.14). With 
both HeLa and HEK cells that were loaded with BAPTA-AM in the number of GFP-LC3 
punctae was reduced to basal, or even sub-basal, levels. These data are consistent with a 
scheme in which InsP3Rs provide a Ca2+ signal that suppresses autophagy, and so 
prevention of InsP3R-mediated Ca2+ release switches on autophagy. At the same time, 
another Ca2+ signal, which can be buffered by BAPTA-AM loading, is required for autophagy 
to occur. The nature and source of the Ca2+ signal that is buffered by BAPTA-AM is unclear. 
However, it obviously cannot be from InsP3Rs.  
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Figure 4.13. Preincubation of HeLa cells with BAPTA-AM inhibited the induction of 
autophagy by InsP3 5'-phosphatase. Panel A represents GFP-LC3 cells that are untreated 
(control). Panel B represents cells transfected with mCherry-tagged InsP3 5’-phosphatase 
(12-hour transfection), showing an increased number of GFP-LC3 punctae. Panel C 
represents cells treated with 10 µM BAPTA-AM for one hour at the 11th hour of InsP3 5’-
phosphatase transfection; the number of GFP-LC3 punctae was similar to those at basal 
level (control). Panel D is a quantitative representation of the effects of InsP3 5’-
phosphatase and BAPTA-AM on autophagy. The data are mean ± S.E.M of 3 - 4 experiments 
(40 - 60 cells per condition). The data were analysed with a one-way ANOVA. * indicates p 
< 0.05, *** indicates p < 0.001 and **** indicates p < 0.0001. The scale bars in Panels A-C 
indicate 10 µm. Panel E is a Western blot showing the expression of LC3-II protein with 
GAPDH as a loading control (note that two of the blot columns were shown in Figure 4.1). 
The intensity of the LC3-II band was increased in InsP3 5’-phosphatase-expressing cells, but 
reduced by BAPTA-AM loading (n = 1). 
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Figure 4.14. Preincubation of HEK cells with BAPTA-AM inhibited the induction of 
autophagy by InsP3 5'-phosphatase. Panel A shows an image of GFP-LC3-expressing HEK 
cells that were transfected with mCherry-tagged InsP3 5’-phosphatase (12-hour 
transfection). An increased number of GFP-LC3 punctae is evident in the GFP-LC3 image 
(Panel A, bottom). Panel B represents GFP-LC3-expressing HEK cells treated with BAPTA-
AM (10 µM) for one hour at the 11th hour of the InsP3 5’-phosphatase transfection.  
Autophagy was significantly inhibited by the BAPTA-AM incubation, and GFP-LC3 punctae 
numbers were similar to the basal levels observed in control cells (untransfected cells). 
Panel C is a quantitative representation of the effects of InsP3 5’-phosphatase, and InsP3 5’-
phosphatase + BAPTA-AM, on autophagy. The data are mean ± S.E.M of 3 - 4 experiments 
(40 - 50 cells per condition). The data were analysed with a one-way ANOVA. * indicates p 
< 0.05, ** indicates p < 0.01 and **** indicates p < 0.0001. The scale bars in Panels A and 
B indicate 10 µm. 
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4.3.8 Confirming autophagic flux in InsP3 5’-phosphatase-transfected cells 
Accumulation of GFP-LC3 punctae can occur in situations where the processing of 
autophagic vesicles is blocked [225]. It was therefore important to examine whether the 
increase of GFP-LC3 punctae seen following InsP3 5’-phosphatase transfection was due to 
interference with autophagic flux. For this purpose, control experiments were performed 
using 3-MA and BafA1, as described in Chapter 3. HeLa and HEK cells were transfected with 
the mCherry-InsP3 5’-phosphatase for 12 hours, and BafA1 or 3-MA were added to the cells 
for the hour prior to imaging cells (i.e., at the 11th hour post-transfection). As expected, 
BafA1 caused an accumulation of GFP-LC3 punctae when applied to untransfected cells, 
but also increased the number of GFP-LC3 punctae in InsP3 5’-phosphatase-transfected 
cells (Figures 4.15 and 4.16). Correspondingly, incubation with 3-MA reduced the numbers 
of GFP-LC3 punctae in both untransfected and InsP3 5’-phosphatase-transfected cells 
(Figures 4.17 and 4.18). These data are consistent with expression of the InsP3 5’-
phosphatase triggering an increase in autophagic flux via the canonical PI3-kinase-
dependent autophagy pathway.  
An important point to make about the results obtained using BAPTA-AM (Figures 4.13 and 
4.14) and 3-MA (Figures 4.17 and 4.18) is that the stimulation of autophagy by the InsP3 5’-
phosphatase, and GFP-LC3 punctae accumulation, would have occurred before the 
compounds were applied to the cells (i.e., autophagy would have been activated during the 
12-hour transfection with InsP3 5’-phosphatase). Therefore, the reduction of GFP-LC3 
punctae caused by BAPTA-AM and 3-MA suggests that the existing autophagic vesicles 
completed their processing, and that no new vesicles were formed. This is significant 
because it indicates that vesicles can be processed in cells transfected with InsP3 5’-
phosphatase, again consistent with functional autophagic flux. 
180 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.15. Expression of an InsP3 5’-phosphatase stimulated autophagic flux in HeLa 
cells. Panel A represents HeLa cells transfected with mCherry-tagged InsP3 5’-phosphatase 
(12-hour transfection), showing an increased number of GFP-LC3 punctae. Panel B 
represents cells treated with 0.1 µM BafA1 for one hour at the 11th hour of InsP3 5’-
phosphatase transfection; the number of GFP-LC3 punctae was further increased. Panel C 
is a quantitative representation of the effects of InsP3 5’-phosphatase and BafA1 on 
autophagy. The data are mean ± S.E.M of 3 experiments (25 - 40 cells per condition). The 
data were analysed with a one-way ANOVA. *** indicates p < 0.001 and **** indicates p < 
0.0001. The scale bars in Panels A and B indicate 10 µm.  
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Figure 4.16. Expression of an InsP3 5’-phosphatase stimulated autophagic flux in HEK 
cells. Panel A represents HEK cells transfected with mCherry-tagged InsP3 5’-phosphatase 
(12-hour transfection), showing an increased number of GFP-LC3 punctae. Panel B 
represents cells treated with 0.1 µM BafA1 for one hour at the 11th hour of InsP3 5’-
phosphatase transfection; the number of GFP-LC3 punctae was further increased. Panel C 
is a quantitative representation of the effects of InsP3 5’-phosphatase and BafA1 on 
autophagy. The data are mean ± S.E.M of 3 experiments (40 - 50 cells per condition). The 
data were analysed with a one-way ANOVA. ** indicates p < 0.01 and **** indicates p < 
0.0001. The scale bars in Panels A and B indicate 10 µm. 
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Figure 4.17. Autophagy induced by expression of an InsP3 5’-phosphatase was inhibited 
by 3-MA in HeLa cells. Panel A represents cells transfected with mCherry-tagged InsP3 5’-
phosphatase (12-hour transfection), showing an increased number of GFP-LC3 punctae. 
Panel B represents cells treated with 5 mM 3-MA for one hour at the 11th hour of InsP3 5’-
phosphatase transfection; autophagy was significantly inhibited and GFP-LC3 punctae 
numbers are similar to those at basal level. Panel C is a quantitative representation of the 
effects of InsP3 5’-phosphatase and 3-MA on autophagy. The data are mean ± S.E.M of 3 - 
4 experiments (25 - 55 cells per condition). The data were analysed with a one-way ANOVA. 
** indicates p < 0.01 and *** indicates p < 0.001. The scale bars in Panels A and B indicate 
10 µm. 
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Figure 4.18. Autophagy induced by expression of an InsP3 5’-phosphatase was inhibited 
by 3-MA in HEK cells. Panel A shows an image of GFP-LC3-expressing HEK cells that were 
transfected with mCherry-tagged InsP3 5’-phosphatase (12-hour transfection). An 
increased number of GFP-LC3 punctae is evident in the GFP-LC3 image (Panel A, bottom). 
Panel B shows an image of GFP-LC3-expressing HEK cells that were transfected with 
mCherry-tagged InsP3 5’-phosphatase (12-hour transfection) and treated with 5 mM 3-MA 
for one hour at the 11th hour of the InsP3 5’-phosphatase transfection. Autophagy was 
significantly inhibited by the 3-MA treatment, and GFP-LC3 punctae numbers are similar to 
the basal levels observed in control (untransfected) cells. Panel C is a quantitative 
representation of the effects of the InsP3 5’-phosphatase, and the InsP3 5’-phosphatase + 
3-MA, on autophagy. The data are mean ± S.E.M of 3 - 4 experiments (50 - 60 cells per 
condition). The data were analysed with a one-way ANOVA. * indicates p < 0.05, ** 
indicates p < 0.01 and **** indicates p < 0.0001. The scale bars in Panels A and B indicate 
10 µm. 
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4.3.9 Expression of the InsP3 5’-phosphatase caused a reduction in cellular ATP levels, but 
did not trigger ER stress 
 
The accumulation of GFP-LC3 punctae caused by 2-APB (Figure 4.9), U73122 (Figure 4.10) 
and the InsP3 5’-phosphatase (Figures 4.1 and 4.2), suggest that inhibition of InsP3Rs 
induced a cellular response that triggers autophagy. Since the expression of the InsP3 5’-
phosphatase reduced the Ca2+ transfer from InsP3Rs to mitochondria (Figures 4.3 and 4.4), 
it was considered plausible that there could have been a change in mitochondrial 
respiration. In addition, alteration of InsP3R activity could potentially lead to ER stress by 
changing the environment within the lumen of the ER. Both a change in mitochondrial 
respiration and ER stress have been linked to the induction of autophagy [281, 293, 389] 
Therefore, both potential outcomes were assessed.  
To examine changes in mitochondrial respiration that might result from a reduced flux of 
Ca2+ from InsP3Rs to the mitochondrial matrix, cellular ATP levels were measured. 
Specifically, ATP levels were examined in untreated HeLa and HEK cells, and in those 
transfected with the InsP3 5’-phosphatase. In addition, oligomycin and antimycin A 
(inhibitors of mitochondrial respiration) and 2-deoxyglucose (2-DG) (a glucose molecule 
used to inhibit glycolysis), were applied to untransfected cells as positive controls to 
deplete cellular ATP levels.  Expression of the InsP3 5’-phosphatase significantly reduced 
ATP levels in both HeLa and HEK cells, whereas expression of a catalytically inactive InsP3 
5’-phosphatase did not (Figures 4.19 and 4.20). The reduction in ATP levels due to InsP3 5’-
phosphatase expression was comparable to that obtained with addition of oligomycin + 
antimycin A (Figure 4.20B), but less than that seen when cells were treated with oligomycin 
+ antimycin A + 2-DG (Figure 4.20). 
ER stress can be induced when the Ca2+ stores are chronically empty, or when the 
physiological Ca2+ signalling is disturbed. Along with the unfolded protein response (UPR), 
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ER stress can cause ER-associated degradation (ERAD) and autophagy [390]. ER stress was 
measured with two methods; Thioflavin T labelling of living cells, and qRT-PCR 
measurement of GRP78/BiP expression. Thioflavin T is a cell-permeant fluorescence 
molecule that selectively binds protein aggregates, especially β-sheets, and consequently 
displays enhanced fluorescence upon binding [391]. HeLa cells were transfected with the 
InsP3 5’-phosphatase, and then acutely labelled with Thioflavin T at 12-, 24- and 48-hours 
post-transfection. Hydrogen peroxide (H2O2) was used as a positive control for ER stress 
induction. Treatment of cells with H2O2 caused a significant labelling of cells with Thioflavin 
T (Figure 4.21). However, cells expressing either the catalytically active or inactive InsP3 5’-
phosphatase displayed the same intensity of Thioflavin T labelling as control cells at all time 
points measured (Figure 4.21). These data suggest that expression of the InsP3 5’-
phosphatase did not cause accumulation of misfolded proteins, which could be indicative 
of ER stress. Moreover, qRT-PCR analysis of GRP78/BiP expression indicated that 
expression of the InsP3 5’-phosphatase did not alter the mRNA level of this ER protein 
chaperone (Figure 4.22). Whereas, application of H2O2 caused a significant increase in 
GRP78/BiP mRNA (Figure 4.22). 
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Figure 4.19. Cellular ATP levels were reduced in HeLa cells transfected with InsP3 5’-
phosphatase. The cellular ATP concentration was determined via the production of 
bioluminescence from a luciferin-luciferase assay reaction (Panel A). Panel B shows 
background-subtracted luminescence data values (mean ± S.E.M of 3 experiments) 
obtained from untreated cells, cells transfected with active and inactive forms of InsP3 5’-
phosphatase, and cells treated with oligomycin, antimycin A (5 µM) and 2-DG (5.5 mM) 
(positive controls). Luminescence levels were reduced following a 1-hour treatment of 
HeLa cells with oligomycin, antimycin A and 2-DG. Luminescence counts in cells transfected 
with the active InsP3 5’-phosphatase were also significantly reduced. Panel Ci represents 
luminescence versus ATP concentration relationship that was generated by using a series 
of ATP concentrations ranging from 50 nM to 1000 nM. Panel Cii represents the calibrated 
concentrations of ATP in cells following the various treatments shown. The data were 
analysed with a one-way ANOVA test. ** indicates p < 0.01, *** indicates p < 0.001 and 
**** indicates p < 0.0001. 
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Figure 4.20. Cellular ATP levels were reduced in HEK cells transfected with InsP3 5’-
phosphatase. The cellular ATP concentration was determined via the production of 
bioluminescence from a luciferin-luciferase assay reaction (Panel A). Panel B shows 
background-subtracted luminescence data values (mean ± S.E.M of 3 experiments) 
obtained from untreated cells, cells transfected with the active and inactive forms of InsP3 
5’-phosphatase, and cells treated with oligomycin, antimycin A (5 µM) and 2-DG (5.5 mM) 
(positive controls). Luminescence levels were reduced following a 1-hour treatment of HEK 
cells with oligomycin and antimycin A, and further reduced by a combination of oligomycin, 
antimycin A and 2-DG. Luminescence counts in cells transfected with the active InsP3 5’-
phosphatase were also significantly reduced. Panel Ci represents luminescence versus ATP 
concentration relationship that was generated by using a series of ATP concentrations 
ranging from 50 nM to 500 nM. Panel Cii represents the calibrated concentrations of ATP 
in cells with the various treatments shown, obtained using the standard curve in Panel Ci. 
The data were analysed with a one-way ANOVA test. * indicates p < 0.05, ** indicates p < 
0.01, *** indicates p < 0.001 and **** indicates p < 0.0001. 
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Figure 4.21 Expression of the InsP3 5’-phosphatase did not cause accumulation of 
protein aggregates in HeLa cells. To assess the accumulation of misfolded protein 
aggregates, cells were incubated with 0.5 µM Thioflavin T for 10 minutes prior to acquiring 
fluorescence images. Panel Ai shows a representative image of Thioflavin T-labelled cells in 
complete imaging medium. Panel Aii shows a representative image of Thioflavin T-labelled 
cells in complete imaging medium, which were treated with hydrogen peroxide (H2O2; 100 
µM) for 3 hours. Panels B, C and D show images of Thioflavin T fluorescence in cells 
transfected with either a functional or inactive InsP3 5’-phosphatase enzyme, for 12, 24 and 
48 hours. These time points were chosen since they correlated with the times when 
transfection of a functional InsP3 5’-phosphatase enzyme would induce autophagy. Panel E 
is a quantitative representation of the effect of active and inactive InsP3 5’-phosphatase 
transfection on misfolded protein levels. The data are mean ± S.E.M of 3 - 4 experiments 
(35 - 150 cells per condition). The data were analysed with a one-way ANOVA test. **** 
indicates p < 0.0001. The scale bars in Panels A-C indicate 10 µm.  
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Figure 4.22. The concentration of GRP78/BiP mRNA in HEK cells was not affected by 
expression of an InsP3 5’-phosphatase. The column graph depicts the quantitation of 
GRP78/BiP mRNA expression in HEK cells calculated from qRT PCR results, as a measure of 
ER stress. HEK cells were either non-transfected, or transfected for 24 hours with 
expression vectors encoding active or inactive forms of the InsP3 5’-phosphatase, as 
indicated. The addition of hydrogen peroxide (H2O2; 100 µM) for 3 hours as a positive 
control resulted in a ~3-fold increase in GRP78/BiP expression relative to GAPDH and 
normalised to untreated conditions using the ΔΔCt method. Whereas, transfection of the 
cells with either active or inactive forms of InsP3 5’-phosphatase had no effect on 
GRP78/BiP expression. The data are mean ± S.E.M of 3-5 experiments. The data were 
analysed with a one-sample t-test. * indicates p < 0.05.  
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4.3.10 Expression of InsP3 5’-phosphatase did not protect HeLa or HEK cells from cell death 
induced by menadione, an apoptotic agent 
 
A number of publications have shown a connection between apoptosis and autophagy 
[268, 273, 392]. For example, it has been shown that autophagy can inhibit the induction 
of apoptosis, but, in some circumstances, autophagy or autophagy-associated proteins may 
trigger apoptosis or necrosis. It was therefore of interest to examine whether the 
expression of InsP3 5’-phosphatase, which activates autophagy, affected the sensitivity of 
cells to apoptotic stimulation.  For this purpose, HeLa and HEK cells were transfected with 
the catalytically active and inactive mCherry-InsP3 5’-phosphatase constructs, and treated 
with menadione to induce apoptotic cell death. Following menadione application (100 µM 
for 24 hours), cellular metabolic activity was measured using an MTT assay. Although MTT 
measurements are not a direct measure of cell death or cell viability, they monitor changes 
in cellular dehydrogenase activity, which is an indicator of metabolic homeostasis. The 
expression of neither the catalytically active or inactive mCherry-InsP3 5’-phosphatase 
forms reduced the effect of menadione on cellular metabolism (Figure 4.23). These data 
indicate that an increase in autophagy as a result of InsP3 5’-phosphatase expression did 
not protect cells from apoptotic cell death.  
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Figure 4.23 Expression of InsP3 5’-phosphatase did not protect HeLa or HEK cells from 
reduced metabolic activity induced by menadione, an apoptotic agent. HeLa and HEK cells 
were transfected with the catalytically active and inactive mCherry-InsP3 5’-phosphatase 
constructs, and exposed to 100 µM menadione for 24 hours prior to performing an MTT 
assay. The column graphs (A, HeLa cells; B, HEK cells) show that menadione had a similar 
effect on the cells whether or not they were transfected with InsP3 5’-phosphatase (or the 
inactive form of InsP3 5’-phosphatase). The data are mean ± S.E.M of 3 experiments and 
were analysed with a one-way ANOVA. * indicates p < 0.05 and *** indicates p < 0.001.  
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 4.3.11 Inhibiting Ca2+ uptake into the mitochondria by blocking MCU increased cellular 
autophagy levels   
 
Given the importance of MCU in mediating Ca2+ uptake into the mitochondria, we sought 
to determine whether this mitochondrial protein was critical in maintaining cellular 
autophagy at basal levels. The MCU gene encodes a Ca2+ transporter that localises to the 
inner membrane of the mitochondria [393, 394]. Experiments were carried out using siRNA 
to reduce expression of the MCU, and pharmacological inhibition of MCU-dependent Ca2+ 
uptake into the mitochondria. For this purpose, HEK Cells were transfected with 25 nM 
siRNA MCU or a negative control (non-silencing) siRNA as described in Chapter 2: Materials 
& methods. MCU Protein expression was consequently determined with Western blotting, 
confirming siRNA-mediated knockdown of the MCU (Figure 4.25A-B). Following the 
confirmation that the siRNA substantially reduced MCU expression, GFP-LC3 HEK cells were 
seeded on glass coverslips for imaging experiments, as described in Chapter 2: Materials & 
methods. The cells were transfected with the siRNAs described above, and their GFP-LC3 
punctae numbers were counted. As shown in Figure 4.25C, cells with a reduced expression 
of MCU displayed elevated GFP-LC3 punctae numbers compared to cells in control 
conditions, or cells transfected with the non-silencing siRNA.  
Ru360 is a ruthenium amine complex that binds to mitochondria, and has been shown to 
inhibit mitochondrial Ca2+ uptake [395, 396]. Incubation of cells in complete imaging 
medium with Ru360 (10 µM for 1 hour), and was used at to inhibit Ca2+ uptake into 
mitochondria in HEK cells. Similar to the effect of MCU siRNA (Figure 4.25C), Ru360 
triggered an increase in GFP-LC3 punctae (Figure 4.25D). 
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Figure 4.25. The inhibition of MCU by siRNA transfection, and the inhibition of 
mitochondrial Ca2+ uptake by Ru360, elevated autophagy in HEK cells. Panels A – B (n=1) 
show Western blot analysis of MCU expression using protein lysates obtained from HEK 
cells in complete imaging medium that were transfected with either human MCU siRNA or 
a negative control siRNA (non-targeting siRNA). β-actin was used as a loading control. Panel 
C is a quantification of GFP-LC3 punctae within the cells following the siRNA treatments. 
Panel D is a quantification of the effect of Ru360 (10 µM for 1 hour) application to HEK cells 
in a complete imaging medium on GFP-LC3 punctae accumulation. The data were analysed 
with a one-way ANOVA. **** indicates p < 0.0001. The data are mean ± S.E.M of 3 
experiments (for Panels C and D).  
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4.3.12 Expression of the InsP3 5’-phosphatase did not affect the cell cycle  
 
Foskett et al., proposed that InsP3R-mediated Ca2+ signalling was necessary for the viability 
of cancer cells [397]. In their model, the constitutive transfer of Ca2+ from the ER to 
mitochondria via InsP3Rs is important in maintaining mitochondrial bioenergetics and 
metabolism. They demonstrated that inhibition of InsP3Rs caused the selective killing of 
cancer cells due to the lack of mitochondrial metabolism, and an ensuing catastrophic 
necrotic death during cytokinesis [378]. Since the expression of the InsP3 5’-phosphatase 
used in this study also caused an apparent decline in both mitochondrial Ca2+ uptake 
(Figures 4.3 and 4.4) and mitochondrial ATP production (Figurex 4.19 and 4.20), similar to 
the effects shown by Foskett and colleagues, it was plausible that a similar defect in 
cytokinesis was occurring. This could potentially confound the interpretation of the results 
in this study, since the cells could be unhealthy and undergoing necrotic cell death. 
Therefore, cells were transfected with the catalytically active and inactive mCherry-InsP3 
5’-phosphatase constructs, and the distribution of cells within the stages of the cell cycle 
was assessed using an image-based cytometer. Mitotic catastrophe occurs as a result of 
G2/M checkpoint blockade, and therefore nocodazole was used as a positive control in 
these experiments. The analysis of cell cycle distributions indicated that InsP3 5’-
phosphatase-transfected cells had a similar cell cycle progression as control cells (Figure 
4.26). In contrast, nocodazole-treated cells showed a significantly increased proportion of 
cells in the G2/M phase, and a reduced fraction of cells in G1. These results suggest that 
InsP3 5’-phosphatase expression did not induce alteration in the cell cycle, or cause mitotic 
catastrophe. Moreover, the lack of cells in the sub-G1 population, which are typically 
associated with apoptosis [398], indicates that mCherry-InsP3 5’-phosphatase constructs 
did not trigger apoptotic cell death. 
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Figure 4.26 Expression of an InsP3 5’-phosphatase did not induce mitotic catastrophe or 
apoptosis in HEK cells. The column graph depicts the percentage of cells in each phase of 
the cell cycle under the conditions shown. The positive control for cell cycle arrest at G2/M 
was nocodazole (100 nM for 12 hours). HEK cells were either non-transfected or 
transfected with vectors encoding active or inactive forms of InsP3 5’-phosphatase. The 
untreated sample (control) and InsP3 5’-phosphatase transfected cells show a similar cell 
cycle progression with highest percentages of cells present in the G1 phase. The data are 
mean ± S.E.M of 3 experiments. The data were analysed with a Two-way ANOVA. ** 
indicates p < 0.01. 
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4.3.13 Expression of InsP3 5’-phosphatase did not induce autophagy during methyl 
pyruvate treatment 
 
Following expression of the InsP3 5’-phosphatase, cellular ATP levels were reduced (Figures 
4.19 and 4.20). To determine whether an increased mitochondrial substrate supply could 
rectify the induction of autophagy caused by InsP3R inhibition, cells were treated with 
methyl pyruvate (MP), a compound used for stimulating ATP production in cells.  MP (5mM) 
was added to InsP3 5’-phosphatase expressing cells, and compared to InsP3 5’-phosphatase 
expressing cells only, GFP-LC3 punctae numbers were significantly reduced to basal 
numbers (Figure 4.27). By increasing mitochondrial metabolism with MP alone was 
sufficient to maintain autophagy at a basal state. 
 
 
 
 
 
 
 
 
 
 
Figure 4.27. Expression of InsP3 5’-phosphatase did not induce autophagy in presence of 
methyl pyruvate HEK cells. The column graph is a quantitative representation of the effect 
of mCherry-tagged InsP3 5’-phosphatase on the accumulation of GFP-LC3 punctae in HEK 
cells in the presence or absence of methyl pyruvate (5 mM). Cells transfected with 
mCherry-tagged InsP3 5’-phosphatase (12-hour transfection) displayed an increased 
number of GFP-LC3 punctae, whereas the supplementation of methyl pyruvate 
concurrently with transfection reduced the number of punctae to basal levels. The data are 
mean ± S.E.M of 3 experiments (35 - 70 cells per condition). The data were analysed with a 
one-way ANOVA. ** indicates p < 0.01 and *** indicates p < 0.001. 
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4.3.14 Electron microscopic visualisation of autophagic vesicles in InsP3 5’-phosphatase-
expressing cells  
 
As discussed in Chapter 3, electron microscopy has been used in many studies to establish 
the presence and form of autophagic vesicles. In this study, electron microscopy was used 
to examine whether expression of the InsP3 5’-phosphatase altered the form or clustering 
of autophagy vesicles. Studies have shown that Tg, an inhibitor of SERCA, led to the 
persistent accumulation of mature autophagosomes by blocking autophagosomal fusion 
with lysosomes as well as clustering of punctae with more dense labelling of LC3 and 
changes in vesicle shape.  It is rather difficult to detect any clustering in InsP3 5’-
phosphatase treated cells using fluorescence microscopy, therefore it was important to 
examine any abnormalities by employing electron microscopy. 
As depicted in Figures 4.28 and 4.29, autophagic vesicles could be clearly identified within 
cells under nutrient-replete conditions, and also following InsP3 5’-phosphatase 
transfection. No obvious differences in the structure or size of the 
autophagosomes/autolysosomes were evident between control cells and InsP3 5’-
phosphatase-expressing cells. The contents of autophagosomes also appeared to be 
heterogeneous, with no evidence of a specific type of material having being engulfed.  
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4.3.15 Expression of InsP3 5’-phosphatase did not alter the expression of calreticulin or 
SERCA2 
 
The results present earlier in this chapter indicated that expression of the mCherry-InsP3 
5’-phosphatase altered both cytosolic and mitochondrial Ca2+ signalling (Figure 4.3 and 
Figure 4.4), but did not cause ER stress or accumulation of misfolded proteins (Figure 4.21 
and Figure 4.22) or trigger cell death. To assess whether expression of the mCherry-InsP3 
5’-phosphatase caused cells to alter the expression of components of their Ca2+ signalling 
toolkit, Western blotting was used to measure two proteins, calreticulin (CRT) [399] and 
SERCA2 [34], which are critical for ER Ca2+ storage and homeostasis.The results shown in 
Figure 4.30 indicate that CRT and SERCA2 expression levels were similar in InsP3 5’-
phosphatase-transfected cells compared to untransfected cells, suggesting that inhibition 
of Ca2+ release from the ER does not provoke wholesale changes in the expression of the 
cells’ Ca2+ signalling toolkit. Moreover, the addition of BAPTA-AM to InsP3 5’-phosphatase-
transfected cells did not cause any change in CRT and SERCA2 expression (Figure 4.29).  
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Figure 4.30. InsP3 5’-phosphatase transfection did not alter the expression in CRT or 
SERCA2 levels. Panels A and B show Western blot analysis of CRT and SERCA2 expression 
using protein lysates obtained from HeLa cells in complete imaging medium that were 
either transfected with InsP3 5’-phosphatase (12-hour transfection; Panel A), or transfected 
with InsP3 5’-phosphatase and loaded with BAPTA-AM (10 µM, added for one hour at the 
11th hour of InsP3 5’-phosphatase transfection; Panel B).  Panel C shows a Western blot 
illustrating expression of CRT and SERCA2 proteins with GAPDH used as a loading control. 
The data are mean ± S.E.M of 3 experiments.  
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4.3.16 The nutrients present in complete imaging medium triggered Ca2+ oscillations 
The data presented in this chapter support the hypothesis that expression of InsP3 5’-
phosphatase blocks InsP3R-mediated Ca2+ transfer from the ER to mitochondria (Figures 4.4 
and 4.4), thereby causing a decrease in ATP production (Figures 4.19 and 4.20). For this 
hypothesis to be correct, InsP3 5’-phosphatase-sensitive Ca2+ signals should occur under 
nutrient-replete conditions (i.e., when cells are superfused with complete imaging 
medium). To examine this notion, HEK cells were loaded with Fura-2 whilst in starvation 
medium (i.e., imaging medium without amino acids, FBS, L-glutamine or sodium pyruvate, 
described in Chapter 3), and then placed on the stage of the microscope ready for imaging. 
Following 10 minutes of recording, the cells were superfused with complete imaging 
medium, followed by ATP (100 µM) as a positive control (Figure 4.31). Spontaneous Ca2+ 
signals were infrequently observed in cells maintained in starvation medium, whereas 60 - 
90% of cells (n = 120, 3 independent experiments) responded to superfusion of complete 
imaging medium with one, or more, Ca2+ oscillations (Figure 4.31C and D). As shown in 
Figure 4.31B, the Ca2+ oscillations persisted, albeit infrequently, for tens of minutes. 
Application of a maximum ATP concentration evoked a Ca2+ increase in 100% of cells (n = 
120, 3 independent experiments), with typically larger Ca2+ signal amplitudes than those 
evoked by complete imaging medium (Figure 4.31A and B).  
To examine whether the InsP3 5’-phosphatase could affect the Ca2+ signals evoked by 
completed imaging medium, GFP-InsP3 5’-phophatase-transfected HEK cells were loaded 
with Fura-2 whilst in starvation medium, as described above. No spontaneous Ca2+ signals 
were observed in cells that expressed the InsP3 5’-phosphatase when they were maintained 
in starvation medium (n = 120, 3 independent experiments). Moreover, the expression of 
the InsP3 5’-phosphatase prevented Ca2+ responses to superfusion with complete imaging 
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medium, and substantially blunted the response of cells to application of ATP (Figure 4.32). 
These data suggest that the supplements added to complete imaging medium caused both 
acute and long-lasting Ca2+ signals, albeit more weakly than stimulation with a maximum 
dose of ATP, and that these Ca2+ signals were inhibited by expression of the InsP3 5’-
phosphatase enzyme. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.31. Complete imaging medium evoked Ca2+ oscillations in HEK cells. Panels A and 
B  illustrate  cytosolic Ca2+ signals recorded in individual representative Fura-2-loaded HEK 
cells during superfusion with starvation medium, complete imaging medium, and ATP. 
Panels C and D are a quantitative analysis of cell responses for the experiment shown in 
Panel A. For both Panels A and B, typical cellular responses are shown from individual 
experiments, but both experiments were repeated three times with similar outcomes.  
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Figure 4.32 The expression of InsP3 5-phosphatase prevented Ca2+ signals in HEK cells in 
response to superfusion with complete imaging medium and ATP. Panel A is an image of 
a field of HEK cells loaded with Fura-2. Panel B is an image of the same field of cells 
indicating those cells that were transfected with GFP-InsP3 5’-phosphatase. Panel C 
illustrates cytosolic Ca2+ signals recorded in individual representative Fura-2-loaded HEK 
cells during superfusion with starvation medium, complete imaging medium, and ATP. For 
Panel C, typical cellular responses are shown from an individual experiment. The 
experiment was repeated three times with similar outcomes.  
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4.4 Summary of Chapter 4 
The work described in this chapter investigated the role of InsP3R -mediated Ca2+ signals in 
autophagy. A range of tools were used to either inhibit InsP3Rs or Ca2+ release from InsP3Rs, 
and their consequent effect on autophagy was measured using GFP-LC3 expressing HeLa 
and HEK cells. The cells were also tested for signs of ER stress that may occur as a 
consequence of interfering with Ca2+ signalling. Additionally, the role of autophagy in 
relation to cell death was briefly investigated where apoptosis was induced in cells to 
determine whether autophagy acts as a protective mechanism.  
The key findings in this Chapter are: 
 The expression of InsP3 5’-phosphatase in HeLa and HEK cells resulted in an increase 
of autophagic flux (Figures 4.1, 4.2, 4.15-4.18). BafA1 and 3-MA treatments given in 
the last 1 hour of InsP3 5’-phosphatase transfection caused an increase or a 
decrease in GFP-LC3 punctae numbers, respectively.  
 The addition of rapamycin to InsP3 5’-phosphatase-expressing cells did not show 
any additive effects on autophagy induced by InsP3 5’-phosphatase autophagy 
(Figure 4.11).  
 Cytosolic and mitochondrial Ca2+ signals were reduced in InsP3 5’-phosphatase–
expressing HeLa and HEK cells (Figures 4.3 to 4.6).  
 ATP levels were reduced in InsP3 5’-phosphatase transfected HeLa and HEK cells 
(Figures 4.19 and 4.20). 
 Elevated autophagy levels induced by InsP3 5’-phosphatase expression, did not 
protect HeLa or HEK cells from apoptosis (Figure 4.23). 
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 The supplementation of cells with methyl pyruvate suppressed the increase in GFP-
LC3 punctae accumulation caused by expression of the InsP3 5’-phosphatase (Figure 
4.27).  
 Electron microscopy showed that autophagic vesicles in InsP3 5’-phosphatase-
expressing cells were similar in shape and size to those in control cells (Figures 4.28 
and 4.29).   
 Analysis of cell stress markers using qRT-PCR or Thioflavin T indicated that 
transfection of InsP3 5’-phosphatase did not induce cell stress or accumulation of 
misfolded protein aggregates (Figures 4.21 and 4.22). 
 Acute incubation with Ru360 stimulated the accumulation of GFP-LC3 punctae in 
HEK cells (Figure 4.25). 
 Cells expressing InsP3 5’-phosphatase showed a similar cell cycle distribution to 
control cells (Figure 4.26).  
 BAPTA-AM inhibited InsP3 5’-phosphatase-induced autophagy (Figures 4.13 and 
4.14). 
4.5 Discussion 
 
The studies presented in this chapter investigated the regulation of autophagy by Ca2+ 
release from InsP3Rs. Previous studies from other laboratories have indicated that these 
Ca2+ release channels having both pro- or anti-autophagic effects in a range of cell lines 
[287-289] . The results in this chapter support the hypothesis that the transfer of Ca2+ from 
InsP3Rs to mitochondria suppresses autophagy. This was demonstrated using HeLa and HEK 
cell lines expressing an InsP3 5’-phosphatase enzyme that significantly decreased both 
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cytosolic and mitochondrial Ca2+ signals (Figures 4.3 and Figure 4.4). Expression of the InsP3 
5’-phosphatase reversibly increased autophagic flux in both cell types (Figures 4.15 - 4.18). 
These results agree with other evidence whereby a reduction in InsP3 signalling is pro-
autophagic. For example, studies using lithium to inhibit the production of InsP3 [286, 291] 
and treatment of T cells with glucocorticoid to decrease InsP3R-mediated Ca2+ signalling 
[400], also triggered autophagy. Xestospongin B (XeB), an InsP3R antagonist, was found to 
trigger autophagy in various cell lines, but not in DT40 cells that had a triple knockout of all 
InsP3R isoforms (DT40 TKO; [287]). In this study, the putative role of mitochondria Ca2+ 
uptake in suppressing autophagy was supported by finding that the mitochondrial 
uniporter (MCU) is important for maintaining basal level autophagy. Inhibition of the MCU 
(with either Ru360 or siRNA knockdown), significantly increased autophagosome numbers 
in HEK cells (Figure 4.25). These observations agree with results of Foskett et al., where 
MCU inhibition induced autophagy in DT40 cells [288]. 
The notion that of InsP3R-mediated Ca2+ release suppresses autophagy was further 
validated by treatment of cells with the InsP3R inhibitor 2-APB (Figure 4.9), and the 
phospholipase C inhibitor U-73122 (Figure 4.10). It is, however, important to note that 2-
APB is not fully specific for InsP3Rs, and can affect a number of cellular targets including 
TRP channels, SERCA and Orai channels [8] [388, 401]. Other groups have also found that 
2-APB can trigger autophagy. For example, breast cancer cells showed increased cell death 
when exposed to 2-APB, which was correlated with increased autophagy [402]. The 
addition of autophagy inhibitors such as BafA1 or 3-MA suppressed the breast cancer cell 
death. Contrary to the findings presented in this chapter, and those of others, some studies 
have suggested that inhibiting InsP3Rs with 2-APB suppresses autophagy. For example, 
cadmium- and evodiamine-induced autophagy were suppressed by 2-APB [377, 403]. 
These results suggest that InsP3Rs can be pro-autophagic, and are important for cadmium- 
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and evodiamine-induced autophagy, whereas the studies presented here show that InsP3R-
mediated Ca2+ signalling is vital for suppressing autophagy. Further work is clearly required 
to understand the different cellular contexts in which InsP3Rs can be either pro- or anti-
autophagic. Plausibly, these different outcomes could depend on the cell type, their 
dependence on InsP3R-mediated Ca2+ signals, or the nature of the autophagic stimulus.  
ATP levels were found to be reduced in InsP3 5’-phosphatase-expressing cells (Figures 4.19 
and 4.20). The observation of reduced ATP levels following InsP3R inhibition agrees with 
results obtained by Foskett and colleagues, whereby DT40 cells with reduced Ca2+ transfer 
from InsP3Rs to mitochondria had lesser ATP levels [288]. In addition, Foskett and 
colleagues demonstrated that reduced InsP3R opening lead to activation of AMPK, and 
subsequently elevated autophagy even in the presence of nutrients [288].Due to time 
constraints, the mechanism(s) leading from reduced cellular ATP levels to autophagy were 
not investigated. However, it is likely that AMPK will be implicated [136, 404].  
Foskett et al., have additionally shown that inhibiting InsP3R-mediated Ca2+ release killed a 
higher percentage of tumour cells compared to non-tumorigenic cells and induced 
autophagy in both cell types [378]. In those studies, autophagy upregulated in the tumour 
cells was not enough for their survival. Cell death occurred as a consequence of the 
bioenergetic crisis following InsP3R inhibition, which lead to a failure in complete mitosis 
and a consequent triggering of necrosis. However, cell cycle studies carried out in this 
chapter revealed that InsP3 5’-phosphatase-expressing cells have a normal cell cycle profile 
(Figure 4.26). Therefore, the lack of InsP3R activity does not necessarily cause failure of 
mitosis. 
The addition of rapamycin to InsP3 5’-phosphatase-expressing cells did not show any 
additive effects on autophagy (Figure 4.11). It is possible that both treatments might be 
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inducing autophagy through mTOR inhibition, and therefore cannot have an additive 
action. Studies have shown that nutrient starvation of DT40 cells devoid of InsP3R 
expression (which have increased autophagy), upregulated autophagy levels even further 
than in non-starved cells [288]. Although the additive effect of nutrient starvation with 
InsP3 5’-phosphatase-expressing cells was not tested in this chapter, since nutrient 
starvation and rapamycin induce autophagy via mTOR, our results show a different 
outcome than those in the literature. 
Similar to our earlier findings with rapamycin presented in Chapter 3, Figure 3.24, BAPTA-
AM prevented autophagy evoked by InsP3R inhibition (Figures 4.13 and 4.14). These 
observations indicate that the lack of InsP3R-mediated Ca2+ signals triggers autophagy, and 
that a BAPTA-sensitive source of Ca2+ is required for autophagy to proceed. Although the 
source of Ca2+ signals chelated by BAPTA-AM is unknown, these data show that that 
cytosolic Ca2+ has both suppressive and activating roles in the regulation of autophagy. 
Expression of the InsP3 5’-phosphatase was the principal approach used in this study to 
prevent InsP3R opening. Importantly, the expression of this enzyme did not cause ER stress 
(Figures 4.21 and 4.22), accumulation of misfolded proteins (Figure 4.21), changes in the 
expression of components of the Ca2+ signalling toolkit (Figure 4.30), alteration of the cell 
cycle (Figure 4.26) or trigger apoptosis (Figure 4.26). These observations concur with other 
studies from my lab that have used the InsP3 5’-phosphatase to efficiently block InsP3R 
opening without deleterious effects on cells [386]. Studies using HeLa cells have shown that
 InsP3R inhibition with XeB, which also induces autophagy, did not provoke ER stress or 
mitochondrial toxicity [286].   
Interestingly, the autophagy induced by InsP3 5’-phosphatase expression did not protect 
HeLa or HEK cells from apoptotic cell death (Figure 4.23). Published studies have shown 
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autophagy can have a cytoprotective effect on cells undergoing apoptosis [270, 405]. For 
example,  the induction of autophagy following treatment with rapamycin, or Beclin-1 
overexpression, protected PC12, NRK, COS-7 and CSM-14 cells from pro-apoptotic agents 
[406]. The authors proposed that autophagy is able to reduce the mitochondrial load in 
cells, thereby lowering the amount of pro-apoptotic molecules, such as cytochrome c 
released from mitochondria, following apoptotic stimulants. The reason why a 
cytoprotective effect of autophagy was not seen in the studies presented here is unclear. 
It is plausible that autophagy would be protective against a weaker apoptotic stimulus than 
menadione. 
Since the expression of the InsP3 5’-phosphatase was observed to reduce mitochondrial 
Ca2+ uptake (Figures 4.3 and 4.4) and lower cellular ATP levels (Figures 4.19 and4.20), it was 
considered that the lack of Ca2+ transfer from InsP3Rs to mitochondria was decreasing 
mitochondrial bioenergetics and thereby triggering autophagy. To test whether increased 
mitochondrial substrate supply could rectify the induction of autophagy caused by InsP3R 
inhibition cells were treated with methyl pyruvate (Figure 4.27). A number of studies have 
shown that methyl pyruvate is a membrane-permeant mitochondrial substrate that leads 
to increased energetics and ATP production [407-410]. Cells that were expressing the InsP3 
5’-phosphatase and treated with methyl pyruvate showed similar levels of autophagy to 
control cells (Figure 4.27). These observations suggest that the key effect of the InsP3 5’-
phosphatase was to decrease mitochondrial bioenergetics and ATP production.  
If Ca2+ uptake by mitochondria is necessary to maintain mitochondrial bioenergetics and 
cellular ATP levels, and thereby suppress autophagy, there should be some evident form of 
Ca2+ signalling occurring within cells under nutrient rich conditions. Supporting this 
hypothesis it was observed that the supplements (amino acids, FBS, L-glutamine and 
212 
 
sodium pyruvate) contained in the complete imaging medium triggered Ca2+ oscillations 
(Figure 4.31). These Ca2+ responses were inhibited in InsP3 5’-phosphatase expressing cells 
incubated in complete imaging medium (Figure 4.32). Presumably these Ca2+ oscillations 
are nutrient-evoked Ca2+ signals that support mitochondrial bioenergetics, however further 
work is required to confirm this hypothesis.  
It is evident that InsP3Rs play a dual role in autophagy, but it is presently difficult to 
reconcile the discrepant literature. It could be that the cellular context determines the 
autophagic role of InsP3Rs. For example, during chronic starvation, when autophagy is 
upregulated, InsP3R-mediated Ca2+ signalling may be pro-autophagic [317]. Whereas, 
under nutrient-replete conditions, such as those used in this study, InsP3R-mediated Ca2+ 
signalling suppressed autophagy. Additional studies will be needed to resolve these 
seemingly contradictory findings.  
Interest in the role of InsP3Rs in cancer has surged in the last few years, with the suggestions 
that cancer cells rely on InsP3R-mediated Ca2+ signalling for survival and growth [319, 397]. 
Cancer cells undergo a remodelling of their metabolism, which is often denoted as the 
‘Warburg effect’, where glycolysis is principally used for ATP production rather than 
oxidation of pyruvate within mitochondria [411]. However, evidence also shows that 
cancer cells also rely on mitochondrial respiration for energy and for the production of 
metabolites, lipids, DNA and proteins [307, 378]. Therefore it is possible that transfer of 
Ca2+ from InsP3Rs to mitochondria maintains the synthesis of essential building blocks for 
cancer cell survival and cytokinesis. Indeed, cancer cells were shown to be addicted to the 
ER-mitochondrial Ca2+ signals to fuel mitochondrial metabolism in order to maintain their 
fast and uncontrolled proliferation [402, 412]. Future opportunities might benefit from 
combination therapies for manipulating Ca2+ signals/sources to trigger a specific 
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autophagic outcome along with cancer therapies by exploiting some of the autophagy 
inducers and inhibitors that have been tested in clinical trials. 
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Chapter 5: Regulation of autophagy by store-operated Ca2+ entry (SOCE) 
5.1 Introduction 
As discussed earlier, a number of studies have shown that intracellular Ca2+ is involved in 
either activation or inhibition of autophagy [7, 8, 290, 371]. Several Ca2+ sources have been 
proposed, along with a number of downstream signalling steps. In many situations, it is 
experimentally difficult to dissociate cytosolic Ca2+ signals arising from different sources. 
Moreover, it can be tricky to precisely control the delivery of Ca2+ so that specific Ca2+ 
signals can be correlated with a particular cellular outcome. One experimental approach 
that has been used for this purpose is photolytic liberation of caged messengers such as 
InsP3 and Ca2+. Although for a process such as autophagy, which takes many minutes to 
develop, photolysis of caged precursors would require the continual delivery of energy for 
uncaging. The work presented in this Chapter describes a different approach to control 
cytosolic Ca2+ signals so that autophagy could be stimulated in a Ca2+-dependent manner. 
The rationale for these experiments was to compare the kinetics of cytosolic Ca2+ signals 
and autophagy, and to develop a simple system to undertake a screen of signalling 
processes that mediate the effects of Ca2+ on autophagy.  
Store-operated Ca2+ entry (SOCE) is a common mechanism for Ca2+ entry into cells [413] 
[414] and operates in almost all cell types, except perhaps some electrically-excitable cells 
[38]. SOCE is triggered following depletion of intracellular Ca2+ stores as a means of 
replenishing their Ca2+ content, but may also be constitutively active with minimal store 
depletion [415]. Ca2+    influx arising from SOCE supports global, whole-cell signals such as 
Ca2+ oscillations, which are known to affect various aspects of cell function and fate [416]. 
In addition, Ca2+ signals occurring in the vicinity of SOCE channels may have local signalling 
functions [417]. A similar approach, using depleted Ca2+ stores to activate SOCE and 
thereby allow the deliberate generation of Ca2+ signals upon superfusion with medium 
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containing extracellular Ca2+, has been employed to investigate cellular responses in other 
studies [418]. 
Some previous studies have investigated the role of SOCE in the regulation of autophagy. 
However, as with other aspects of the relationship between Ca2+ and autophagy, the 
published literature is somewhat contradictory. It has been demonstrated that inhibiting 
SOCE via knock down of STIM1, or by pharmacological blockade, prevented cell cycle 
progression from G1 to S phase and also activated autophagy in cervical cancer cells, 
although the link between lack of Ca2+ influx and autophagy was not determined [419]. 
Plausibly, an absence of SOCE could cause the progressive decline of Ca2+ within cellular 
organelles such as the ER, which would activate the unfolded protein response (UPR) 
and lead to cellular stress [420]. Indeed, a link between ER stress, consequent UPR and 
autophagy has been demonstrated [421]. Pharmacological blockage of SOCE in colorectal 
cancer cells with SKF-96365 was shown to induce cell death via apoptosis, but cell death 
was slowed by the concomitant triggering of autophagy. Autophagy had a cytoprotective 
effect by preventing the release of cytochrome c from mitochondria [295]. Additionally, 
resveratrol was shown to downregulate STIM1 expression and thereby inhibit SOCE in 
prostate cancer cells, which consequently caused ER stress and autophagy-mediated cell 
death. These studies indicate that a lack of SOCE is pro-autophagic and can affect cell fate.  
Conversely, it has been shown that activation of SOCE can trigger autophagy. It was 
observed that autophagy induction correlated with both increased STIM1 expression and 
intracellular Ca2+ concentration in bone marrow-derived endothelial progenitor cells (EPCs) 
[299]. The authors found that oxidized low-density lipoprotein (ox-LD), used to mimic 
hypercholesterolemia, inhibited cellular proliferation as well as activating autophagic flux 
in the EPCs. Inhibition of autophagy further reduced cellular proliferation, revealing that 
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autophagy acted as a protective response against ox-LDL-induced proliferative inhibition 
[299].  In vivo studies using murine pancreatic acini have shown that deletion of TRPC3 
(Trpc3−/−) reduced SOCE activity by about 50%, indicating that the native TRPC3 functions 
as a store-operated Ca2+ channel. Moreover, the reduced Ca2+ influx in the Trpc3−/− cells 
protected the cells by lowering ER stress and self-destruction by autophagy. Further 
research suggests that inhibition of autophagy prevents acute pancreatitis [422], and that 
a sustained increase of cytosolic Ca2+ concentration is a trigger for the cell damage that 
occurs during pancreatitis [423]. It is therefore plausible that inhibition of acinar cell TRPC3, 
and other Ca2+ influx channels, may reduce the severity of pancreatitis by preventing 
autophagic cell demise.  
Although the studies described above have invoked a role for SOCE and Ca2+ influx in the 
triggering, or inhibition, of autophagy, they largely correlated the effect of long-term 
inhibition of cells with various compounds with autophagic markers. To induce autophagy 
in a Ca2+-dependent manner, whilst avoiding the pleiotropic effects of membrane receptor 
stimulation, this study used the SERCA inhibitors thapsigargin (Tg) or cyclopiazonic acid 
(CPA) along with the controlled removal and re-addition of extracellular Ca2+. In particular, 
experimental conditions were sought that allowed both Ca2+ and autophagy to be 
monitored over the same time course, without appreciable cell stress, and the least 
experimental time that allowed significant measurement of cytosolic Ca2+ and autophagy. 
Tg and CPA are well known inhibitors of SERCA pumps, and both are widely employed for 
depleting intracellular Ca2+ stores. To examine the role of SOCE on autophagy, GFP-LC3-
expressing HeLa and HEK cells were treated with Tg or CPA in the presence or absence of 
extracellular Ca2+ for one hour. In the absence of extracellular Ca2+, the Tg- or CPA-
mediated release of Ca2+ from intracellular stores caused a transient (~3 minutes) cytosolic 
Ca2+signal that eventually returned to basal levels. In the continual presence of Tg or CPA 
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the intracellular Ca2+ stores were not able to refill. Therefore, using Tg- or CPA-treated cells 
enabled the distinction between Ca2+ signals arising from intracellular stores and SOCE. The 
effect of SOCE on autophagy in HEK cells was compared with ionomycin, which also causes 
Ca2+ influx when cells are suspended in medium containing Ca2+.  
5.2 Results 
Imaging medium contains Ca2+ 
 
(Complete imaging medium) 
Imaging medium does not contain Ca2+ 
 
(Ca2+ -free medium) 
Figure 5.1 Figure 5.5 
Figure 5.2 Figure 5.6 
Figure 5.3 Figure 5.7 
Figure 5.4 Figure 5.8 
Figure 5.8 Figure 5.9 
Figure 5.9 Figure 5.11 
Figure 5.10 Figure 5.12 
Figure 5.14 Figure 5.13 
Figure 5.15 Figure 5.14 
Figure 5.16 Figure 5.15 
Figure 5.17  
Figure 5.18  
Table 5.1 Experiments of Chapter 5 which were carried out in either complete imaging medium or  
Ca2+ -free medium. 
 
5.2.1 Inhibiting SERCA pumps with Tg or CPA stimulated autophagic flux in HeLa cells. 
 
Tg and CPA are both commonly used to inhibit SERCA pumps, thereby causing the gradual 
depletion of ER Ca2+ stores and activation of SOCE [424]. Tg and CPA are often considered 
to have a similar action. Although, Tg is lipophilic and has a nanomolar affinity for SERCA, 
whereas CPA is hydrophilic and inhibits SERCA pumps when applied in micromolar 
concentrations. In addition, Tg is irreversible and can permanently block SERCA function, 
whilst CPA is reversible and can be readily washed out of cells. An effect of Tg on autophagy 
has been reported in several studies. However, the effect of Tg on autophagy was variable, 
with some reports suggesting that autophagy was activated [199] [293] [425], whilst others 
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observed an inhibitory effect [6] [291]. Moreover, Ganley et al. [372] found that Tg did not 
affect the initial steps of autophagy, such as the formation of autophagosomes, but led to 
the persistent accumulation of mature autophagosomes by blocking autophagosomal 
fusion with lysosomes. The authors concluded that the reported accumulation of 
autophagosomes in Tg-treated cells was not due to induction of autophagy, but rather due 
to failure to clear existing autophagic vesicles. Since the principal method used in this study 
for detecting the dynamic activation of autophagy was accumulation of GFP-LC3-labelled 
punctae, it was important to examine whether SERCA inhibition blocked autophagic flux in 
the cell types used here. GFP-LC3-expressing HeLa cells were therefore treated with Tg (3 
µM) for 1 or 5 hour(s) in Ca2+-containing medium in the presence or absence of BafA1, and 
the numbers of GFP-LC3 punctae were subsequently monitored. As depicted in Figure 5.1, 
Tg elevated the number of GFP-LC3 punctae in HeLa cells. Importantly, BafA1 significantly 
increased the number of GFP-LC3 punctae in Tg-treated cells, consistent with an activation 
of autophagic flux by Tg (if Tg had blocked autophagic flux, BafA1 would have been 
ineffective). These data indicate that Tg increased autophagic flux when applied in Ca2+-
containing medium.  
Similar to Tg, CPA induced an increase in GFP-LC3 punctae numbers that was also enhanced 
by concurrent incubation with BafA1 (described in detail below). For reasons that are 
presently unclear, CPA evoked a more rapid accumulation of autophagic vesicles than Tg 
(Figure 5.2). With CPA, a statistically significant increase in autophagic vesicles was 
observed after one hour, whereas Tg required longer. From an experimental perspective, 
CPA is much simpler to use than Tg. CPA is water soluble, easier to make up in solution, 
cheaper, reversible, and unlike Tg, CPA did not persistently stick to the imaging chambers 
used in this study. Following experiments with Tg, the imaging chambers needed treatment 
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with ethanol and copious washing to remove all of the compound. For these reasons, the 
bulk of the studies presented in this Chapter used CPA as a SERCA inhibitor.  
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Figure 5.1. Thapsigargin, an inhibitor of SERCA pumps, increased the number of GFP-LC3 
punctae in HeLa cells and did not block the autophagic flux. Panel A is a representative 
image of cells in complete imaging medium. Panel B is a representative image of cells 
incubated with 3 μM thapsigargin (TG) in complete imaging medium for five hours. Panel C 
represents cells treated similarly to those shown in Panel B, but with the addition of 0.1 
µM BafA1 in the last one hour of incubation. Panel D is a quantitative representation of the 
effect of TG, BafA1 and TG + BafA1 on autophagy; the number of GFP-LC3 punctae per cell 
was increased by TG following a 5-hour incubation. Autophagy was further increased by 
the addition of BafA1. The data are mean ± S.E.M of 3 - 5 experiments (45 - 100 cells per 
condition). The data were analysed with an one-way ANOVA test. **** indicates p < 0.0001. 
The scale bars in Panels A-C indicate 10 µm. 
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5.2.2 Activating SOCE with CPA induces autophagy in Ca2+-containing media 
 
To monitor the influence of SOCE on cytosolic Ca2+ signals and autophagy, GFP-LC3-
expressing HeLa and HEK cells were loaded with Fura-2 and placed on the stage of an 
epifluorescence microscope, as described in Chapter 2: Materials and Methods. Following 
a 1-minute recording of the basal 340/380 Fura-2 ratio, the HeLa and HEK cells were either 
incubated in complete imaging medium supplemented with 50 µM CPA for a further 59 
minutes, or they were maintained in complete imaging medium without CPA. For both 
conditions, the 340/380 Fura-2 ratio was monitored for the duration of the experiment. To 
examine the status of the intracellular Ca2+ stores, InsP3-generating agonists (histamine for 
HeLa and ATP for HEK cells) were added for the last 10 minutes of the experiment. At the 
end of the experiment, the numbers of autophagic vesicles were counted in both the CPA-
treated cells and the untreated control cells. As depicted in Figures 5.2 and 5.3, it is evident 
that treatment of both cell types with CPA stimulated a significant increase in GFP-LC3 
punctae accumulation. With both cell types, the Fura-2 measurements indicated that CPA 
caused a sustained elevation of cytosolic Ca2+, consistent with perpetual activation of SOCE 
(Figures 5.2D and 5.3D), although, the amplitude of the SOCE response was greater and 
more sustained in HeLa cells than in HEK cells. The lack of responses to addition of InsP3-
generating agonists indicated that CPA had depleted the cells’ intracellular Ca2+ stores. To 
show that processing of autophagic vesicles was not chronically affected by SERCA 
inhibition, an important control experiment was to wash out CPA following a 1-hour 
treatment in complete imaging medium. Results (Figure 5.4) show that incubation with CPA 
increased the number of GFP-LC3 punctae, and subsequently removing the CPA led to a 
reduction in the numbers of punctae. SOCE-induced autophagy was therefore found to be 
reversible. 
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Figure 5.2. Activating SOCE with cyclopiazonic acid (CPA) increased the number of GFP-
LC3 punctae in HeLa cells. Panel A is an image of cells in complete imaging medium. Panel 
B is an image of the same region of cells as shown in Panel A, but following treatment with 
50 µM CPA for one hour. Panel C is a quantitative representation of the effect of CPA on 
autophagy; there was a significant increase in GFP-LC3 punctae. Panel D is the profile of 
cytosolic Ca2+   signals in cells incubated with CPA, following a one-minute baseline 
recording, with an addition of 100 µM histamine for the last 10 minutes. The data are mean 
± S.E.M of 3 experiments (30 cells per condition). The data were analysed with an unpaired 
Student’s t-test. * indicates p < 0.05. The scale bar in Panel B indicates 10 µm. 
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Figure . Increasing cytosolic calcium concentration with cyclopiazonic acid (CPA) stimulated
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Figure 5.3. Activating SOCE with cyclopiazonic acid (CPA) increased the number of GFP-
LC3 punctae in HEK cells. Panel A is an image of cells in complete imaging medium. Panel 
B is an image of the same region of cells as shown in Panel A, but following treatment with 
50 µM CPA for one hour. Panel C is a quantitative representation of the effect of CPA on 
autophagy; GFP-LC3 punctae numbers increased nearly two-fold. Panel D is the profile of 
cytosolic Ca2+ signals in cells incubated with CPA, following a one-minute baseline 
recording, with addition of 100 µM ATP during the last 10 minutes. The data are mean ± 
S.E.M of 3 experiments (20 cells per condition). The data were analysed with a paired 
Student’s t-test. * indicates p < 0.05. The scale bar in Panel B indicates 10 µm. 
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Figure . Increasing cytosolic calcium concentration with cyclopiazonic acid (CPA) stimulates
autophagy in HEK cells. Panel (A) is a representative image of cells in amino acid/growth
factor-replete medium. Panel (B) is a representative image of the same region of cells as (A),
but treated with 50 µM CPA for one hour. Panel (C) is a quantitative representation of the
effect of CPA on autophagy; GFP-LC3 punctae numbers increased by nearly two-fold. Panel
(D) is the profile of [Ca2+] cyt signals in cells incubated with CPA, following a one-minute
baseline recording ,with an addition of 100 µM ATP in the last 10 minutes. The data are mean
± S.E.M of 3 experiments (20 cells per condition). The data were analysed with a paired
Student’s t-test. * indicates p < 0.05. The scale bar in panel (B) indicates 10 µm.
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Figure 5.4. CPA reversibly increased the number of GFP-LC3 punctae in HEK cells. The 
column graph is a quantitative representation of numbers of GFP-LC3 punctae in HEK cells 
incubated in complete imaging medium (control), followed by treatment with CPA (50 µM) 
for 1 hour, followed by washout of CPA using superfusion with fresh complete imaging 
medium and recovery for 1 hour. The graph shows that incubation with CPA increased the 
number of GFP-LC3 punctae, and that subsequently removing the CPA led to a reduction in 
the numbers of GFP-LC3 punctae. The data are mean ± S.E.M of 3 experiments (60 - 100 
cells per condition). The data were analysed with one-way ANOVA test. **** indicates p < 
0.0001.  
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5.2.3 Inhibiting SERCA pumps with CPA does not induce autophagy in a Ca2+-free media 
 
To examine whether Ca2+ influx was necessary for the CPA-evoked increase of autophagy 
depicted in Figures 5.2 and 5.3, GFP-LC3-expressing HeLa and HEK cells were treated with 
50 µM CPA using a similar experimental protocol, but for these experiments Ca2+ was 
omitted during the preparation of the extracellular medium. Moreover, 0.5 mM EGTA was 
included in order to chelate Ca2+  ions that might be present in distilled water or other 
chemicals that were used to prepare the medium. This Ca2+-free, EGTA-containing medium 
(hereafter denoted ‘Ca2+-free medium’) had the same supplements as complete imaging 
medium (i.e., it was supplemented with glutamine, amino acids and growth factors to 
prevent the induction of autophagy due to starvation). HeLa and HEK cells were either 
incubated in Ca2+-free medium supplemented with 50 µM CPA for 59 minutes, or they were 
maintained in Ca2+-free medium without CPA (control). For both conditions, the 340/380 
Fura-2 ratio was monitored for the duration of the experiment. To examine the status of 
the intracellular Ca2+ stores, InsP3-generating agonists (histamine or ATP for HeLa and HEK 
cells, respectively) were added for the last 10 minutes of the experiment. At the end of the 
experiment, the numbers of GFP-LC3 punctae were counted in both CPA-treated and 
control cells. As depicted in Figures 5.5 and 5.6, it is evident that the numbers of GFP-LC3 
punctae were not affected by treatment with CPA in Ca2+-free medium for either cell type. 
With both cell types, the Fura-2 measurements indicated that CPA caused a transient 
elevation of cytosolic Ca2+ that lasted for a few minutes (black traces of Figures 5.5D and 
5.6D). The lack of responses to addition of InsP3-generating agonists indicated that CPA had 
depleted the cells’ intracellular Ca2+ stores. These data suggest that a sustained Ca2+ influx 
induces autophagy, but depletion of intracellular Ca2+ stores with CPA for 1 hour does not.  
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Figure 5.5. Treatment of HeLa cells with cyclopiazonic acid (CPA) in the absence of 
extracellular Ca2+ did not alter the number of GFP-LC3 punctae. Panel A is a representative 
image of HeLa cells in complete imaging medium. Panel B shows the same field of cells as 
in Panel A, but after treatment with CPA (50 µM) for one hour in a Ca2+-free medium. Panel 
C is a quantitative representation of the effect of CPA on autophagy in Ca2+ free medium; 
there was no difference in the number of GFP-LC3 punctae. Panel D shows the profile of 
cytosolic Ca2+ in HeLa cells incubated in Ca2+-free medium. The black trace was recorded 
from cells treated with CPA (50 µM). The CPA was added following a one-minute baseline 
recording. The grey trace was recorded from cells that were solely incubated in Ca2+-free 
medium (i.e., no addition of CPA). Histamine (100 µM) was applied to the cells for the last 
10 minutes of the recordings to examine the Ca2+ content of the ER. The data are mean ± 
S.E.M of 3 - 4 experiments (25 – 50 cells per condition). The data were analysed with a one-
way ANOVA. The scale bar in Panel A indicates 10 µm. 
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Figure 5.6. Treatment of HEK cells with cyclopiazonic acid (CPA) in the absence of 
extracellular Ca2+ did not alter the number of GFP-LC3 punctae. Panel A is a representative 
image of HEK cells in complete imaging medium. Panel B is the same field of cells as in Panel 
A, but following treatment with CPA (50 µM) for one hour in Ca2+-free medium. Panel C is 
a quantitative representation of the effect of CPA on autophagy in Ca2+-free medium; there 
was no difference in the number of GFP-LC3 punctae. Panel D shows the profile of cytosolic 
Ca2+ in HEK cells incubated in Ca2+-free medium. The black trace was recorded from cells 
treated with CPA (50 µM); CPA was added following a one-minute baseline recording. The 
grey trace was recorded from cells that were solely incubated in Ca2+-free medium (i.e., no 
addition of CPA). For both traces, ATP (100 µM) was applied to cells for the last 10 minutes 
of the recordings to examine the Ca2+ content of the ER. The data are mean ± S.E.M of 3 - 
4 experiments (40 - 50 cells per condition). The data were analysed with a one-way ANOVA. 
The scale bar in Panel A indicates 10 µm. 
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5.2.4 The transient release of intracellular Ca2+ stores evoked by inhibiting SERCA pumps 
with CPA did not induce autophagy  
 
To explore whether the transient release of Ca2+ from intracellular stores evoked by 
inhibition of SERCA pumps with CPA affected autophagy, the numbers of GFP-LC3 punctae 
in HeLa cells were monitored at 10 minute intervals after the addition of CPA in Ca2+-free 
medium. As depicted in Figure 5.7A, addition of 50 µM CPA in Ca2+-free medium caused a 
transient cytosolic Ca2+ signal that returned to basal levels within 2 minutes. Monitoring 
GFP-LC3 punctae numbers in the same CPA-treated cells indicated that the transient 
release of Ca2+ evoked by CPA did not affect autophagy (Figure 5.7B). Taken together, these 
data indicate that a sustained Ca2+ influx signal triggers autophagic flux in HeLa cells, 
whereas neither a transient release of Ca2+ from intracellular stores, nor Ca2+ store 
depletion, induces autophagy. 
 
 
 
 
 
 
Figure 5.7. Exposing HeLa cells to cyclopiazonic acid (CPA) in the absence of extracellular 
Ca2+ did not alter the number of GFP-LC3 punctae. To examine whether a transient Ca2+ 
release from intracellular stores was able to affect autophagy, GFP-LC3-expressing HeLa 
cells were stimulated with CPA (50 µM) in Ca2+-free medium. Panel A shows an averaged 
response of HeLa cells to addition of CPA in Ca2+-free medium; a transient cytosolic Ca2+ 
signal was evident. Panel B shows the number of GFP-LC3 punctae within HeLa cells during 
the CPA treatment. The data are mean ± S.E.M of 3 experiments. 
 
0 2 4 6 8 10
0.0
0.2
0.4
0.6
0.8
1.0
Time (minutes)
Fu
ra
-2
si
gn
a
l(
3
4
0/
3
80
ra
tio
)
0
5
10
15
20
25
G
F
P
-L
C
3
p
u
n
ct
ae
p
e
r
ce
ll
 0
CPA in calcium - free buffer
 10  20  30  40 Minutes post
CPA addition
HeLa
A BCPA in calcium - free buffer
229 
 
5.2.5 CPA stimulated autophagic flux in the presence of extracellular Ca2+, but not in its 
absence. 
 
To explore whether in the absence of extracellular Ca2+ CPA had interfered with the 
autophagic flux, control tests were carried out with BafA1. As shown in Figures 5.8 and 5.9, 
CPA did not prevent the enhanced accumulation of GFP-LC3 punctae in cells incubated with 
BafA1, suggesting that autophagic flux was occurring in the presence of CPA in Ca2+-free 
medium. Moreover, the co-addition of 3-MA with CPA in complete imaging medium 
prevented GFP-LC3 punctae accumulation, revealing that CPA-induced autophagy was 
sensitive to a blocker of the canonical autophagy pathway (Figure 5.10). 
 
 
Figure 5.8. CPA stimulated autophagic flux within HEK cells in presence of extracellular 
Ca2+, but not in its absence. The column graph is a quantitative representation of the effect 
of CPA (50 µM for 1 hour) on GFP-LC3 punctae accumulation in HEK cells in a Ca2+-free or 
Ca2+-containing, complete medium. Co-addition of BafA1 (0.1 µM) with CPA caused an 
increase in GFP-LC3 punctae compared to CPA treatment only. The data are mean ± S.E.M 
of 3 experiments (25 - 75 cells per condition). The data were analysed with a one-way 
ANOVA. * indicates p < 0.05 and ** indicates p < 0.01.  
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Figure 5.9. CPA stimulated autophagic flux in HeLa cells in presence of extracellular Ca2+, 
but not in its absence. The column graph is a quantitative representation of the effect of 
CPA (50 µM for 1 hour) on GFP-LC3 punctae accumulation in HeLa cells in a Ca2+-free or 
Ca2+-containing, complete medium. Co-addition of BafA1 (0.1 µM) with CPA caused an 
increase in GFP-LC3 punctae compared to CPA treatment only. The data are mean ± S.E.M 
of 3 experiments (20 - 30 cells per condition). The data were analysed with a one-way 
ANOVA. *** indicates p < 0.001.   
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Figure 5.10.  3-MA, an inhibitor of class III PI 3-kinases, prevented the increase of GFP-
LC3 punctae induced by CPA in HEK cells. The panel is a quantitative representation on the 
effect of CPA (50 µM) in complete imaging medium on numbers of GFP-LC3 punctae in GFP-
LC3 HEK cells, following a 1-hour incubation. CPA significantly increased the number of GFP-
LC3 punctae, but the concurrent addition of 3-MA (5 mM) with CPA suppressed the 
increase in GFP-LC3 punctae numbers to near basal levels. The data are mean ± S.E.M of 3 
experiments (40 cells per condition). The data were analysed with a one-way ANOVA. ** 
indicates p < 0.01 and **** indicates p < 0.0001.  
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5.2.6 Chronic CPA treatment in a Ca2+-free media induces autophagy  
 
The observation that treatment of cells with CPA for 1 hour in the absence of extracellular 
Ca2+ did not induce an increase in GFP-LC3 punctae suggests that the Ca2+ entry occurring 
during activation of SOCE was critical to the triggering of autophagy. However, the 
depletion of ER Ca2+ stores with agents such as CPA is known to trigger cell stress responses 
that can subsequently activate autophagy [426] [427]. To examine whether the cells used 
in this study behaved in a similar manner to other those used in other reports, the effects 
of a prolonged incubation with CPA in Ca2+-free medium were investigated.  To this end, 
HeLa and HEK cells were treated for 12 hours with CPA in the Ca2+-free medium described 
above. The prolonged incubation of cells with CPA in Ca2+-free medium evoked an increase 
in GFP-LC3 punctae numbers (Figure 5.11 and Figure 5.12). Incubating the cells in Ca2+-free 
medium for 12 hours without CPA had no effect on GFP-LC3 punctae accumulation. 
Importantly, the addition of BafA1 during the CPA treatment increased the number of GFP-
LC3 punctae, consistent with CPA triggering autophagic flux.  
A plausible explanation for the autophagic flux triggered by prolonged incubation of cells 
with CPA in Ca2+-free medium would be the triggering of ER stress due to chronic Ca2+ store 
depletion. However, qRT-PCR analysis of GRP78/BiP mRNA indicated that treatment of cells 
with CPA for either 1 hour or 12 hours did not induce an increase in ER stress (Figure 5.13). 
Whereas, treatment of cells with H2O2, used as a positive control, evoked a significant 
increase in GRP78/BiP mRNA. 
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Figure 5.11. Prolonged treatment of HeLa cells with cyclopiazonic acid (CPA) in the 
absence of extracellular Ca2+ stimulated an increase in GFP-LC3 punctae. The column 
graph is a quantitative representation of the effect of treating HeLa cells with CPA (50 µM) 
for 12 hours in Ca2+-free medium. The addition of CPA to cells in a Ca2+-free medium 
increased GFP-LC3 punctae numbers significantly, with greater punctae accumulation in 
the presence of BafA1. The data are mean ± S.E.M of 3 experiments (40 - 60 cells per 
condition). The data were analysed with a one-way ANOVA. **** indicates p < 0.0001. 
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Figure 5.12. Prolonged treatment of HEK cells with cyclopiazonic acid (CPA) in the absence 
of extracellular Ca2+ stimulated an increase in GFP-LC3 punctae. The column graph is a 
quantitative representation of the effect of treating HEK cells with CPA (50 µM) for 12 hours 
in Ca2+-free medium. The addition of CPA to cells in a Ca2+-free medium increased GFP-LC3 
punctae numbers significantly, with greater punctae accumulation in the presence of 
BafA1. The data are mean ± S.E.M of 3 experiments (40 - 60 cells per condition). The data 
were analysed with a one-way ANOVA. **** indicates p < 0.0001. 
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Figure 5.13. Prolonged treatment of HEK cells with CPA for 12 hours in the absence of 
extracellular Ca2+ did not alter the transcription of GRP78/BiP mRNA. The column graph 
depicts the quantitation of GRP78/BiP mRNA in HEK cells assayed using qRT-PCR, as a 
measure of ER stress. HEK cells were treated for 1 or 12 hours with CPA (50 µM) in Ca2+-
free medium. The addition of hydrogen peroxide (H2O2; 100 µM) for 3 hours as a positive 
control resulted in a ~2-fold increase in GRP78/BiP expression relative to GAPDH and 
normalised to untreated conditions using the ΔΔCt method. Neither acute nor prolonged 
CPA treatment affected GRP78/BiP transcription. The data are mean ± S.E.M of 3 
experiments. The data were analysed with a one-way ANOVA. * indicates p < 0.05.  
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5.2.7 The absence of extracellular Ca2+ prevented the induction of autophagy by rapamycin  
 
The data presented in Chapter 3, Figures 3.12 to 3.15, showed that incubation of cells in 
complete imaging medium with rapamycin increased GFP-LC3 punctae accumulation that 
was enhanced by BafA1 and prevented by 3-MA. To investigate whether canonical mTOR-
dependent autophagy requires Ca2+ storage within the ER or extracellular Ca2+ influx, cells 
were treated with rapamycin in complete imaging medium or in Ca2+ -free medium, with 
or without (CPA 50 µM) for 1 hour. As depicted in Figures 5.14 and 5.15, and shown in 
Figures 3.12 and 3.13, application of rapamycin in complete imaging medium stimulated 
an increase in the number of GFP-LC3 punctae. However, application of rapamycin to cells 
in the absence of extracellular Ca2+ did not alter the number of GFP-LC3 punctae, whether 
the cells were treated with CPA or not. Since HeLa cells retain their ER Ca2+ stores when 
incubated in Ca2+-free medium without CPA (Figure 5.5), these data indicate that 
rapamycin-evoked autophagy does not depend on Ca2+ release from the ER, but does 
require Ca2+ influx.  
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Figure 5.14. Rapamycin-stimulated induction of autophagy in HeLa cells was dependent 
on the presence of extracellular Ca2+, but not Ca2+ storage in the ER. The column graph is 
a quantitative representation of the effects of rapamycin (1 µM) on GFP-LC3 punctae 
formation in the presence or absence of extracellular Ca2+, with or without application of 
CPA (50 µM). All incubations were for 1 hour. The addition of rapamycin caused a significant 
increase in GFP-LC3 punctae only if extracellular Ca2+ was present. The data are mean ± 
S.E.M of 3 - 5 experiments (25 - 60 cells per condition). The data were analysed with a one-
way ANOVA. **** indicates p < 0.0001. 
 
 
 
 
 
Figure . Rapamycin-stimulated induction of autophagy in HeLa cells was not dependent on
calcium storage in the ER, but on the presence of extracellular calcium. The column graph is
a quantitative representation of the effects of CPA (used to deplete ER calcium) and calcium-
free medium (used to prevent calcium entry) on rapamycin-induced autophagy. The addition
of rapamycin to HeLa cells caused a significant increase in GFP-LC3 punctae only if
extracellular calcium was present. The data are mean ± S.E.M of 3 / 5 experiments (25 - 60
cells per condition). The data were analysed with a one-way ANOVA. **** indicates p <
0.0001.
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Figure 5.15. Rapamycin-stimulated induction of autophagy in HEK cells was dependent 
on the presence of extracellular Ca2+, but not Ca2+ storage in the ER. The column graph is 
a quantitative representation of the effects of CPA (used to deplete ER calcium) for 1 hour 
and Ca2+-free medium (used to prevent calcium entry) on rapamycin-induced autophagy. 
The addition of rapamycin for 1 hour to HEK cells caused a significant increase in GFP-LC3 
punctae only if extracellular Ca2+ was present. Also, the addition of rapamycin and CPA 
together in a Ca2+-containing medium showed similar punctae numbers to CPA or 
rapamycin treatments alone, which reveals that the two compounds did not have additive 
effects. The data are mean ± S.E.M of 3 experiments (20 - 60 cells per condition). The data 
were analysed with a one-way ANOVA. * indicates p < 0.05 and **** indicates p < 0.0001. 
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5.2.8 Ionomycin-mediated Ca2+ influx does not trigger autophagy in HEK cells 
The data presented in this Chapter indicate that prolonged activation of SOCE leads to the 
induction of autophagy in HEK cells (Figure 5.3). Ca2+ influx via SOCE can lead to a global 
cytosolic Ca2+ rise, which may affect cellular functions. In addition, SOCE has been shown 
to have specific local signalling actions [417]. To examine whether the pro-autophagic 
effect of SOCE was due to global or local Ca2+ signalling, ionomycin was used to generate a 
prolonged Ca2+ influx signal that was not dependent on plasma membrane channel 
activation.  
The effect of ionomycin on autophagy was investigated using Fura-2-loaded GFP-LC3-
expressing HEK cells with an experimental protocol similar to that used for the experiments 
shown in Figure 5.3. Following a 1-minute recording of the basal 340/380 Fura-2 ratio, HEK 
cells were incubated in complete imaging medium supplemented with 1 µM ionomycin for 
a further 59 minutes. The 340/380 Fura-2 ratio was monitored for the duration of the 
experiment. To examine the status of the intracellular Ca2+ stores, 100 µM ATP was added 
for the last 10 minutes of the experiment. At the end of the experiment, the numbers of 
GFP-LC3 punctae were counted. As shown in Figure 5.16, treatment with ionomycin did not 
affect GFP-LC3 punctae accumulation in HEK cells (Figures 5.16 A-C). The Fura-2 
measurements indicated that ionomycin caused a sustained elevation of cytosolic Ca2+, 
consistent with perpetual Ca2+   influx (Figure 5.16D). The lack of responses to addition of 
ATP indicated that ionomycin had depleted intracellular Ca2+ stores. Increasing the 
extracellular Ca2+ concentration to 5 mM during ionomycin application did not enhance the 
number of GFP-LC3 punctae (Figure 5.16C). 
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Figure 5.16. Increasing cytosolic Ca2+   concentration with ionomycin did not affect GFP-
LC3 punctae accumulation in HEK cells. Panel A is a representative image of cells in 
complete imaging medium. Panel B is an image of the same cells as in Panel A, but following 
incubation with 1 µM Ionomycin for one hour. Panel C is a quantitative representation of 
GFP-LC3 punctae numbers in control cells and cells treated with ionomycin in complete 
imaging media containing either 1.8 mM or 5 mM Ca2+. Panel D is the profile of cytosolic 
Ca2+ signals recorded from cells in complete imaging medium containing 1.8 mM Ca2+. A 
one-minute baseline recording was followed by addition of 1 µM Ionomycin. 100 µM ATP 
was added to cells for the last 10 minutes of the recording. The data are mean ± S.E.M of 3 
experiments (15 - 45 cells per condition). The data were analysed with a one-way ANOVA 
test. The scale bars in Panels A and B indicate 10 µm. 
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5.2.9 Ionomycin does not prevent autophagic flux 
 
Unlike CPA, ionomycin did not stimulate a significant accumulation of GFP-LC3 punctae in 
HEK cells, despite both treatments giving similar cytosolic Ca2+ signals that were dependent 
on Ca2+ influx (Figures 5.3 and 5.16). To test whether ionomycin prevented the 
accumulation of GFP-LC3 punctae by inhibiting the formation of autophagosomes, HEK cells 
were incubated with BafA1 to assess autophagic flux. As shown in Figure 5.17, ionomycin 
did not trigger a significant increase in GFP-LC3 punctae accumulation. Moreover, 
ionomycin did not prevent the significant accumulation of GFP-LC3 punctae in cells 
incubated with BafA1, suggesting that there was on-going autophagic flux in the presence 
of ionomycin.  
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Figure 5.17. Ionomycin did not prevent autophagic flux in HEK cells. Panel A is a 
representative image of cells in complete imaging medium. Panels B and C are 
representative images of cells in complete imaging medium treated with 1 µM ionomycin 
for one hour, in the absence or presence of BafA1, respectively. Panel D is a quantitative 
representation of the effect of ionomycin and ionomycin + BafA1 on autophagy; no 
significant change in GFP-LC3 punctae number was obtained with ionomycin alone. The 
data are mean ± S.E.M of 3 experiments (35 - 80 cells per condition). The data were 
analysed with a one-way ANOVA. **** indicates p < 0.0001. The scale bars in Panels A - C 
indicate 10 µm. 
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5.2.10 Inhibition of Ca2+/calmodulin-dependent kinase kinase (CaMKK) with STO-609 
prevented CPA-induced autophagy 
 
To investigate the molecular pathways involved in CPA-induced autophagy, HeLa cells were 
treated with compounds that inhibit three signalling mediators commonly reported in the 
literature to be involved in autophagy induction [428-430]. Go6983, Sto-609 and KN-93 
(and its inactive form KN-92) were used to inhibit PKC, CaMKK-α/β and CaMKII respectively. 
Control conditions involved cells either incubated in complete imaging medium, or cells 
treated with the compounds mentioned above in the absence of CPA to determine if they 
have any effect on basal autophagy. As shown earlier (Figure 5.2 and Figure 5.3), incubation 
of cells with CPA for 1 hour in complete imaging medium caused an increase in GFP-LC3 
punctae accumulation (Figure 5.18). Of the compounds applied to the cells with CPA, only 
STO-609 caused a significant decrease of GFP-LC3 punctae numbers. None of the 
compounds had any effect on the basal level of GFP-LC3 punctae formation in the absence 
of CPA. 
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Figure 5.18. The CaMKK-α/β antagonist STO-609 inhibited GFP-LC3 punctae accumulation 
induced by CPA in HeLa cells. Panel A is a representative image of cells in complete imaging 
medium. Panel B shows cells that were incubated in complete imaging medium 
supplemented with CPA (50 µM) for 1 hour. Panel C shows cells that were incubated in 
complete imaging medium supplemented with both CPA and STO-609 (25 µM). Panel D is 
a quantitative representation of the effect of CPA and the compounds on autophagy; only 
STO-609, an inhibitor of CaMKK-α/β, reduced CPA-evoked autophagy, whereas neither PKC 
nor CaM Kinase II inhibitors had a significant effect. The data are mean ± S.E.M of 3 
experiments (25-70 cells per condition). The data were analysed with a one-way ANOVA. 
**** indicates p < 0.0001. The scale bars in Panels A - C indicate 10 µm. 
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5.3 Summary  
 
The work presented in this Chapter examined the ability of Ca2+ influx via SOCE, or Ca2+ 
release from intracellular stores, to regulate autophagy. All experiments were performed 
using supplements that maintain cells in a basal autophagic state with consistent numbers 
of GFP-LC3 punctae for several hours (Chapter 3, Figures 3.3 and 3.4). Any change in GFP-
LC3 punctae numbers would therefore result from stimulation or inhibition of autophagy, 
or an effect on autophagic flux. The key findings in this Chapter are: 
 Prolonged Ca2+ influx via CPA-evoked SOCE triggered an increase in autophagic flux 
in HeLa and HEK cells (Figures 5.2 and 5.3). 
 ER Ca2+ store depletion for 1 hour, in the absence of Ca2+ influx, did not induce or 
inhibit autophagy; GFP-LC3 punctae numbers remained similar to basal levels in 
HeLa and HEK cells (Figures 5.5 and 5.6). 
 ER Ca2+ store depletion for 12 hours, in the absence of Ca2+ influx, induced 
autophagy (Figures 5.11 and 5.12). However, autophagy was not upregulated due 
to ER stress. 
 Rapamycin-induced autophagy required the presence of extracellular Ca2+, but not 
ER Ca2+ stores (Figures 5.14 and 5.15). 
 Thapsigargin, another activator of SOCE, triggered autophagy in HeLa cells (Fig. 5.1) 
 CPA and Thapsigargin do not inhibit autophagic flux. 
 Ionomycin evoked a similar cytosolic Ca2+ signal to CPA, but did not significantly 
stimulate autophagy in HEK cells (Figures 5.16). 
 The lack of effect of ionomycin on autophagy was not due to inhibition of 
autophagic flux.   
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 Cytosolic Ca2+ elevation with CPA treatment induced autophagy via CaMKK-
mediated phosphorylation in HeLa cells (Figure 5.18). 
5.4 Discussion 
 
This Chapter investigated the role of Ca2+ influx via SOCE on autophagy in two distinct cell 
lines. The results reveal that a prolonged cytosolic Ca2+ signal, caused by application of Tg 
or CPA in Ca2+-containing medium, induced autophagy. The experiments carried out in the 
presence or absence of extracellular Ca2+ suggest that a sustained Ca2+ influx via SOCE 
induces autophagy (Figures 5.2 & 5.3), but depletion of ER Ca2+ stores does not change 
autophagy levels (Figures 5.5 & 5.6). The lack of autophagy induction by ER Ca2+ store 
release during CPA application does not necessarily indicate that Ca2+ release cannot trigger 
autophagy. Rather, it is possible that prolonged Ca2+ signals (i.e., longer than the 15 minutes 
for ER Ca2+ store depletion; Figure 5.7) are required for the induction of autophagy, and 
that ER Ca2+ release, when triggered by SERCA inhibition, is too brief. The induction of 
autophagy by rapamycin similarly relied on extracellular Ca2+, suggesting that mTOR-
induced autophagy requires constitutive Ca2+ signals (Figure 5.14 and 5.15), and that Ca2+ 
release from ER stores is not sufficient. Further work is required to understand why 
rapamycin-induced autophagy is reliant on Ca2+ influx. SOCE-induced autophagy was found 
to be reversible (Figure 5.4). This was an important control to show that processing of 
autophagic vesicles was not chronically affected by SERCA inhibition. Published evidence 
has shown that CPA-induced Ca2+ signals are reversible [431] [432].  
Neither CPA nor Tg halted autophagic flux (Figures 5.1, 5.8 and 5.9). This result differs from 
that reported by Ganley et al. [372], who suggested that SERCA inhibition led to the 
accumulation of GFP-LC3 punctae due to a blockade or autophagosome/lysosome fusion. 
The reasons why Ganley et al. observed an inhibition of autophagic flux when using Tg, 
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whereas the data presented in this study show that using either Tg or CPA did not block 
autophagic flux, are unclear. The conditions used by Ganley et al. (5 µM Tg for 7 hours with 
MEF cells) are not that different from those used in this study (e.g., Figure 5.1). Consistent 
with the data shown in this study, Ganley et al. found that punctae formed in the presence 
of Tg were susceptible to inhibition of PI3-kinase (in their case using wortmanin, rather 
than 3-MA), but they could not find any enhancement of punctae numbers by addition of 
BafA1 with Tg. Moreover, Ganley et al. reported that the GFP-LC3 punctae observed during 
TG application were larger in diameter, and proposed that they represented clusters of 
unprocessed autophagosomes. In the present study, the size of the GFP-LC3 punctae 
observed during Tg or CPA application did not obviously change (e.g., Figure 5.1, Figure 5.2 
and Figure 5.3). Also, whereas Ganley et al, found that Tg evoked only a modest change in 
GFP-LC3 punctae numbers over basal conditions, the present study found a marked fold 
increase in GFP-LC3 puncate numbers (Figure 5.1). The study by Ganley et al. did not show 
the effect of Tg on cytosolic Ca2+ concentration, and it is therefore impossible to compare 
the effects of SERCA inhibition in the MEF cells those authors used versus the HEK and HeLa 
cells employed in this study with regards to Ca2+ signalling. Although, it is presently unclear 
why SERCA inhibition led to a blockade of autophagic flux in the work by Ganley et al., 
whereas the present study found that autophagic flux was evident in Tg- and CPA-treated 
cells, both studies agree that SERCA inhibition does not affect the initial stages of 
autophagosome formation. This validates the approach employed in this study to use SOCE 
as a means for activating a Ca2+-dependent form of autophagy. The use of CPA to cause 
SOCE-dependent autophagic flux therefore provides a useful system in which autophagy is 
Ca2+-dependent, and screening for factors that mediate the effects of Ca2+ can be 
performed.  
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Ionomycin, however, did not have a significant effect on autophagy in HEK cells, despite 
evoking a similar prolonged cytosolic Ca2+ elevation to that seen with CPA (Figures 5.16). 
This outcome could be due to the fact that SOCE allows local Ca2+ signalling around the 
mouth of a channel, whereas ionomycin gives a more global Ca2+signal and therefore does 
not trigger effectors that are local to SOCE channels [433]. Contrary to these findings, 
ionomycin elevated autophagy levels in MCF-7 cells [199]. However, the upregulation of 
autophagy in that study might not have been due to a direct effect of cytosolic Ca2+, but as 
a consequence of long-term effects of ionomycin such as mitochondrial depolarisation and 
fragmentation of organelles [434], since the ionophore was applied for 24 hours.  
A number of experimental studies, using a variety of means to elevate cytosolic Ca2+ 
concentration, have suggested that Ca2+ can cause an increase in autophagy through a 
Ca2+/CaMKK-β-stimulated pathway [199]. Similarly, the findings in this chapter showed that 
CPA-induced SOCE increased autophagy following a 1 hour incubation in HeLa cells through 
a CaMKK-α/β-dependent pathway. Although a number of different cellular signalling 
pathways have been suggested to mediate the effects of Ca2+ on autophagy, a majority of 
studies have pinpointed CaMKK-α/β, which can phosphorylate and activate AMPK thereby 
leading to autophagy.  In support of our data, Racioppi et al., have highlighted a critical link 
between Ca2+ and AMPK, where an increase in intracellular Ca2+ activates AMPK via CaMKK2 
and CaMKK2 forms a complex with AMPK [435]. 
The findings in this chapter also suggest that the Ca2+ sensor must have a high affinity for 
Ca2+, given that the sustained SOCE-dependent cytosolic Ca2+ increase is most cell types is 
~100 nM. The published literature has shown SOCE to have both pro- and anti- autophagic 
roles [13] [14]. The findings in this study support the notion that SOCE is pro-autophagic, 
since acute depletion of ER Ca2+ stores triggered GFP-LC3 punctae accumulation when 
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extracellular Ca2+ was present (Figure 5.2 and Figure 5.3). With colorectal cells, inhibition 
of Ca2+ influx following application of SKF-96365 triggered autophagy, suggesting that 
constitutive Ca2+ entry is required to suppress basal autophagy. However, in this study, the 
removal of extracellular Ca2+ did not alter the basal number of GFP-LC3 punctae (Figure 5.5, 
Figure 5.11 and Figure 5.12), suggesting that for the cells used here SOCE was not required 
to suppress autophagy. This study did not therefore furnish any results suggesting that 
SOCE is anti-autophagic. Long term treatment of cells with CPA in absence of extracellular 
Ca2+ did induce accumulation of GFP-LC3 punctae, however, this induction of autophagy 
was evidently not dependent on SOCE since no extracellular Ca2+ was present. Further work 
is required to understand why long-term depletion of ER Ca2+ stores in the absence of 
extracellular Ca2+ lead to autophagy. 
Although a number of studies have directly, or indirectly, used SOCE to examine the role of 
Ca2+ signalling in the regulation of autophagy, the results are not entirely consistent. 
However, it is clear from the present study that Ca2+ influx can trigger autophagy, and is 
vital for the induction of autophagy via mTOR inhibition. Which channels underlie the 
effects of SOCE on autophagy were not examined in this study. Whilst STIM1-activated Orai 
channels are believed to account for substantial proportion of SOCE, they are not the only 
channels that may respond to ER Ca2+ depletion [436]. For example, transient receptor 
potential canonical channel-1 (TRPC1), is also believed to mediate Ca2+ entry in response 
to depletion of ER Ca2+ stores, and increased in intracellular Ca2+ arising through TRPC1 
activation has been demonstrated to trigger autophagy [437]. Interestingly, a common 
finding with studies that have investigated the role of SOCE in autophagy is that the 
resulting autophagy is cytoprotective and acts to delay cell death [295] [437]. These studies 
suggest that extracellular Ca2+ is necessary to trigger autophagy that promotes cell survival. 
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Plausibly, inhibiting SOCE-dependent autophagy, and its cytoprotective effect, may help in 
situations where increased cell death is required, such as during chemotherapy for cancer.   
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Chapter 6: General Discussion and Future Perspectives 
6.1 General Discussion 
 
The work described in this thesis sought to develop an understanding of the spatial and 
temporal characteristics of Ca2+ signals that control autophagy in mammalian cells, and to 
characterise sources of Ca2+ that lead to the generation of these Ca2+ signals. In particular, 
this project aimed to understand the regulation of autophagy by cytosolic and 
mitochondrial Ca2+ signals. 
The experiments described in Chapter 3 characterised the utility of fluorescence for 
studying Ca2+ signalling and autophagy within the same cells over an acute time period, as 
opposed to the many hours of cell stimulation that had been used in previously published 
studies. Different stimuli were employed to induce autophagy in HeLa and HEK cell lines, 
two commonly used cell lines in the Ca2+ and autophagy fields respectively. A microscopy-
based method measuring GFP-LC3 punctae was validated for use in real-time monitoring 
of autophagic flux with the use of autophagy modulators such as 3-MA and BafA1 to 
determine any defects in the early and late stages of the process respectively. Additionally, 
results revealed that chelating cytosolic Ca2+ with BAPTA-AM prevented the induction of 
basal or stimulated autophagy. However the source and nature of the Ca2+ signals 
necessary for these putative Ca2+-sensitive steps is unclear. 
The work presented in Chapter 4 investigated the regulation of autophagy by Ca2+ release 
from InsP3Rs. Recent studies investigating the regulation of autophagy have indicated that 
InsP3Rs are involved in both anchoring proteins involved in autophagy (e.g., Beclin-1 and 
Bcl-2) and providing Ca2+ signals that impact on the induction of autophagy. However, as 
with much of the literature on Ca2+ and autophagy, the actual role of InsP3Rs (whether pro- 
or anti-autophagic) is controversial. Moreover, InsP3Rs have received great attention in 
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relation to cancer in the last few years, with proposals that cancer cells are addicted to 
InsP3R-mediated Ca2+ signalling for survival and growth in order to keep up with their fast 
and uncontrolled proliferation [402, 412]. The results presented in this study support the 
hypothesis that the transfer of Ca2+ from InsP3Rs to mitochondria suppresses autophagy, 
and agree with other evidence whereby a reduction in InsP3 signalling is pro-autophagic. 
Reduced Ca2+ transfer from InsP3Rs to mitochondria in InsP3 5’-phosphatase-expressing 
cells caused reduced ATP levels. Additionally, the mitochondrial uniporter (MCU) was found 
to be vital for maintaining suppression of autophagy. InsP3 5’‐phosphatase-expressing cells 
were shown to have a normal cell cycle profile without failure of mitosis, which is contrary 
to literature findings [320]. BAPTA-AM prevented autophagy induction by InsP3R inhibition, 
revealing that a BAPTA-sensitive source of Ca2+ is required for autophagy to proceed. These 
data show that that cytosolic Ca2+ has both suppressive and activating roles in the 
regulation of autophagy. The effectiveness of BAPTA-AM loading as a blocker of autophagy 
is the seemingly one universal finding in the Ca2+ and autophagy literature, and has been 
interpreted to mean that there is an essential, permissive Ca2+ signal at the core of the 
canonical autophagic pathway. Although, the source of Ca2+ signals chelated by BAPTA-AM 
has not been identified, its identification could provide a key mechanism for regulating 
autophagy in most cell types. Additional results in Chapter 4 supported the concept that 
Ca2+ uptake by mitochondria is vital for maintaining mitochondrial bioenergetics and 
consequently maintaining basal autophagy. Ca2+ oscillations were shown to occur in cells 
under nutrient replete conditions. These oscillations were inhibited in InsP3 5’-phosphatase 
expressing cells, supporting the notion that the pro-autophagic effect of the InsP3 5’-
phosphatase was to inhibit Ca2+ signals stimulated by the nutrients in the complete imaging 
medium, and that the nutrients themselves were not sufficient to suppress autophagy..  
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The findings in Chapter 5 revealed that a prolonged cytosolic Ca2+ signal via SOCE 
upregulated autophagy in HeLa and HEK cell lines. Given that the sustained SOCE-
dependent cytosolic Ca2+ increase is most cell types is ~100 nM, the Ca2+ sensor must have 
a high affinity for Ca2+. Depletion of ER Ca2+ stores did not acutely affect autophagy levels. 
However, the lack of autophagy induction by ER Ca2+ store release does not imply that Ca2+ 
release cannot trigger autophagy, rather that a prolonged Ca2+ signal (>15 minutes) is 
required. Ca2+ release from ER stores was not sufficient for rapamycin-induced autophagy, 
suggesting that autophagy caused by direct inhibition of mTOR also required constitutive 
Ca2+ signals. Ionomycin, however, did not have a significant effect on autophagy in HEK 
cells, despite evoking a similar prolonged cytosolic Ca2+ elevation to that seen with CPA. 
SOCE allows local Ca2+ signalling around the vicinity of a channel, whereas ionomycin gives 
a more global Ca2+ signal and therefore does not trigger effectors that are local to SOCE 
channels. Studies reporting the role of SOCE in autophagy are not entirely consistent. The 
findings in this study support the notion that SOCE is pro-autophagic; CPA-induced SOCE 
upregulated autophagy in HeLa cells through a CaMKK-α/β-dependent pathway. An anti-
autophagic role, which is also reported in literature, was not evident in our studies. 
However, one common finding with SOCE studies in autophagy is that the resulting 
autophagy acts to delay cell death, suggesting that extracellular Ca2+ is necessary to trigger 
cytoprotective autophagy.  
Whereas the published literature has shown Ca2+ to be either pro- or anti-autophagic in 
different cell types and experimental systems, the results presented here reveal the novel 
finding that Ca2+ exerted both suppressive and stimulatory effects in the same cell models. 
This is the first reported case where Ca2+ is having a dual role in the same study. Indeed a 
triple effect of Ca2+ was evident in this study with Ca2+ providing three different forms of 
control of autophagy; InsP3R-mediated Ca2+ signals were anti-autophagic via mitochondrial 
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effects (Chapter 4), SOCE-evoked Ca2+ signals were pro-autophagy in part via CaMKK2 
(Chapter 5) and BAPTA-AM was anti-autophagic for all stimuli (Chapters 3, 4 and 5). These 
findings provide additional evidence that Ca2+ is essential for both acute and chronic 
autophagy induction, and that it can have multiple roles in the same cells. Discrepancies 
between pro- and anti-autophagic Ca2+ roles reported in the literature are sometimes 
attributed to the use of differing cell lines/incubation times with Ca2+ modulators. The 
evidence gathered in this study implies that intracellular Ca2+ can indeed switch roles in the 
same cells depending on cellular conditions. Opposing observations in literature could be 
due to the behaviour of different cell lines used such as primary cell lines compared to 
immortal cell lines used in this study.  
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6.2 Future perspectives 
 
Collectively, the data in this thesis demonstrate that Ca2+ signals arising from different 
sources have contrasting effects on autophagy. Ca2+ release from InsP3Rs suppresses 
autophagy, plausibly by stimulating mitochondrial ATP production (Figures 4.1-4.4). 
Whereas, Ca2+ entry via SOCE stimulates autophagy, at least in part via activation of CaMKK-
β (Figure 5.18). Despite these findings, there is clearly more to understand about the 
regulation of autophagy by Ca2+. For example, the profound inhibitory role of BAPTA-AM 
loading on autophagy is presently unexplained (Figure 3.24). BAPTA-AM loading does not 
solely block autophagy in response to stimuli that elevate cytosolic Ca2+ concentration 
[290].Rather, BAPTA-AM blocks autophagy evoked by seemingly all stimuli, such as 
rapamycin which is a direct inhibitor of mTOR (Figure 3.24). The block of autophagy by 
BAPTA-AM must be proximal to phagophore formation, since BAPTA-AM loading prevents 
accumulation of autophagic vesicles rather than blocking their processing. These 
observations suggest that there is a critical Ca2+-dependent step required for the initiation 
of autophagy that is plausibly part of the core autophagy signalling pathway. 
Understanding the source and characteristics of the BAPTA-AM-sensitive Ca2+ signals are 
obviously critical to understanding how autophagy could be regulated in pathological 
conditions in which altered autophagic flux would be desired.  
The induction of autophagy following activation of SOCE, but not by ionomycin (Figures 5.2 
and 5.3), is consistent with a scheme in which local Ca2+ signals arising near to the mouth 
of Orai or TRP cation channels activate signalling pathways leading to autophagy. It is 
becoming apparent that TRP, Orai and STIM proteins can associate with multiple accessory 
protein partners [438], and it is plausible that local Ca2+ signals activate an as yet unknown 
signalling  pathway (containing CaMKK-β) that leads to the activation of autophagy. Further 
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work is required to establish how the SOCE-CaMKK-β-autophagy pathway functions within 
cells, and whether there are other signalling components in the pathway.  
Additional studies are required to establish the role of other Ca2+ sources and channels in 
the regulation of autophagy. For example, endosomes/lysosomes have been proposed as 
a Ca2+ store that modulates autophagy, potentially with Ca2+ being release by two-pore 
channels (TPCs) [325, 439]. Preliminary experiments were conducted in this study to 
investigate the role of TPCs, which indicated that they may have a significant role in the 
regulation of autophagy, but a lack of time precluded a full investigation. Rapamycin- and 
nutrient starvation-induced autophagy was inhibited in TPC 1/2 knockout murine 
embryonic fibroblast cells (MEF cells) (Figure 6.1).  Additionally, it was observed that TPC-/- 
cells showed signs of cell death following starvation.   
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Figure 6.1. Rapamycin and nutrient starvation did not stimulate autophagy in two-pore channel 
null (TPC-/-) MEF cells. Autophagy was monitored by transiently transfecting the MEF cells with GFP-
LC3. Panel A shows representative images of wild-type (WT) and TPC-/- cells in complete imaging 
medium. Panel B shows images of WT and TPC-/- cells incubated with rapamycin (1 µM for 1 hour). 
Panel C shows images of WT and TPC-/- cells in starvation medium (2 hours). Panel D shows images 
of WT and TPC-/- cells, where TPC-/- cells showed signs of cell death when nutrient starved in two 
out of three independent experiments. Panel E is a quantitative representation of the effect of 
rapamycin and nutrient starvation on autophagy in WT and TPC-/- cells; rapamycin and nutrient 
starvation increased autophagy in WT but not in TPC-/- cells. The data are mean ± S.E.M of 3 
experiments (25 - 50 cells per condition). The data were analysed with one-way ANOVA. ** 
indicates p < 0.01. The scale bar in Panels A, B and C indicate 10 µm.  
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Whilst GFP-LC3 provided a reliable and convenient method for assessing autophagy in this 
study, it would be beneficial to develop other quantitative measures of autophagic flux. A 
considerable amount of effort was given to using Western blotting, but the results were 
rather mixed. In particular, with Beclin-1 and p62, which have been used with Western 
blotting in other studies. Beclin-1 is vital for the initiation of autophagy, and has been 
widely used as a marker for autophagy in studies using Western blotting, alongside LC3 
[440]. Beclin-1 is involved in sensitisation of InsP3Rs [441] which is essential in increasing 
autophagic flux. Expression of Beclin-1 is expected to increase upon induction of autophagy 
[171, 172]. Western blots were carried out to determine Beclin-1 expression in HeLa cells 
following InsP3 5’‐phosphatase transfection, however, results showed an unexpectedly 
decreased expression (Figure 6.2), and should be repeated in future studies.  
p62, another commonly used marker of autophagy, was also evaluated. Since p62 is 
constantly degraded, p62 levels are expected to decrease with autophagy induction making 
it a popular choice for determining the autophagic flux. However, in this study, Western 
blotting for p62 was found to give inconsistent results; p62 expression levels were 
increased when they were expected to decrease, and vice versa (Figure 6.2). This work was 
performed in the laboratory of Dr Geert Bultynck (KU Leuven, Belgium), and other 
members of the lab had found that p62 could be an unreliable marker for autophagy. Due 
to time constraints, this marker was not further used in this study, but it would be ideal to 
resolve the use of p62 as an autophagy marker in future work.   
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Figure 6.2. Western blotting for Beclin-1 and p62 expression in HeLa cells. Panels A and B show 
Western blot analysis for Beclin-1 and p62, with GAPDH and vinculin used as loading controls. The 
Western blots were performed using protein lysates obtained from HeLa cells superfused with 
complete imaging medium (control), and treated with 1 µM rapamycin ( 1 hour) or transfected with 
1 µg InsP3 5’-phosphatase for 12 -24 hours. 
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The induction of autophagy by Ca2+ has been shown to occur via a few signalling pathways, 
including AMPK. The results in Chapter 4 reveal that methyl pyruvate suppressed the 
autophagy increase in InsP3 5’-phosphatase-expressing cells. Whilst these observations 
suggest that the main effect of the InsP3 5’-phosphatase was to reduce mitochondrial 
bioenergetics and ATP production, further studies are required to ensure that cellular ATP 
levels were indeed restored by methyl pyruvate treatment, and to test whether AMPK, 
which is sensitive to the AMP: ATP ratio inside cells, was mediating the effect of InsP3R 
inhibition on autophagy. Additionally, studying mitochondrial bioenergetics in more detail 
(with the use of a Seahorse analyser) could give us insights into the metabolic and 
enzymatic processes in cells with treatments which modify ER-mitochondrial Ca2+ 
signalling. 
Exploring additional cellular systems, such as primary cell lines, might prove beneficial for 
the further understanding of how Ca2+ signals exert its dual role in autophagy.  Differences 
in the kinetics, amplitude or spatial extent of cytosolic Ca2+ signals presumably determine 
a pro- or anti-autophagic fate.  
If the opportunity arises, investigating the relationship between autophagy and Ca2+ in 
disease states in vivo would be one vision.  This research would allow the translation some 
of the findings in this thesis into therapeutic use, by looking at autophagy and Ca2+ in 
combination as potential approach for manipulating Ca2+ permeable channels and 
autophagy levels. Possibly the use of compounds such as HCQ, which is already approved 
by the FDA together with well-known inhibitors or activators of Ca2+ permeable channels 
might give insights into the best compound combinations for specific desired autophagy 
outcomes needed in relation  to a particular state of a disease. 
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